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Abstract 
Adult bone marrow contains a population of mesenchymal stem cells capable 
to self-renew and to differentiate into haematopoietic-supportive stroma, osteo, 
adipo- and chondrocytes. However, the identity of mesenchymal stem cells still 
remains uncertain. The complex population of their descendants, bone marrow 
mesenchymal stromal cells (BM MSCs), represents a model to study the principles of 
differentiation and commitment into mesodermal lineages. The experiments using 
BM MSCs are often hampered by their low proliferative capacity in vitro. In the 
present study, we established conditionally immortalized BM MSCs from tetracycline-
regulated SV40 Large T-antigen transgenic mice. The identity of the conditionally 
immortalized BM MSCs was confirmed by marker expression, ability to support 
haematopoiesis and differentiation potential. The advantages of the conditional 
immortalization are encompassed in (1) indefinite expansion of cell populations, (2) 
possibility to perform cellular cloning and (3) prevention from spontaneous 
differentiation. 
We demonstrated the heterogeneity of BM MSCs and identified at least 6 
types of progenitors within BM MSCs population based on their differentiation 
potential (“OAC”, “OA”, “OC”, “AC”, “O”, “A”). A hypothetical model of BM MSC 
hierarchy and the relationships between the progenitors has been proposed. 
We observed that the Wnt/β-catenin signaling pathway and GSK3 activity 
could modulate the efficiency of osteo- and adipogenic differentiation pathways, but 
we didn’t find evidence that the lineage commitment of BM MSCs is determined by 
Wnt.   
We elucidated the mechanism of transcriptional regulation of the adipogenic 
induction of BM MSCs in vitro. Our data revealed the key regulatory role of PPARγ1 
during adipogenesis in BM MSCs. Furthermore, we assume that PPARγ1 is a 
potential trigger of the adipogenic commitment of the BM MSCs progenitors. Finally, 
the non-adipogenic BM MSCs progenitors were converted into the adipogenic 
lineage using ectopical expression of the transcription factors C/EBPα, C/EBPβ and 
C/EBPδ. Our findings provide a novel insight into the molecular mechanisms of BM 
MSCs lineage commitment. 
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1. Introduction 
 Bone marrow represents a complex structure combined of two interacting 
tissues, haematopoietic and stromal. Haematopoietic tissue within the bone marrow 
generates all blood lineages, and in mammals serves as the only permanent source 
of blood cells in the adults. Bone marrow stroma plays an integral role providing a 
mechanical support for haematopoietic tissue and regulatory signals supporting the 
blood homeostasis. At the same time stromal cells have the function on their own, 
which is to form the skeletal tissues and differentiate into the cells of mesodermal 
origin: osteocytes, adipocytes, chondrocytes. Those two compartments, 
haematopoietic and stromal, are distinct and interdependent, therefore often 
considered in parallel. Haematopoietic system has one of the fastest turnovers in the 
organism. Little is known about the cycling of the stroma itself, but the skeleton as a 
derivative of stromal progenitors is renewed about 3-5 times during the life. 
Haematopoietic tissue is formed by haematopoietic stem cells, which are well 
defined phenotypically and physiologically. The existence of self-renewing stem cells 
within the stroma was proven in the experiments maintaining the intact bone marrow 
tissue, but for a long time those cells have not been identified in situ and have not 
been obtained as a pure cell population in vitro. The main obstacle for the 
experiments in cell culture conditions was the low proliferation capacity of stromal 
cells. At the same time, the low migratory capacity and engraftment potential restrict 
in vivo transplantation assays, which are the only ones rigorously proving the self-
renewal and hence stemness. As a result, till latest years the stem cells within bone 
marrow stroma were actually defined neither by marker expression nor by 
physiological properties. According to the current nomenclature, the cell populations 
from stroma should be called Bone Marrow Mesenchymal Stromal Cells (BM MSCs), 
and Mesenchymal Stem Cells might exist as a subset of this cell population. 
Although BM MSCs in vitro represent a mixed cell population of the 
mesenchymal stem cells progeny, they still can serve as a relevant model to study 
stroma functions, origin and homeostasis. Those cells support haematopoiesis in 
vitro and differentiate into mesenchymal lineages. Additionally to application in 
fundamental studies, BM MSC properties in vitro promoted them in the category of 
cells that have an invaluable therapeutic potential.  
In this literature review we aimed to describe the original studies from the 
past, which formed understanding of the main principles of bone marrow stroma 
biology, and to present the current state of the art in this field. Particularly, we will 
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concentrate on the mechanisms of differentiation of BM MSCs. Special attention will 
be paid to the heterogeneity of BM MSCs, as a mixed population of the cells with 
different differentiation potential. 
The second part of the introduction will be dedicated to the strategies 
efficiently used to study cell populations. In particular, we will consider the cellular 
immortalization method as a powerful tool for cell expansion. 
 
1.1 Bone marrow mesenchymal stromal cells  
1.1.1. Bone marrow stroma structure and developmental origin 
Bone marrow stroma is located in the cavity of the bones between the 
sinusoidal walls and endosteum, and includes the cells, which do not belong to 
haematopoietic lineage, Fig. 1 (Krebsbach, Kuznetsov et al. 1999; Bianco and 
Gehron Robey 2000). The bone marrow stroma is a heterogeneous tissue composed 
of the different cell types and extracellular matrix, which form a complex three-
dimensional network. The cellular elements of the bone marrow include reticular cells 
(or adventitial cells, or Westen-Bainton cells), marrow adipocytes, osteoblastic cells, 
fibroblasts, and other cell types. The cellular composition of stromal tissue is dynamic 
and strongly depends on the age and physiological state of the organism. The 
reticular cells are important myelosupportive elements of haematopoietic 
microenvironment. They are located along the sinusoidal walls and phenotypically 
represent pericytes. These cells are able to convert into osteoblasts and adipocytes 
in vivo (Bianco, Costantini et al. 1988) and probably contain the population of marrow 
stem cells.  
The osteoblasts form the bone tissue and possibly build the niche for the 
haematopoietic stem cells (Zhang, Niu et al. 2003). Bone marrow adipocytes differ 
from the adipocytes of the other sites of the body. It is known that these adipocytes 
do not supply a reserve of energy and do not loose the fat inclusions during 
starvation (Tavassoli 1974). Recently it was shown that marrow adipocytes 
contribute to the negative regulation of haematopoiesis by repressing the 
proliferation of haematopoietic progenitors (Naveiras, Nardi et al. 2009). Possibly, the 
balance between the osteoblastic and adipocytic differentiation of marrow stem cells 
provides the regulation of haematopoiesis in the bone marrow. 
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During embryonic development the stroma is established after the bone 
rudiment has formed. The precursors of stromal cells are located outside in the 
periosteum, and have characteristics of osteoblasts. The osteoclasts erode the bone 
tissue to form the bone cavity allowing the vessels invasion, which guides the 
migration of the osteogenic cells, and those cells have perivascular location (as 
pericytes). When the primitive haematopoietic microenvironment is established inside 
the bone, the blood-borne haematopoietic stem cells migrate to complete the bone 
marrow formation (Bianco and Gehron Robey 2000). 
The ontogeny of the stem cells within bone marrow stroma is much less 
understood. The development of primitive embryonic bone marrow stromal tissue 
from the periosteum suggests that the stromal stem cells might evolve from the 
osteogenic cell population. It was shown that different cells in the bone marrow 
stroma express markers implicated in the early bone development (runt-related 
transcription factor 2, RUNX2), independently of their osteogenic properties 
(Satomura, Krebsbach et al. 2000). Hence, this might indicate that the stromal stem 
cells arise from the cells that have been committed to the osteogenic lineage in the 
embryo and maintain the expression of RUNX2 as an “imprint” of their origin. But the 
mechanism of stromal stem cells development might be more complex. Using the 
cell fate mapping approach in mouse embryonic stem cells and mice, it was 
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demonstrated that stromal stem cells originate from different sources, and the 
earliest wave of those cells in the embryo rises from neuroepithelium and neural 
crest (Takashima, Era et al. 2007; Morikawa, Mabuchi et al. 2009). However, the 
presence of neural crest-originated stromal stem cells in the adults remains 
controversial. The fact that stromal stem cells have multiple origins may explain the 
heterogeneity of stromal cell population and phenomenon of plasticity, which we will 
discuss in the further chapters. 
 
1.1.2. Identity of bone marrow mesenchymal stromal cells 
 The evidence for the osteogenic potential of bone marrow was known long 
time ago. However, the particular elements responsible for the formation of bone 
tissue were not identified. The important information about non-haematopoietic cells 
with the properties of stemness appeared in the 1960-70s. It was shown that 
ectopical transplantation of the bone marrow cylinder subcutaneously or under the 
renal capsule leads to the formation of bone structure with fully functioning bone 
marrow (the terms usually used for this structure are “ossicle” or “haematopoietic 
foci”) (Friedenstein, Piatetzky et al. 1966; Friedenstein, Petrakova et al. 1968; 
Tavassoli and Crosby 1968). The cellular components of haematopoietic tissue were 
identical to the bone marrow in the regular sites, but the interesting finding was that it 
was originating from the cells of the host. On the contrary, the stromal tissue and the 
bone were formed from the cells of donor transplant. The formed foci were present in 
the site of transplantation indefinitely long during the life of the host. The 
descendants of the transplanted cells could not be found in the other tissues. Finally, 
the marrow from the ossicle could be passaged through the series of hosts virtually 
indefinitely. The conclusions from the series of those pioneer works were (1) the 
existence of elements in the bone marrow, which can differentiate into the bone 
tissue, (2) the existence of components, which attract HSCs from the host and 
support haematopoiesis, (3) the cells with osteogenic differentiation potential and the 
cells with haematopoietic supportive function can self-renew presuming stemness, 
and (4) it was most likely that the non-haematopoietic stem cells cannot migrate and 
be recruited to the host tissues. At the same time whether those properties are 
possessed by the same cell and which kind of cell was not known. The breakthrough 
was done in the studies of Friedenstein (Friedenstein, Deriglasova et al. 1974). It 
was found that plating of the bone marrow in the low density leads to the formation of 
single-cell derived clones of fibroblastic cells (colony forming units-fibroblasts, CFU-
F’s). Those cells could induce the formation of heamatopoietic foci in the ossicle 
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upon transplantation. Importantly, single-cell derived clone could establish the bone 
tissue and induce the marrow, connecting those two functions in one cell type. 
Hence, the existence of stem cells supporting haematopoiesis and differentiating into 
the bone tissue was proved. The clonogenic presursors of CFU-F’s within bone 
marrow were termed “stromal stem cells” or “osteogenic stem cells” (Owen and 
Friedenstein 1988). 
 Since that time a number of studies concerning stromal stem cells appeared, 
attempting to improve methods for isolation, to find a set of surface markers 
(Gronthos, Graves et al. 1994), to characterize differentiation potential (Ashton, Allen 
et al. 1980; Bennett, Joyner et al. 1991) and to elucidate the role in regeneration 
(Haynesworth, Goshima et al. 1992). The evidence grew that stromal stem cells can 
differentiate into multiple lineages including osteocytes, adipocytes, chondrocytes, 
fibroblastic tissues, myocytes. Summarizing all accumulating information, Caplan 
proposed the concept of “mesenchymal stem cell” as a cell from adult bone marrow 
capable for multilineage differentiation (Caplan 1991; Caplan 1994), and this was the 
moment when the “mesenchymal stem cell” term was applied for stromal stem cells. 
Some years later Pittenger and colleagues reported the isolation of homogeneous 
population of mesenchymal stem cells from human bone marrow and hence, the 
validation of the concept (Pittenger, Mackay et al. 1999). They described plastic-
adherent cells from the bone marrow stroma, which proliferated extensively, were 
characterized by the expression of the markers SH2, SH3, CD29, CD44, CD71, 
CD90, CD106, CD120a, CD124. These cells were able to form osteocytes, 
adipocytes and chondrocytes in vitro. Remarkably, single-cell derived lines were also 
obtained and tested for the differentiation, and around 1/3 (2 out of 6) showed tri-
potential differentiation. However, self-renewal, an essential property of stem cells, 
has not been demonstrated. Hence, the actual stemness of “mesenchymal stem 
cells” was not completely proven.  
This work was a milestone of the whole stromal stem cell field and was 
followed by a huge increase of the interest to those studies. Despite the historical 
and scientific significance, some confusion was generated and for a long time the 
term “mesenchymal stem cell” was not subjected to doubts and widely and often 
inappropriately used (Bianco, Robey et al. 2008). The methods for isolation were not 
standardized and the criteria to define the population as “mesenchymal stem cell” 
were not considered. As a result, a lot of discrepancies appeared in the literature. In 
2006 the scientific community postulated that the cell populations isolated from bone 
marrow stroma should be called “Mesenchymal Stromal Cells” (MSCs) and not “stem 
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cells” until stemness at the single-cell level is proved, and defined minimal criteria for 
characterization of MSCs (Dominici, Le Blanc et al. 2006). 
 Here we will use the term “MSC” for “mesenchymal stromal cells”, and in turn 
“mesenchymal stem cells” will be specially noted, when appropriate. We will give a 
brief review on some basic properties of MSCs in vitro, without aiming to include all 
vast information circulating in the literature. Despite undoubted importance of the 
therapeutic potential and application of MSCs (Horwitz, Prockop et al. 1999; Le 
Blanc, Frassoni et al. 2008), those topics are not included since they are not relevant 
to the object of our study and have been described in detail elsewhere. 
 
1.1.3. Sources of mesenchymal stromal cells 
 Mesenchymal stromal cells were identified first in the bone marrow (BM 
MSCs); nevertheless a large number of studies were dedicated to isolation of MSCs 
from the other tissues of mesodermal origin. Cells with properties of MSCs were 
obtained from human lipoaspirates (Zuk, Zhu et al. 2001; Zuk, Zhu et al. 2002). The 
comparison of those cells with BM MSCs revealed many similarities in the potential 
and marker expression (De Ugarte, Morizono et al. 2003). For the moment it is not 
exactly known whether those cells are identical to BM MSCs by the function in the 
organism and how close they are in their developmental origin. This reasoned to 
name MSC-like cells from adipose tissue as “adipose-derived stromal cells” (ADSC). 
 The cells similar to BM MSCs and ADSCs were also isolated from bone 
(Nakahara, Goldberg et al. 1991), tendon (Bi, Ehirchiou et al. 2007), umbilical cord 
blood (Erices, Conget et al. 2000), umbilical cord (Romanov, Svintsitskaya et al. 
2003), placenta (In 't Anker, Scherjon et al. 2004) and other tissues. At the same 
time, the comprehensive analysis and comparison of those cells with similar 
properties has never been performed. It cannot be excluded that the related or even 
identical progenitor cells reside in many mesodermal tissues maintaining the 
homeostasis and regeneration of the hosting tissue (Caplan 2008; Ratajczak, Zuba-
Surma et al. 2008). On the other hand, the similarity in properties can be a result of 
cell culture methods artifacts. However, the origin and the properties of those cells 
have to be thoroughly studied to make a conclusion. 
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1.1.4. Isolation of bone marrow mesenchymal stromal cells 
 Different isolation procedures are applied to derive MSCs from the bone 
marrow. The basic property of stromal cells in the bone marrow is plastic adherence 
(despite other cell types like macrophages can also attach). The bone marrow can be 
plated as a whole cell suspension or after centrifugation in the Percoll or Ficoll 
gradient to isolate mononuclear fraction (Haynesworth, Goshima et al. 1992; 
Pittenger, Mackay et al. 1999). The negative selection to deplete haematopoietic 
cells from the leukocyte (CD45+) and erythrocyte lineage (TER199+ or GlyA+) is 
widely used. The positive selection for different markers can enrich the MSC 
population (CD90, CD105), but specifically might be applied for isolation of the 
specific subsets of cells, described below in details. 
 The cell density of the primary culture has a significant influence to the 
properties of MSC culture. As initially was discovered, MSC represent population of 
clonogenic cells, hence, the bone marrow should be plated at a low density (105-106 
cells per 10cm dish) to select for the cells capable to grow in the density-independent 
manner. Plating of the bone marrow with higher density enables more committed 
cells from stroma to survive and grow in the monolayer (Sacchetti, Funari et al. 
2007). Hence, the population from high-density cultures is more heterogeneous and 
might contain more progenitors than stem cells. 
It should be noted that most of the methods were developed for the cells from 
human bone marrow, and work with the mouse tissues is still obstructed with many 
difficulties (Sun, Guo et al. 2003; Peister, Mellad et al. 2004). The cells have much 
less proliferative potential and stop growing very fast. One of the possible 
explanations was proposed that mouse bone marrow cultures are contaminated with 
macrophages and other blood cell types more substantially than the human ones 
(Krebsbach, Kuznetsov et al. 1999; Tropel, Noel et al. 2004). Another possibility 
could be that murine equivalents of the human BM MSCs require the presence of 
unknown growth factors. 
 
1.1.5. Markers of bone marrow mesenchymal stromal cells 
 The absence of the specific markers defining BM MSCs was always a serious 
obstacle for the isolation, studies in vitro and search for BM MSCs in situ. BM MSCs 
can be characterized by a set of surface molecules, but none of them can specifically 
recognize BM MSCs from the other cells types. According to the accepted rules 
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(Dominici, Le Blanc et al. 2006), populations of BM MSCs should express CD105, 
CD73 and CD90, and lack the expression of CD45, CD34, CD14 or CD11b, CD79α 
or CD19 and HLA-DR. Specific subpopulations of BM MSCs defined by the markers 
will be described in the other chapters. 
 
1.1.6. Differentiation of bone marrow mesenchymal stromal cells 
 One of the basic properties of BM MSCs is the ability to differentiate in vitro 
into the cells of mesodermal origin, at least to osteocytes, chondrocytes and 
adipocytes. Most of the protocols of in vitro differentiation were established for the 
human BM MSCs, but from our experience can be translated to mouse cells 
(Anastassiadis, Rostovskaya et al. 2010). The fundamental mechanisms of 
differentiation can be studied using an in vitro model. The next chapter will be 
dedicated to the differentiation of BM MSCs, the molecular control and mechanisms 
of in vitro induction. Most of the information in the literature is devoted to the osteo- 
and adipogenesis, thus those pathways will be discussed more detailed. 
 
1.1.6.1. Adipogenic induction and molecular control of adipogenesis 
 The mechanism of adipogenic induction in vitro is probably the best 
understood amongst the lineages of MSC differentiation. For a long time it was 
intensively studied on the alternative model, adipogenic clones of 3T3 fibroblasts L1 
and F442A, which provided a lot of information on the adipogenic induction in vitro 
(Green and Meuth 1974). It has to be taken into consideration that those clones of 
fibroblasts were selected specifically for their ability to generate adipocytes, and the 
exact identity of these cells and the relevance to the adipogenic differentiation of 
MSCs is not obvious. The protocols for adipocyte induction of L1 and F442A are not 
identical to the one for MSCs and also differ from each other (Wu, Xie et al. 1995).  
The regulation of adipogenic differentiation involves numerous positive and 
negative signals, which interact to keep a controlled balance (Fig. 2). The activation 
of adipogenic program involves the cooperation of transcription factors, PPARγ 
(peroxisome proliferator-activated receptors) and C/EBP family (CCAAT-enhancer 
binding proteins, (Wu, Bucher et al. 1996; Wu, Rosen et al. 1999)). PPARγ is a 
known master gene for adipogenesis (Tontonoz, Hu et al. 1994). There are 2 
isoforms, PPARγ1 and PPARγ2. PPARγ1 is widely expressed in the tissues, whereas 
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PPARγ2 is restricted to the adipose tissue. Those 2 isoforms perform the same 
function during adipogenesis, but γ2 was found to be more active (Mueller, Drori et 
al. 2002). PPARγ forms heterodimers with RXRα (retinoid X receptor α) and in the 
presence of activators regulates the transcription of genes responsible for lipid 
methabolism and adipocyte development. PPARγ is an orphan receptor and natural 
ligands for it were not identified, although there is an evidence of their existence 
(Kim, Wright et al. 1998). It was shown that prostaglandins could activate PPARγ, 
although in the concentrations that are non-physiological. The synthetical activators 
are thiazolidinediones (TZDs, rosiglitazone, troglitazone).  
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C/EBP’s are a family of transcription factors that contain basic-leucine zipper 
domain (bZIP) that is involved in dimerization and DNA binding. The expression of 
different C/EBP’s is not restricted to the particular tissues, but the combination of 
them might be tissue-specific. C/EBPα plays an important role in terminal adipocyte 
differentiation. C/EBPα activates the expression of some genes involved in 
adipogenesis in cooperation with PPARγ, in turn C/EBPα and PPARγ cross-activate 
each other. Ectopical expression of C/EBPα and PPARγ is enough to stimulate the 
adipogenesis in fibroblasts even in the absence of PPARγ ligands (Tontonoz, Hu et 
al. 1994). At the same time the role of C/EBPα and PPARγ is not redundant, and 
PPARγ is believed to be the main activator of adipogenesis in fibroblasts. This was 
demonstrated in the fibroblasts lacking one of those factors. Both C/EBPα-/- and 
PPARγ-/- cells fail to undergo adipogenesis. Adipogenic properties of C/EBPα-/- 
fibroblasts can be rescued by ectopical expression of PPARγ, but not the other way 
around indicating that adipogenesis can occur in the absence of C/EBPα, but PPARγ 
is essential (Rosen, Hsu et al. 2002). 
C/EBPα is expressed in two isoforms, 42kDa and 30kDa. This is one exon 
gene and the alternative splicing cannot take place, the generation of the two 
isoforms occurs through the alternative ATG. Presumably, 30kDa isoform can act as 
a dominant-negative regulator of 42kDa (Ramji and Foka 2002). 
C/EBPβ and C/EBPδ stand upstream of C/EBPα and PPARγ. It was shown 
that glucocorticoids could induce C/EBPδ, which forms heterodimers with C/EBPβ, 
and this was enough for initiation of PPARγ and C/EBPα expression (Wu, Bucher et 
al. 1996). Conditional ectopical expression of C/EBPβ in non-adipogenic cells 
(fibroblasts and myoblasts) can induce adipogenesis, whereas C/EBPδ was not 
efficient (Wu, Xie et al. 1995). 
Several isoforms were shown for C/EBPβ, larger 38kDa and 35kDa (liver-
activated protein, LAP), and smaller 21kDa (liver inhibitory protein, LIP) and 14kDa. 
The smaller isoforms are lacking the transactivation domain and cannot activate 
transcription of downstream genes. Those isoforms can form complexes with 
C/EBPδ, but stay inactive and serve as dominant-negative forms. Particularly, it is 
known that expression of LIP blocks adipogenesis. It is interesting, that the gene of 
C/EBPβ has one exon, and the formation of isoforms occurs similarly to C/EBPα, 
through the alternative ATG usage (Ramji and Foka 2002; Farmer 2005). 
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Later two other factors were suggested to participate in the cascade of 
adipogenic induction, Krox20 and Klf5. Zinc finger-containing transcription factor 
Krox20 (early growth response-2, Egr-2) was induced during the first minutes of 
adipogenic stimulation in vitro, and presumably was responsible for activation of 
C/EBPβ expression (Chen, Torrens et al. 2005). Klf5 (krueppel-like factor 5) was 
upregulated by C/EBPβ and C/EBPδ and in concert with C/EBPβ;C/EBPδ complex 
could activate the expression of PPARγ (Oishi, Manabe et al. 2005). Taken together, 
the complex system of transcriptional factors activating expression of adipogenic 
genes and each other is involved in the induction of the differentiation.  
The negative regulation of adipogenesis particularly involves Wnt/β-catenin 
signaling (wingless-type MMTV integration site), Fig. 3. Wnt’s are the family of 
secreted paracrine and autocrine factors that regulate cell growth and cell 
differentiation. The canonical and non-canonical Wnt pathways are described, and 
canonical Wnt/β-catenin pathway is believed to play an important role in the 
regulation of adipogenesis (Prestwich and Macdougald 2007). Wnt signal is 
transmitted through Dishevelled proteins that inhibits the kinetic activity of the 
complex containing glycogen synthase kinase 3 (GSK-3), axin, adenomatosis 
poliposis coli (APC) and other components. In the absence of Wnt signaling, GSK-3 
complex phosphorylates β-catenin targeting it to the proteasomal degradation. When 
Wnt binds to its receptor Frizzled (Fz) and the kinetic activity of GSK-3 is inhibited, 
unphosphorylated β-catenin is stabilized, translocates to the nucleus and forms the 
complex with T-cell factor/lymphoid-enchancing factors family (TCF/LEF’s) activating 
the trascription of downstream genes (Nelson and Nusse 2004). 
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Pre-adipocytic fibroblast lines L1 and F442A express Wnt10b and Wnt 
receptors, Fz-1, 2 and 5. It was suggested, that active endogenous canonical Wnt 
pathway prevents 3T3-L1 cells from adipogenic differentiation. Ectopical expression 
of the canonical Wnt1 blocks adipogenic properties of L1 cells. The expression of 
C/EBPβ and C/EBPδ was not affected, but C/EBPα and PPARγ were largely 
repressed. Additional ectopical expression of C/EBPα and PPARγ could rescue the 
differentiation potential of L1-Wnt1 cells (Ross, Hemati et al. 2000). These data were 
confirmed by activation of Wnt/β-catenin pathway using GSK3 inhibitors such as 
lithium chloride and CT99021 (Bennett, Ross et al. 2002). The differentiation of L1 
cells was sensitive to the inhibition of GSK3 on the early stages (1-3 days of 
induction), but was not susceptible later anymore. This was correspondent to the 
time of initiation of C/EBPα and PPARγ expression. The authors concluded that Wnt 
blocks the establishment of C/EBPα and PPARγ expression, but once the expression 
is established, then it is maintained. Conversely, during the adipogenic induction of 
3T3-L1 cells PPARγ suppresses Wnt/β-catenin signaling allowing differentiation to 
proceed (Moldes, Zuo et al. 2003). Hence, there is a reciprocal relationship between 
PPARγ and Wnt in the maintenance of balance between 
differentiated/undifferentiated state. 
Inactivation of Wnt/β-catenin pathway by the expression of dominant-negative 
form of TCF4 in myogenic cell line C2C12 caused the spontaneous differentiation of 
myoblasts into adipocytes (Ross, Hemati et al. 2000). Those data suggested that 
canonical Wnt pathway might function as the main adipogenic switch in the cells. 
Adipogenic differentiation of BM MSCs can be induced by hormonal coctail of 
dexamethasone, methyl-isobutyl-xanthine (MIX), indomethacin and insulin (Sekiya, 
Larson et al. 2004), Fig. 2. The role of dexamethasone is to enhance the expression 
of C/EBPδ. MIX is a phosphodiesterase inhibitor, which inhibits cAMP decay. This 
results in the activation of protein kinase A (pkA)-dependent and pkA-independent 
signaling (Martini, Plaza et al. 2009). The pkA-dependent mechanism leads to the 
translocation of CREB (cAMP-responsive element binding protein) to the nucleus 
and hence, to the activation of C/EBPβ expression. Another effect is the production 
of PPARγ cellular ligands, which are not identified yet (Farmer 2005). Indomethacin 
itself can also serve as a ligand for PPARγ (Lehmann, Lenhard et al. 1997). 
Alternative protocol suggests the use of dexamethasone, troglitazone and insulin for 
the differentiation. Troglitazone is a synthetic agonist of PPARγ, which can substitute 
MIX and indomethacin. The main morphological sign of the differentiation is the 
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accumulation of oil drops in the cytoplasm, which can be visualized by Oil Red 
staining. The main markers used to verify adipocytes are adipsin, adiponectin, AP2 
(adipocyte protein 2), PEPCK (phosphoenolpyruvate carboxylase), LPL (lipoprotein 
lipase). 
 
1.1.6.2. Osteogenic induction and molecular control of osteogenesis 
 Most of the information about the transcriptional control of osteogenesis rises 
from the studies of the phenotypes of mutant mice. However, most of the effects are 
associated with osteogenesis in the embryo, and this makes it difficult to separate 
the role of those factors during the osteogenesis from adult BM MSCs. Nevertheless, 
the expression of main transcription factors and markers during osteogenic 
differentiation of BM MSCs in vitro reproduces the ones during embryonic bone 
formation, suggesting that the main principles may be translated (Fig. 4A). 
  The key regulator of osteoblast development in vivo is Runt-related 
transcription factor 2 (RUNX2, also known as Cbfa1, AML3 or PEBP2αB). RUNX2 is 
expressed in chondrogenic mesenchyme in the embryo, chondrocytes, hypertrophic 
chondrocytes and the whole osteoblastic lineage. RUNX2 forms heterodimers with 
Cbfb and activates transcription of osteoblast-specific genes. The RUNX2 null-
mutant mice die just after birth and lack completely bone formation (Komori, Yagi et 
al. 1997). The skeleton of RUNX-/- mice is built exclusively from the mesenchymal 
tissue, which is not maturated into the cartilage, and hypertrophic chondrocyte 
differentiation was inhibited. Similar phenotype was observed in mice deficient for 
Osterix (Osx), which is a zinc-finger transcription factor expressed specifically in 
osteoblasts (Nakashima, Zhou et al. 2002). The skeletal tissue of these mutants was 
structured to chondrogenic phenotype. In Osx-null mutants the level of RUNX2 was 
comparable to the wild type, whereas Osx was not detected in RUNX-/- mice 
indicating that these factors belong to one pathway, but Osx is downstream of 
RUNX2. It was suggested that the osteoblasts in Osx-mutants are arrested in the 
development and acquire the phenotype of chondrocytes expressing Sox9, Sox5 and 
Collagen II. The formation of hypertrophic cartilage was not affected in Osx-null mice. 
These data allowed to propose a model of the embryonic bone development 
(Nakashima and de Crombrugghe 2003). Osteoblast progenitors differentiate into 
pre-osteoblasts and RUNX2 plays an essential role in this process (Fig. 4B). Those 
pre-osteoblasts are bi-potential and could develop into both osteo- and 
chondrocytes. Osterix is required to commit the cells into mature osteoblasts and to 
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restrict from chondrocyte phenotype. In the absence of RUNX2 osteoblasts and 
chondrocytes  cannot be formed, and knockout of Osterix blocks the specification to 
osteoblasts and the cells adopt the phenotype of chondrocytes. 
 
 
The signaling pathways modulating osteogenesis are far from clear 
understanding. Mitogen-activated protein kinase family members, MAPK, were 
shown to enhance the osteogenic potential of pre-osteoblasts in vitro by the positive 
regulation of RUNX2 (Xiao, Jiang et al. 2000). Wnt has an evident role in the 
regulation of osteogenesis, however the reported effects of Wnt’s are often 
controversial, depending on the model used in the study. Ectopic expression of the 
canonical Wnt10b in bi-potential ST2 cells led to the inhibition of adipogenic potential 
and enhancement of osteogenic properties (Kang, Bennett et al. 2007). This is in 
agreement with the observation that mice mutant for Lrp5, a co-receptor of Wnt, have 
impaired bone development (Krishnan, Bryant et al. 2006). The other studies on 
primary BM MSCs suggested an inhibitory effect of exogenous Wnt1 and Wnt3a on 
the osteogenic differentiation (Baksh, Boland et al. 2007; Liu, Vijayakumar et al. 
2009). The reason for such discrepancy is unclear. In the context of different models, 
cell lines and cell culture conditions, it is difficult to compare the results of the 
experiments. It cannot be excluded that the effect of Wnt on the osteogenesis might 
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be stage-specific or concentration-dependent (De Boer, Wang et al. 2004). In this 
case it is not possible to make a clear conclusion using constitutive overexpression 
assays or exogenous factors. 
Osteogenic differentiation of BM MSCs can be induced in subconfluent 
cultures by adding dexamethasone, ascorbic acid and β–glycerophosphate. The cells 
undergo the stage of transient proliferation until they reach monolayer, and then stop 
proliferating and differentiate terminally after 3-4 weeks. The differentiation is usually 
accompanied by the synthesis of extracellular matrix composed of collagen I and 
calcification of the matrix. Calcification of the matrix visualized by histological staining 
(Alizarin Red or Von Kossa) serves as the most often used validation of 
differentiation. It is unlikely that differentiation conditions in vitro reflect physiological 
signals in vivo. According to some studies, bone morphogenic proteins promote the 
bone growth. It was shown that BMP-2 and BMP-6 (bone morphogenic proteins 2 
and 6) increase the expression of osteogenic markers in BM MSCs and can induce 
osteogenic differentiation (Hanada, Dennis et al. 1997; Sammons, Ahmed et al. 
2004; Friedman, Long et al. 2006). Interestingly, parathyroid hormone and vitamin 
D3 increase the efficiency of osteogenic differentiation of MSCs, probably 
reproducing the development of the bone tissue (Sammons, Ahmed et al. 2004). At 
the same time the differentiation of BM MSCs by the classical protocol using 
dexamethasone reproduces the changes of the markers and transcription factors 
during osteoblast development. Particularly, RUNX2, osterix, Msx2 (msh homeobox-
2), osteopontin, osteocalcin and osteonectin are upregulated during the osteogenic 
differentiation in vitro. 
 
1.1.6.3. Chondrogenic induction and molecular control of 
chondrogenesis 
 The regulation of chondrogenic differentiation is less described in the 
literature than the other pathways. Chondrogenesis in BM MSCs can be induced by 
the cell aggregation and adding TGFβ (transforming growth factor β) and 
dexamethasone for 21 days (Johnstone, Hering et al. 1998). The cell aggregation 
can be achieved by centrifugation, and then the cells are cultured in the dense pellet. 
It was observed, that some MSC and ADSC lines express low level of TGFβ-
receptor, in this case BMP-6 can induce TGFβR expression and make the cells 
permissive to TGF signaling (Sekiya, Colter et al. 2001). The detailed mechanism of 
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chondrogenic induction is not described. The microarray studies characterized the 
progression of the events during the chondrogenic differentiation (Sekiya, Vuoristo et 
al. 2002). The authors found that chondrogenesis occurs through the particular 
stages, and the expression of the transcription factors and markers changes 
sequentially. Differentiation was accompanied with a large increase in the expression 
of matrix proteins (in case of collagen II more than 500-fold upregulation). The early 
stages were connected with the increase in collagen II and XI, COMP (cartilage 
oligomeric matrix protein), dermatopontin, aggrecan. Later on, the components 
present in hypertrophic cartilage appeared, such as collagen X, fibromobulin and 
osteomodulin. The transcription factors were expressed also stepwise according to 
the stage of the differentiation. The earliest detected event was the upregulation of 
Sox4 (on the 1 day of induction, and then downregulation on the day 14). Sox5, Sox9 
and HoxA7 were upregulated from day 7 till 21. BMP-2 and TGFβ3 were elevated 
during the whole course of differentiation.  
The verification of differentiation usually includes the detection of specific 
cartilage matrix components, as aggrecan and collagen II using the antibodies, and 
glycosaminoglycans with Alcian Blue. The important parameter is the structure of the 
pellet; it reproduces the structure of articular cartilage, where chondrocytes are 
located in the lacunas of the matrix. 
 
1.1.7. Plasticity of bone marrow mesenchymal stromal cells 
 The above described pathways are considered as “classical” pathways of BM 
MSC differentiation. BM MSCs can give rise to osteocytes, adipocytes, 
chondrocytes, haematopoietic-supportive stroma, and fibroblastic tissue in the in vitro 
and in vivo environments. The lack of BM MSC markers makes it impossible to 
perform lineage tracing experiments, therefore it has never been demonstrated, 
which cell populations within the stroma develop into those pathways and how they 
pass through the sequence of intermediate progenitors. However, several 
observations could suggest the principles of BM MSC development. It was reported 
that clonal strains of primary bone marrow adipocytes could de-differentiate in vitro 
and in the transplantation assay, and then can be induced to the osteogenic lineage 
(Bennett, Joyner et al. 1991). Different studies showed that primary hypertrophic 
chondrocytes could de-differentiate in culture and shift to osteogenic phenotype 
(Descalzi Cancedda, Gentili et al. 1992). At least similar process takes place in the 
organism during ossification of cartilage (Galotto, Campanile et al. 1994). Those 
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studies suggest, that it shouldn’t be excluded, that the primary cells from different 
lineages of BM MSC differentiation can switch between each other. It has been also 
noted, that differentiated cells derived in vitro from BM MSCs can transdifferentiate 
upon inductive extracellular signals (Song and Tuan 2004; Schilling, Noth et al. 2007; 
Schilling, Kuffner et al. 2008). It was claimed that switch happens through the de-
differentiation step and possible in all the directions between osteo-, adipo- and 
chondrogenic pathways. The stromal lines applied in those works were not clonal 
and represented heterogeneous populations, but the authors sorted out the 
committed osteoblasts based on the expression of osteocalcin reporter and observed 
the same phenomenon of transdifferentiation.  
In some literature sources the property of BM MSC progeny to switch 
between lineages within the classical context of differentiation (osteo, adipo, 
chondro) is termed “orthodox plasticity” (Bianco, Riminucci et al. 2001). It is not clear 
whether and how this phenomenon occurs in the organism, and so far it has not 
been possible to present the evidence of those events. But it was shown that the key 
regulator of osteogenic lineage commitment Cbfa1/RUNX2 is expressed in BM MSC 
capable for adipogenesis (Satomura, Krebsbach et al. 2000). According to our 
observations, the main regulator of adipogenic commitment, PPARγ, is expressed at 
the protein level in clonal lines of BM MSC capable for osteogenesis (unpublished 
data). The model explaining such “orthodox” plasticity implies that undifferentiated 
BM MSCs can possess “lineage imprinting” at the single-cell level before 
specialization. This means, that the commitment into osteo-, adipo, and 
chondrogenic pathways might exist independently in the cells, and maintained after 
the cell enters into one or another pathway (Satomura, Krebsbach et al. 2000; 
Bianco, Riminucci et al. 2001). As a consequence, the transdifferentiation can occur. 
In this case, the classical and apparent logical hierarchical model of progressive 
restriction of differentiation potential is not applicable. The well-known example of 
such system is haematopoiesis, where the stem cells undergo multistep and 
unidirectional commitment and differentiation, and every intermediate stage is 
described as a specific identity. But for the BM MSCs this model has never been 
demonstrated and can’t be taken without the proof. Taken together, the mechanism 
of BM MSC commitment has to be investigated with having regard to the uniqueness 
nature of the system and with unbiased consideration. 
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1.1.8. Cell fate choice 
 Bone marrow mesenchymal stromal cells have the potential to differentiate 
into osteo-, adipo- and chondrogenic lineages. There is accumulated information 
about the mechanisms regulating one or another differentiation pathway, and the 
essential regulators are already known. However, the control of the lineage 
commitment of multipotential cell is not understood. The primary events for the cell 
fate choice and the signals, which direct the cell to make this decision still remain 
mysterious. Several mechanisms are currently discussed in the literature, and most 
of them consider the switch between adipogenic and osteogenic pathways driven in 
BM MSCs by the key regulators, PPARγ and RUNX2, respectively. 
The transcriptional modulation of PPARγ and RUNX2 activity was suggested 
as a mechanism of osteo/adipogenesis switch (Hong, Hwang et al. 2005), Fig. 5. 
TAZ (transcriptional coactivator with PDZ-binding motif) contains WW domain that 
binds Pro-Pro-R-Tyr motif. It was found that PPARγ and RUNX2 contain such motif 
and physically interact with TAZ. It was shown that interaction of TAZ with RUNX2 
stimulates osteogenesis in primary MSC, on the other hand binding of PPARγ inhibits 
adipogenesis. This was an indication, that TAZ functions upstream of PPARγ and 
RUNX2 and participates in the lineage switch between osteo and adipogenesis. TAZ 
was found to be responsive to BMP-2, and BMP-2 was suggested as the main 
extracellular signal for the cell commitment. Inhibition of TAZ in zebrafish embryos by 
morpholino injection led to the block of bone formation demonstrating the role of TAZ 
in vivo (Hong, Hwang et al. 2005). 
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 In another study the main role in the cell fate decision was given solely to 
PPARγ (Takada, Mihara et al. 2007). The authors reasoned that young animals 
during extensive skeletal growth have suppressed PPARγ function, and PPARγ 
haploinsufficiency causes the loss of adipocytes and increase in the bone mass. The 
opposite phenotype was observed in Wnt5a+/- adult mice providing an evidence of 
negative regulation of PPARγ by non-canonical Wnt signaling. The assumption was 
that many nuclear receptors function through the formation of complexes including 
epigenetic modification enzymes. In the inactive state the complex contains 
epigenetic repressors, such as histone deacetylases (HDAC) and histone 3 lysine 9 
methyltransferases (H3K9 HKMT). Ligand binding to the nuclear receptor leads to 
the remodeling of the complex and recruiting epigenetic activators, such as histone 
acetylases (HAT) and histone 3 lysine 4 methyltransferases (H3K4 HKMT). Taking 
this into consideration, the authors proposed the epigenetic regulation of PPARγ 
function in response to non-canonical Wnt signaling as a mechanism for the lineage 
switch in MSCs (Fig. 6). The study was done on ST2 cells with osteo/adipogenic 
potential. The authors demonstrated, that activation of non-canonical Wnt5a favored 
cells to osteogenic differentiation in expense of adipocyte formation. The analysis of 
the key players in the chain allowed the authors to suggest a model of 
activation/repression of PPARγ. In the absence of Wnt5a PPARγ is active and the 
promoters of target genes have active epigenetic marks with methylated H3K4. 
Wnt5a activates NLK (Nemo-like kinase), which in turn phosphorylates a histone 
methyltransferase, SETDB1 (Set domain bifurcated 1), leading to the formation of co-
repressor complex that methylates H3K9 of PPARγ target genes and inhibits its 
transactivation function. The inactivation of PPARγ function results in the switch to 
osteogenic cell fate. 
 The role of canonical and non-canonical Wnt signaling in the BM MSC 
lineage commitment is extensively discussed in the literature. At the same time, the 
data and the conclusions are non consistent and sometimes opposite. For example, 
the canonical Wnt pathway was suggested to have a role in the lineage switch in ST2 
cells by stimulation of osteoblastogenesis and inhibition of adipogenesis (Kang, 
Bennett et al. 2007). In another study, it was observed that canonical Wnt3a inhibits 
osteogenic differentiation and non-canonical Wnt5a pathway enhances osteogenesis 
(Baksh, Boland et al. 2007). The authors proposed a model of functional antagonism 
between canonical and non-canonical Wnt pathways. As we mentioned earlier, the 
application of different models complicates the comparison of the results from 
different studies and makes it impossible to bring to consistence. 
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Indeed, there is a growing evidence that those signaling pathways interact 
and cross-talk in the cells, providing a balance and fine tuning of the cellular state 
(Ling, Nurcombe et al. 2009). The utilization of multiply pathways reflects a large 
responsiveness of the cells to the extracellular stimuli, which is required for the 
specification of the cells in the complex system of the whole tissue and for the 
maintenance of the integrity of the organism. However, the dual role of the signals 
being inductive/repressive for the different processes does not imply the role in the 
lineage choice, and may stay downstream from the initial events. Taking into account 
the possible plasticity of the BM MSC descendants between osteo-, adipo- and 
chondrogenic lineages, which we discussed earlier, the dual function of the signaling 
can maintain the cell in the particular lineage and prevent from the escape into 
another pathway. From this point of view, the critical role of the factor in the lineage 
commitment cannot be proven by the opposite effects to the alternative types of 
differentiation. 
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1.1.9. Heterogeneity of bone marrow mesenchymal stromal cells 
 Bone marrow stroma represents a complex tissue of mesenchymal stem cell 
descendants. The in vitro differentiation potential presumes the presence of 
intermediate progenitors of different lineages and probably mesenchymal stem cells 
themselves in the heterogeneous cell population. The first findings connected 
stromal stem cells with CFU-F’s (colony forming unit-fibroblasts), showing that the 
progeny of single CFU-F can differentiate and self-renew (Friedenstein, Gorskaja et 
al. 1976). However, only proportion of CFU-F’s exhibited such properties. Later, 
characterization of CFU-F’s from rabbit bone marrow revealed differences in the size, 
morphology and alkaline phosphatase activity in the CFU-F’s indicating that they 
might represent cells on the different stages of development (Owen, Cave et al. 
1987). The differences in the osteogenic potential of human CFU-F’s was confirmed 
in the transplantation assays (Kuznetsov, Krebsbach et al. 1997). 
The first study summarizing the multilineage differentiation properties of BM 
MSCs was done by Pittenger and colleagues (Pittenger, Mackay et al. 1999), and 
since then differentiation potential into osteo-, adipo- and chondrocytes started to be 
intensively analysed. Already in this work, the authors noted that only 2 out of 6 
clonal lines possessed three-lineage potential, the others were bipotent (osteo/adipo) 
or monopotential (osteo). These observations were extended further in the larger 
scale in two works from the group of R. Quarto (Banfi, Muraglia et al. 2000; Muraglia, 
Cancedda et al. 2000). Human CFU-F’s were assessed by the differentiation 
potential (80 CFU-F’s in the first study and 185 CFU-F’s in the second), and 24-34% 
of them were tripotential, 61-71% combined osteo and chondrogenic properties, and 
4-5% were purely osteogenic. The differentiation was checked on different passages. 
It was observed, that the clones were loosing their differentiation abilities with 
passaging, and they displayed at first the loss of adipogenic potential (great 
reduction after 19 doublings) and then chondrogenic (drop after 22 doublings), at the 
end becoming osteoblasts. The authors suggested that osteoblastic cell fate as a 
“default” lineage in BM MSC, and the existence of “linear hierarchy” in the 
differentiation pathway. They proposed, that BM MSCs proceed differentiation 
gradually from multipotent state through stepwise diverging of (1) adipogenic and (2) 
chondrogenic lineages. The heterogeneity of CFU-F’s and the loss of potential with 
passaging was confirmed by the other groups in the analysis of osteo- and 
adipogenic potential in vitro (Digirolamo, Stokes et al. 1999). At the same time their 
observations could be interpreted that BM MSC heterogeneity is a result of the 
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influence of cell culture conditions and spontaneous differentiation, which was not 
taken into account. 
A different result was obtained using human BM MSCs immortalized with 
human telomerase (hTERT) and human papilloma virus E6 and E7 genes (Okamoto, 
Aoyama et al. 2002). Immortalized clonal lines were established and analysed for 
differentiation potential. Only 34 out of 100 clones retained the potential to 
differentiate, and amongst them tripotent (osteo-adipo-chondro), bipotent (osteo-
adipo and osteo-chondro), and monopotent (osteo, adipo or chondro) were found. 
Immortalized BM MSCs did not loose their potential during the passaging. Those 
data contradicted the “linear hierarchy” proposed by Muraglia et al (Muraglia, 
Cancedda et al. 2000) indicating that the process is not completely understood and 
requires more comprehensive analysis.  
 
1.1.10. Subpopulations of BM MSCs and shifting of paradigms 
 Different subpopulations of BM MSCs were isolated by the surface marker 
expression, morphology, proliferation capacity, cell cycle state, clonogenicity or other 
characteristics. The multiple origins of MSCs during the embryonic development can 
explain the differences in the properties between the described subsets of MSCs 
(Takashima, Era et al. 2007). It is possible that some of those subpopulations are 
identical or overlap, but the comprehensive study to consolidate the results of 
different groups has not been performed. Some of those works raised important 
questions on fundamental properties and developmental origin of MSCs, and 
generally adult stem cells. These studies deserve to be specially mentioned. 
 
1.1.10.1. Rapidly Self-renewing (RS) Cells and MSC heterogeneity 
 The stromal cells change their morphology, population doubling time and 
differentiation properties during the passaging, causing the discrepancies in the 
results of the experiments. The morphologically diverse cells in the primary cultures 
turn into homogeneous populations, which can be explained by the selective 
proliferation of one cell type or by the conversion of the different cells into one type in 
vitro. The team of D. Prockop concentrated their efforts on study of primary MSCs 
plated with a low density (3 cells/cm2) to observe different cell types in culture 
(Colter, Sekiya et al. 2001; Prockop, Sekiya et al. 2001; Smith, Pochampally et al. 
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2004). They identified three types of cell: large flattened, spindle-shaped, and small 
rapidly proliferating cells. The small rapidly proliferating (RS) cells were proposed as 
more primitive cells state. Those cells had higher differentiation potential (the 
efficiency of osteo-, adipo- and chondrocyte formation was estimated as 1.4 – 6-fold 
as more efficient) and expressed some specific markers as Flk-1. At the same time 
RS cells could not be maintained in culture as pure cell populations as they were 
rapidly turning into the fibroblastic stromal cells, presumable more mature. Those 
studies did not intensified furthermore, and whether RS cells represent a specific cell 
type and resemble any cells in the bone marrow is unclear. However, this was one of 
the first works attracted attention to the heterogeneity of stromal cells in primary 
cultures. The effort to characterize the stromal cultures on the single-cell level should 
be considered on its merits. 
 
1.1.10.2. Multipotent Adult Progenitor Cells (MAPCs) and the plasticity 
of BM MSCs 
 One of the first and the most-pronounced reports on the existence of the cells 
with extended differentiation potential in the bone marrow was done by the group of 
C. Verfaillie. The cells termed multipotent adult progenitor cells (MAPCs) were 
isolated form human (Reyes, Lund et al. 2001) and mouse (Jiang, Jahagirdar et al. 
2002) bone marrow. MAPCs were identified as a rare subpopulation of cells in the 
bone marrow, which can be expanded indefinitely in the presence of EGF (epidermal 
growth factor) and PDGF-BB (platelet-derived growth factor BB), expressed 
telomerase, Rex-1 and Oct-4 (1000-fold lower than embryonic stem cells according 
to qPCR). Those cells were found to have the potential to differentiate in vitro into 
neuroectoderm, endothelium and hepatocytes. Additionally, MAPCs could engraft to 
many organs (intestine, lung, liver, blood, bone marrow) after intravenous injection. 
The most stricking result was shown that murine MAPCs could contribute to different 
tissues of embryo and adult progeny after injection into blastocyst. Those tissues 
included brain, liver, intestine, kidney, spleen, muscle, bone marrow, blood and 
others. Surprisingly, the germ line transmission was not shown. All those results 
allowed to the authors to claim the pluripotency of MAPCs isolated from the bone 
marrow and to suggest similarity to embryonic stem cells. In support, the murine 
MAPCs required the presence of LIF (leukemia inhibitory factor) in the medium 
similarly to embryonic stem cells. 
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 Several other publications were released on the MAPC biology 
(Subramanian, Geraerts et al. ; Jiang, Vaessen et al. 2002; Serafini, Dylla et al. 
2007). Nonetheless, the results from the first report could not be reproduced by the 
other groups. For the moment, the identity of MAPCs is unclear and their existence is 
questionable. It is possible, that those cells represent cell culture artifact selected by 
the in vitro conditions (Phinney and Prockop 2007), or resulted from the 
chromosomal aberrations and malignization of cells. 
 The phenomenon of differentiation into the cells from another germ layer is 
generally called “plasticity”, or “non-orthodox plasticity” to distinguish from the 
transdifferentiation events within one germ layer. The results of Verfaillie and 
colleagues raised the interest of the scientific society to look for the plasticity of bone 
marrow-derived stem cells (Krause, Theise et al. 2001; Weissman, Anderson et al. 
2001; Graf 2002). The in vitro differentiation of BM MSCs into neurons (Kohyama, 
Abe et al. 2001), hepatocytes (Lee, Kuo et al. 2004), insulin-producing cells 
(Moriscot, de Fraipont et al. 2005) was reported. Many transplantation assays 
confirmed the plasticity of BM MSCs (Petersen, Bowen et al. 1999; Brazelton, Rossi 
et al. 2000; Lagasse, Connors et al. 2000; Mezey, Chandross et al. 2000). On the 
other hand, many of those experiments could be poorly reproduced by the other 
groups (Wagers, Sherwood et al. 2002). Several alternative explanations can be 
proposed how the progeny of BM MSCs can be found in multiply tissues after 
transplantation. According to one point of view, cell fusion can explain the 
persistence of the cells marked as transplanted cells in the tissues, which are not 
actually derived from the latter (Terada, Hamazaki et al. 2002; Ying, Nichols et al. 
2002). The other opinion states that the response to the external stimuli can adopt 
the cell phenotype to the hosting tissue, for example, via epigenetic changes 
(Morshead, Benveniste et al. 2002). At third, the existence of unknown subpopulation 
of cells within bone marrow can never be excluded.  
 
1.1.10.3. Very Small Embryonic-like Stem Cells (VSELs) and pluripotent 
lineages in the adults 
 The plasticity of bone marrow-derived cells observed by some groups 
reasoned for the search of the rare subpopulation of cells capable for the wide 
spectrum of differentiation. Kucia et al applied multiparameter sorting of the mouse 
bone marrow to isolate the side population from lin-Sca-1+CD45- cells by staining with 
Hoechst33342 (Kucia, Reca et al. 2006). The cells were small in size (2-4µm), which 
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might explain why those cells were excluded during the usual sorting procedures. 
Transmission electron microscopy showed that VSEL contained large nucleus with 
opened chromatin (euchromatin). The cells expressed the markers usually 
associated with embryonic stem cells, Oct4, Nanog and SSEA1 at the protein level. 
The authors named the cells as “very small embryonic-like stem cells”, VSELs. It was 
not possible to expand those cells, only to maintain them in culture, possibly 
reflecting quiescence. In the specific conditions VSELs could form spheres in culture, 
which resemble embryoid bodies. VSELs could differentiate in vitro into 
cardiomyocytes, neural and pancreatic cells, showing multipotency. Additionally, 
VSELs expressed CXCR4 (SDF-1 receptor) and could migrate by SDF-1 gradient in 
culture.  
Interestingly, in mice the number of VSELs isolated from bone marrow was 
significantly reducing with the age. It was noted that long-living strains of mice 
(C57Bl/6) have higher number of VSELs than short-living strains (DBA/2J). The 
authors suggested that this phenomenon could explain the impairment of the 
regeneration capacity associated with ageing (Ratajczak, Zuba-Surma et al. 2008; 
Ratajczak, Zuba-Surma et al. 2008). 
The origin of VSEL cells still remains unclear. The authors suggested a 
relation between VSELs and primordial germ cells (PGCs) based on the expression 
of some common markers as Stella, Fragilis, Mvh, Oct4. According to the proposed 
model, the pluripotency is maintained throughout the life of the organism in sequence 
ICM (inner cell mass) - epiblast – PGCs – gonads. The authors hypothesized, that 
epiblast contains common precursors for PGCs and tissue-specific stem cells, and 
they diverge at this stage, but stay in one stream of pluripotency. Those cells express 
CXCR4 and they migrate throughout the body by the gradient of SDF-1. During this 
process the naïve pluripotent Oct4+ precursor cells could be deposited in the 
developing tissues undergoing epigenetic erasure of imprinted genes (Kucia, 
Wysoczynski et al. 2008; Ratajczak, Zuba-Surma et al. 2008; Shin, Zuba-Surma et 
al. 2009). 
Nevertheless, this model stays theoretical and has no practical evidence so 
far. Despite it captures by the elucidation of stem cell plasticity, which still stays at 
the position of unexplained experimental artifacts, it is based on speculations and 
remains as a hypothesis for the moment. 
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1.1.10.4. Marrow-Isolated Adult Multilineage Inducible (MIAMI) cells and 
microenvironment 
 Modeling of niche-specific conditions can provide a new insight on the cell 
interactions in tissue development. It has been proposed that conditions resembling 
the bone marrow microenvironment might result in the population of real stem cells 
identical to their state in the tissue (D'Ippolito, Diabira et al. 2006). The unfractionated 
bone marrow was plated onto fibronectin-coated dishes in the low-serum (2%) and 
low-oxygen (3%) conditions. The isolated cells were termed Marrow-Isolated Adult 
Multilineage Inducible (MIAMI) cells (D'Ippolito, Diabira et al. 2004; D'Ippolito, 
Howard et al. 2006). MIAMI cells were maintained at the low density and passaged 
at 100 cells/cm2. They had the potential to differentiate into osteo-, adipo- and 
chondrocytes, neurons and pancreatic cells. Expression of Oct4 and Rex1 was 
shown at mRNA level. MIAMI cells were considered as pluripotent cells, which might 
serve as a source of cells for regenerative therapy. 
 MIAMI cells were not studied more intensively and the equivalent of those 
cells in situ was not shown. The expansion in a very low density from few cells might 
be a feature of spontaneous immortalization of primary cells, but the karyotype of the 
cells was not tested. But this study called the attention for the natural conditions for 
tissue-residing stem cells. Hypoxic conditions (3% O2) could be more physiological 
and found a wide application in culture of stem cells. 
 
1.1.10.5. Human MCAM-positive cells and pericyte concept. 
One of the most extraordinary studies, in which the issue of the identity of 
mesenchymal stem cells was brought up, was published in 2007 by Sacchetti and 
colleagues (Sacchetti, Funari et al. 2007). The authors postulated that multipotency 
of stem cells has to be shown at the single-cells level and self-renewal can be tested 
only in the transplantation assays (Bianco, Robey et al. 2008). Those stringent rules 
were applied further for the establishment of the experiments and the result 
interpretation. Remarkably, the authors excluded the cell culture methods to 
characterize the differentiation potential of the cells, testing it only in the 
transplantation assays, aiming to obtain the most “physiologically” relevant data and 
to avoid cell culture artifacts. 
CD146 (MCAM, melanoma-associated cell adhesion molecule) was proposed 
as a marker for the primitive MSCs in human bone marrow. The authors showed a 
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clear difference between the populations of MSCs generated from the high-density 
bone marrow cultures and those derived from clonogenic cells. All CFU-F generating 
cells were found in the CD146+ compartment of the bone marrow. Using CD146 as a 
marker allowed the finding of the in situ counterpart of clonogenic CFU-F precursors. 
The authors revealed that those cells are located in subendothelial layer of sinusoidal 
walls and correspond to adventitial reticular cells (pericytes). CD146+ cells shared 
many properties with pericytes, marker expression (PDGFRβ, α-smooth actin) and 
produced factors regulating HSC homeostasis (CXCL12, SCF, Angiopoeitin-1). 
Cell culture-expanded CD146+ cells were tested for their differentiation 
capacity after subcutaneous transplantation into immunodeficient mice. The progeny 
of the cells was recognized by the human mitochondria labeling. The transplanted 
cells formed bone structure, adipocytes and fibroblastic tissue. Remarkably, 
haematopoietic sites originating from the host were induced in the transplants. 
Pericytes appeared to be of human origin. Those cells expressed CD146 and 
demonstrated the same subendothelial position as CD146+ cells observed in the 
human bone marrow. Importantly, human-originating CD146+ cells could be 
recovered as CFU-F’s from the transplants, suggesting self-renewal of the cells. The 
authors did not analyse the passaging of those cells through the series of recipients, 
which could serve as stronger evidence for self-renewal. Nevertheless, this study 
linked the gap between the in vitro cultured BM MSCs and their in situ equivalent. It 
can be considered as a pioneer work to obtain cell culture expanded BM MSCs 
capable to re-establish marrow environment and self-renew. The question marks, 
which the authors put on the cell culture artifacts and interpretation of multipotency 
and self-renewal of adult tissue-specific stem cells, had influenced the concept of 
Mesenchymal Stem Cell in the whole field.  
Another conceptual work should be noted in the regard of CD146+ stem cells. 
The group of Bruno Peault hypothesized that pericytes in multiple organs represent a 
harbor for progenitor cells, which might be integral for the bone marrow MSCs and 
other tissue-specific stem cells (Crisan, Yap et al. 2008). Pericytes were isolated 
from a list of human tissues including skeletal muscle, heart, pancreas, adipose 
tissue, placenta, skin, gut, lung, bone marrow, brain, eye, umbilical cord, and those 
cells were CD146+PDGFRβ+NG2+.  Single-cell derived populations from those cells 
had myogenic potential, they were able to repair the injured muscle, and they also 
had the properties of MSCs, such as differentiation into osteo-, adipo- and 
 
35 
chondrocytes. At the same time, self-renewal capacity and differentiation in the in 
vivo environment were not analysed in this study. 
These two landmark papers together formed the hypothesis of pericytes as 
stem cells in the adult tissues (Fig. 7). Despite the relations between pericytes and 
osteoblastic progenitors had been suggested before (Brighton, Lorich et al. 1992), 
the observation was not developed into the general principal of stem cell localization 
and homeostasis that time. The model proposes that all MSCs represent pericytes, 
whereas not all pericytes are MSCs (Caplan 2008; da Silva Meirelles, Caplan et al. 
2008). This localization makes it possible to respond to the tissue-generated 
chemokines and systemic signals as well. The cells can support the tissue 
homeostasis and be recruited to repair in case of injury. At the same time, there is 
still a controversy in the interpretation of the identity of those cells. The first group of 
the authors suggested that stem cells are tissue-specific, and recruited to the vessel 
walls, where they reside. Therefore, the pericytes in different connective tissues 
share the anatomic identity, but the differentiation capacity is likely to be specific 
(Sacchetti, Funari et al. 2007; Bianco, Robey et al. 2008). The second group 
proposed that a common precursor of MSCs in different tissues reside around the 
vasculature and those cells are identical (Crisan, Yap et al. 2008; Crisan, Chen et al. 
2009). Currently, there is no solid evidence toward one or another model. The 
developmental origin of MSCs and the relations between MSCs in different tissues 
are far from the clear understanding. 
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1.1.10.6. PDGFRα+Sca-1+ (PαS) cells from mouse bone marrow and 
self-renewal 
One of the remarkable works on the isolation of bona fide mesenchymal stem 
cells capable for self-renewal was published in 2009 by Morikawa et al. (Morikawa, 
Mabuchi et al. 2009). Several markers were used for the prospective isolation of 
MSCs from mouse bone marrow. The authors applied negative selection of the bone 
marrow mononuclear cells (BMMNCs) to sort out the haemopoeitic cells 
(CD45+TER199+ fraction), and then from the resulted cells they analysed 
subpopulations separated by the expression PDGFRα (platelet-derived growth factor 
receptor α) and Sca-1 (stem cell antigen-1). PDGFRα is a known early mesodermal 
marker and Sca-1 marks different types of stem cells in mouse and human. Only the 
cells positive for both markers showed fibroblastic morphology, proliferated without 
signs of senescence and differentiated efficiently into osteocytes, adipocytes and 
chondrocytes. Moreover, the cells of PDGFRα+Sca-1+ population, named PαS, were 
highly clonogenic in CFU-F assay. At the same time the population of PαS was not 
homogeneous in terms of differentiation potential, and only the subset of PαS 
clonally derived lines were able to differentiate into three lineages, and additionally to 
endothelium. The cells with phenotype PαS were identified in situ in the perivascular 
space. The most rigorous test for the stemness used in this work was the systemic 
transplantation assay. The freshly sorted PαS cells from the bone marrow of CAG-
GFP transgenic mice were injected intravenously into lethally irradiated recipients, 
together with sorted HSCs to reconstitute haematopoiesis. The progeny of GFP+ 
cells was found 16 weeks later in bone marrow stroma, bone and adipose tissue. 
The engrafted cells gave rise to mature adipocytes, osteocytes and reticulocytes. 
The authors were able to isolate GFP+PαS using flow cytometry and 2% of those 
cells generated colonies with the same properties as transplanted PαS cells. Hence, 
the self-renewal of PαS cells was confirmed. However, the authors did not show the 
cells with phenotype PαS originated from the transplanted cells in situ, probably 
because of the rareness of those cells. Also, the cell fusion has not been excluded in 
the experiment and the cell tracing was performed only by GFP expression. Another 
interesting note was that PαS had lost their ability to engraft after culturing and were 
eliminated form the recipient after 7 days post-transplantaition. This fact can lead to 
the conclusion that cell culture conditions can influence the properties of the cells. On 
the other hand, it’s not clear whether the subpopulation of repopulating PαS cells 
was actually present in the cultured cells. It was found in this work that 70% of PαS 
cells in bone marrow are in G0 phase, presuming quiescence. Hence, it is possible 
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that the real primitive self-renewing PαS cells were not proliferating in the culture 
conditions. 
Nevertheless, PDGFRα and Sca-1 could be considered as the potential 
markers for murine mesenchymal stem cells. The physiological test applied in the 
transplantation experiments attributes a special importance to the work. 
 
1.2. Cellular immortalization 
 
 For a long time it was believed that all cells in the organism have unlimited 
growth capacity and restricted only by insufficient space in the body and lack of 
nutrients. The confusion was generated by the fact that the attempts to obtain the 
somatic cell lines that could grow in the cell culture conditions led to the selective 
propagation of rare spontaneously immortalized cells. Only in 1961 it was 
demonstrated that cultured normal cells are mortal and undergo a limited number of 
cell divisions before reaching unproliferative state called replicative senescence 
(Hayflick and Moorhead 1961; Hahn 2002). Only certain cell types harbor “natural” 
immortality enabling to expand them without alterations virtually indefinitely in vitro, 
amongst them embryonic stem cells (ESC) and neural stem cells (NSC), (Evans and 
Kaufman 1981; Martin 1981; Conti, Pollard et al. 2005). But for most of the cell types 
the aim to obtain a considerable amount of primary cells for biological studies 
represents practically an impossible task. Cellular immortalization is a phenomenon 
to overcome the replicative senescence, and happens in vitro and in vivo during 
carcinogenesis. Thus, the methods used for the directed cell immortalization often 
reproduce the oncogenic transformation events, and conversely the immortalization 
in vitro is often considered as a model to study the cancer development. 
  This chapter is dedicated to the methods of cellular immortalization, in 
particularly using simian virus 40 Large T-antigen; additionally the conditional 
immortalization of primary cells from the Large T-antigen transgenic mice used in this 
project will be described. 
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1.2.1. Cellular senescence of human and mouse cells 
Cellular senescence in human fibroblasts was described as two phases, 
mortality stage 1 and 2, M1 and M2 (Wright and Shay 1992). During the M1 stage 
the cells are arrested in G1 phase of the cell cycle and do not respond to the mitogen 
signals. This stage is correspondent to the replicative senescence. The replicative 
senescence is not a simple unproliferative situation, but a specific cellular state 
characterized by certain markers (such as increased β–galactosidase activity, 
upregulation of p21cip1, p16INK4A) and biochemical processes. The cells are 
metabolically active and can survive in the cell culture conditions for relatively long 
time. The cell cycle is blocked by the factors responsible for DNA damage 
checkpoint, such as p53 and p16INK4A. If the cells escape from the checkpoint by the 
mutations or other events, the cell divisions continue until M2 stage. In the M2 the 
cells proliferate, but the cell population undergo crisis characterized by the significant 
cell death. It is likely that M2 is a consequence of the extensive chromosome 
breakages and end-to-end fusions, which lead to the apoptosis. With a very low 
frequency the cells can overcome the crisis and establish the stably proliferating cell 
line (for the human cells the frequency is approximately 10-7). In all the cases 
spontaneous bypass of the crisis is associated with mutations.  
The mechanisms for M1 and M2 are distinct. Therefore, to overcome the 
senescence the cells should inactivate both thresholds of mortality and the 
probability of such an event is extremely low, at least for the human cells. If that 
happens, the cells are considered to have undergone “establishment”, and the 
derived population is termed “the established cell line” (Hahn 2002).  
 Similar processes occur in cultures of the mouse cells. Nevertheless, it is 
important to note a great difference between the human and the mouse cells in terms 
of proliferation. It is known that the frequency of immortalization of mouse cells, 
spontaneous and induced, is much higher than of human, and according to some 
data reaches a difference up to seven orders of magnitude (107), (Wright and Shay 
2000). The events leading to the immortalization of mouse cells are often inefficient 
for the immortalization of human cells, for example, expression of catalytic subunit of 
telomerase TERT, or early region of simian virus 40. It has to be considered that the 
human and rodent cells exhibit a substantial difference in the growth control, so that 
the interpretation of data should be done very carefully (Wright and Shay 2000). We 
will describe some of those differences between mouse and human cells in more 
details further. 
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1.2.2. Molecular regulators of cellular senescence 
 The phenomenon of cellular senescence is characterized by the irreversible 
proliferative arrest with continued metabolic activity and occurs both in vitro and in 
vivo. Its function in the organism is likely to prevent tumorigenesis. Several lines of 
evidence show that at least three major mechanisms are involved in the regulation of 
cellular growth and senescence – telomere maintenance, Retinoblastoma pathway 
and p53 pathway. Those pathways interact and work in concert to provide a tight 
control for the cell proliferation. 
 
1.2.2.1. Telomere maintenance 
 The induction of replicative senescence is associated most of all with the 
length of telomeres (Vaziri and Benchimol 1996). Telomeres are highly conserved 
nucleoprotein structures at the end of chromosomes essential for the chromosomal 
stability. The telomeres protect the ends of linear chromosomes from exonucleases 
and illegitimate recombination. DNA of telomeres consists of the tandem repeats, 
which are in case of vertebrates TTAGGG/CCCTAA (Blackburn 1991). Telomeres 
cannot be fully replicated due to the linear nature of eucaryotic chromosomes, hence, 
decreasing their length during each round of replication. The repeats can be 
synthesized de novo by the ribonucleoprotein enzyme telomerase consisting of the 
RNA component, TERC, and the catalytic subunit possessing the reverse 
transcriptase activity, TERT, (Greider and Blackburn 1985; Weinrich, Pruzan et al. 
1997). The telomerase is expressed in germline cells, embryonic stem cells and 
many cancer cells, but is absent in most of the somatic cells. Thus, the telomere 
length is a result of constant shortening and elongation during the cell divisions. 
Somatic cells lacking telomerase activity show shortening of telomeres for about 50-
100 nucleotides per one cell cycle (Harley, Futcher et al. 1990). The telomere 
hypothesis of cellular ageing suggests that critically short telomeres serve as a 
“mitotic clock” to signal to the cell to undergo senescence in vitro and possibly in vivo 
(Olovnikov 1971; Vaziri and Benchimol 1996). The M1 stage is induced when the 
shortened telomeres are recognized by the double strand DNA break repair system, 
and as a consequence the cell is arrested in DNA damage checkpoint. If the cells 
bypassed the M1 stage and continue proliferating, the length of telomeres is 
decreasing further leading to the extensive chromosomal aberrations and end-to-end 
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fusions, resulting in the apoptotic death. The ectopical expression of human catalytic 
subunit of telomerase hTERT resulted in the extension of life span in human 
fibroblasts (Bodnar, Ouellette et al. 1998; Vaziri and Benchimol 1998; Vaziri, Squire 
et al. 1999). The cells could pass the Hayflick limit, they had normal karyotype, 
extended telomeres and did not show the signs of senescence. These data provided 
an evidence for the telomere hypothesis. 
The mechanism of telomere maintenance might be greatly different between 
mouse and human cells. Indeed, mouse cells were shown to have extremely long 
telomeres, approximately 150 kilobases compared to human, which are around 10 
kilobases long. Literally, the shortest mouse telomere is longer than the longest 
human one (Kipling and Cooke 1990). The knockout mice for RNA component of 
telomerase (mTR-/-) were viable at least for 6 inbred generations, reducing the 
telomere length each generation, demonstrating that the telomerase is essential for 
the telomere maintenance, but not for the viability of mice (Blasco, Lee et al. 1997). 
Importantly, mTR-/- cells from different generations of those mice were similar in the 
ability to proliferate in culture despite the difference in the telomere length. Those 
cells undergo senescence/crisis and spontaneously immortalize with similar 
dynamics and frequency indicating that (1) the senescence of mouse cells is not 
caused by the telomere shortening, and (2) active telomerase is not required for the 
mouse cell line establishment and oncogenic transformation. These observations 
suggest that there is a substantial difference in the role of telomere length in 
replicative senescence, immortalization and carcinogenesis of human and mouse 
cells. 
 
1.2.2.2. Retinoblastoma pathway 
Retinoblastoma protein (pRb) and two related proteins, p130 and p107 
belong to the family of pocket proteins, and function as negative regulators of the cell 
proliferation. pRb binds and represses the E2F transcription factors, which stimulate 
the expression of genes involved in replication and cell cycle progression (Hurford, 
Cobrinik et al. 1997). pRb binds specifically to the activating E2F1, E2F2 and E2F3. 
p130 and p107 bind to E2F4 and E2F5 and occupy the promoters of E2F-dependent 
genes as a repression complex. In the late G1 stage the positive cell cycle 
regulators, such as complexes CDK2/Cyclin E, CDK2/Cyclin A, CDK4/Cyclin D, 
phosphorylate pRb leading to its inactivation. The E2F1-3 release permits to enter to 
the S-phase. 
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pRb remains active in the senescent and non-dividing cells blocking the enter 
to the cell cycle (Stein, Drullinger et al. 1999). The cell cycle inhibitors p16INK4a and 
p21cip1 bind to the CDK’s suppressing the formation of complexes with Cyclins and 
phosphorylation of pRb. Thus, senescent cells exhibit elevated level of p16 and p21, 
and the spontaneous immortalization of cells is often associated with the loss of p16. 
pRb function is disrupted in nearly every human cancer directly, or indirectly by p16 
inactivation (Duncan, Wadhwa et al. 2000). Mouse embryonic fibroblasts with triple 
knockout of pRb, p130, p107 are immortal (Sage, Mulligan et al. 2000). 
 
1.2.2.3. p53 tumor suppressor 
p53 is one of the main tumor suppressors in the cell (Lane and Crawford 
1979; Linzer and Levine 1979). p53 is a transcription factor that activates the 
expression of genes inducing the cell cycle arrest and apoptosis in response to the 
cellular stress and DNA damage. The level of p53 in the cells is relatively low due to 
the short half-life time of the protein (around 20 minutes), which makes it more 
versatile in cellular regulation (Donehower, Harvey et al. 1992). The expression of 
p53 is regulated by a negative feedback loop with Mdm2 (Murine Double Minute 2). 
p53 activates the transcription of Mdm2, which functions as an E3 ubiquitin ligase. 
Mdm2 ubiquitinates p53 and targets it to the proteasomal degradation. In case of 
DNA breaks, UV radiation, stress or oncogene activation, the positive regulators of 
p53, such as protein kinases p14ARF (alternative reading frame), ATM (ataxia 
telangiectasia mutated), ATR (ataxia telangiectasia and Rad3 related) inhibit Mdm2 
and stabilize p53.  
p53-mediated growth arrest occurs through the induction of p21cip1. p21 binds 
CDK’s inhibiting the formation of CDK/cyclin complexes and therefore pRb remains 
hypophosphorylated and active. As a result, the cell cycle progression is blocked. 
Additionally, p21 might inactivate proliferating cell nuclear antigen, PCNA, a factor 
essential for replication (Stein, Drullinger et al. 1999). In the senescence the level of 
p53 might not be increased but the DNA binding activity is enhanced. It is possible 
that the mechanism of M1 and M2 include activation of p53 in response to short 
telomeres, which are recognized as DNA damage (Duncan, Wadhwa et al. 2000). 
Despite obvious important function of p53, the knockout for p53 mice are 
viable, but sensitive to the tumor formation (Donehower, Harvey et al. 1992). The 
fibroblasts isolated from those mice are immortalized. This data indicates that p53 is 
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not essential for the mouse development but predisposes to neoplastic 
transformation. 
 
1.2.3. Methods of cellular immortalization 
Immortalization is a phenomenon to bypass the replicative senescence and 
break the growth arrest. The three mechanisms involved in the cell growth control 
have to be perturbed to overcome senescence – the telomere shortening, pRb 
pathway and p53 pathway. The immortalization can occur spontaneously, be 
indirectly induced or directly induced. 
Spontaneous immortalization is a capacity of the cells to proliferate 
indefinitely in the cell culture conditions without adding of any exogenous agents. 
The criteria for defining the immortalized state in this case is quite empirical, the 
cultures proceeded more than 150 doublings can be considered as immortal (Shay, 
Wright et al. 1991). In most of the cases the spontaneous immortalization is 
connected to the genetic or epigenetic changes in tumor suppressor genes, namely 
p53, p16INK4a, p14ARF. In addition, in almost 100% of spontaneously immortalized 
human cells telomeres are maintained by the telomerase or other alternative 
mechanism (ALT, alternative lengthening mechanism), (Hahn 2002). 
Most of the mouse cells have a capacity to establish an immortal line 
spontaneously, while for the human cells this event is extremely rare. The example of 
a spontaneously immortalized mouse line is NIH 3T3, which were established from 
primary mouse embryonic fibroblasts (MEFs) using so-called “3T3 protocol – 3 day 
transfer 3x105 inoculum” (Todaro and Green 1963). Frequent passaging of the cells 
in a low density regardless of their growth rate is selective for the cells capable for 
indefinite growth. This protocol can be reproduced and results in the establishment of 
spontaneously immortalized line after 20-30 generations. 
Indirect methods to induce immortalization implicate the increase of 
unspecific chromosomal abnormalities rate and the probability of the mutations 
leading to the immortalized state. Irradiation with UV, X-ray or γ-rays, and chemical 
treatment with carcinogenic agents such as benzoapyrene (BaP) have been used 
widely to immortalize breast epithelial cells (Gudjonsson, Villadsen et al. 2004).  
Directed immortalization can be achieved by the genetic modification of the 
cells using expression of oncogenes or viral oncoproteins. The combination of the 
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immortalizing agents is highly specific on the cell type and the species, as was 
already discussed. In almost all of the cases, this combination should provide 
disabling of p53 and pRb functions, which is sufficient to immortalize mouse cells. 
The human cells need additionally to activate telomerase and in some cases, to 
express oncogenes (such as Myc or Ras) for immortalization. 
Many DNA-containing viruses utilize the mechanism to stimulate DNA 
replication in the host to reproduce themselves. The regulators driving the 
proliferation of the cells are often used for the directed cellular immortalization (Fig. 
8).  
Human Papilloma Viruses are small DNA viruses inducing epithelial 
proliferation. HPV’s 16, 18, 31, 33 are found in 80% of cervical tumors. Papilloma 
Virus proteins E6 and E7 are used for immortalization of many epithelial primary 
cells. E6 protein binds and inactivates p53 and E7 directly inhibits pRb (Munger and 
Howley 2002). 
Adenoviral oncoproteins can also be used for the cellular immortalization. 
Adenoviral protein E1A and E1B bind pRb and p53, respectively. The expression of 
E1A region alone is enough to immortalize rodent cells. Probably, the most famous 
example of adenovirus-immortalized cell line is 293 rising from the human embryonic 
kidney cells transformed with sheared DNA of adenovirus 5a (Graham, Smiley et al. 
1977).  
One of the most well studied and probably most often applied oncogenic 
viruses is simian virus 40 (SV40). The high transforming activity of the early region 
made it an attractive tool for cellular immortalization. We dedicate a special chapter 
to the mechanism utilized by SV40. 
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1.2.4. Cellular immortalization by Simian Virus 40 
Simian virus 40 (SV40) belongs to Polyoma viruses (Sweet and Hilleman 
1960). The genome of SV40 is about 5 kilobases, and the compact structure of 
regulatory sequences, such as origin, expression promoter, polyA signal, splicing 
sites, made it widely used for the genetic engineering. Another wide application of 
SV40 is due to the high immortalization potential. SV40 causes lytic infection in 
monkey cells, and human and rodent cells stay permissive. The immortalization 
properties of SV40 are associated with the expression of the genes of the early 
region encoding Large T-antigen, Small t-antigen, and 17k T-antigen. Three proteins 
are generated through the alternative splicing of early mRNA. The Large T provides 
most of the transforming activity of SV40 by the simultaneous inactivation of the main 
control systems for the cellular growth, pRb and p53. Large T has a distinctive 
domain organization and the domains possess a specific activity for the transforming 
of the host cell (Fig. 9). 
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 The N-terminal part of the Large T forms the J domain. This part of the 
protein targets Hsc70 (heat shock cognate protein 70kDa), which acts as ATPase 
and causes the release of E2F’s from the complexes with p130 and p107.  
 LXCXE domain of the Large T-antigen binds directly to pRb, p130 and p107 
and inactivates pRb-dependent block of the cell cycle. Large T binds preferentially 
unphosphorylated form of pRb causing the release of E2F’s and promoting the 
progression from G1 to S phase. For the immortalization it is required to inactivate 
the functions of all three pocket proteins, pRb, p130 and p107 (Ahuja, Saenz-Robles 
et al. 2005; Cheng, DeCaprio et al. 2009).  
The helicase domain of the Large T-antigen binds directly to the DNA-binding 
domain of p53 resulting in its inactivation. Consequently, the expression of Mdm2, 
the negative regulator of p53, is also reduced and non-ubiquitinated p53 is 
accumulating. The bound to the Large T p53 is greatly stabilized, half-life time of p53 
is reaching around 24 hours. Inactivation of p53 by Large T is essential for the cell 
transformation (Hahn, Dessain et al. 2002). 
 The role of Small t-antigen is less studied. Small t-antigen cannot immortalize 
the cells alone, but contributes to the Large T-promoted immortalization. The main 
target of the Small t is serine-threonine phosphatase A (PP2A), interaction with which 
leads to the activation of several signaling pathways, stabilization of Myc, and other 
effects. 
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The mouse cells are readily immortalized by SV40, the block of pRb and p53 
by the Large T is enough for cellular immortalization of murine cells. At the same 
time, infection of human fibroblasts by SV40 extends the lifespan for about 20-30 
doublings and then the cells undergo crisis. The cooperation of SV40 Large T-
antigen with hTERT in the human cells can efficiently immortalize them (Cheng, 
DeCaprio et al. 2009). 
However, any type of immortalization might interfere with the cellular 
processes and affect the signaling pathways. The reversible immortalized state 
would have a great advantage to avoid this interference. There are several attempts 
to obtain an inducible SV40 Large T-antigen that discussed in the literature. Wright et 
al. generated a steroid inducible mouse mammary tumor virus (MMTV)-driven Large 
T (Wright, Pereira-Smith et al. 1989) and transfected it to human fibroblasts. The 
cells expressed T-antigen and proliferated only in the presence of Dexamethasone 
(Dex). The cells passed through the crisis yielding the immortal cell line. However, 
the growth was still Dex-dependent and Dex withdrawal blocked the cell proliferation 
of those cells. It was suggested that M1 (replicative senescence) and M2 (crisis) 
have distinct mechanisms, and Large T-antigen can inactivate the M1 mechanism 
but does not eliminate it. Upon deinduction of T-antigen the cells turned into M1 
stage, which was not abolished by T-antigen but bypassed.  
A temperature-sensitive version of Large T-antigen, named tsA58, was found 
by the screening of mutated forms of SV40 (Tegtmeyer 1975). tsA58 exhibited 
immortalization activity only at the permissive temperature of 33°C, and the 
temperature shift to 39°C inactivated it (in some studies permissive temperature was 
35°C). tsA58 was successfully used for generation of the inducible immortalized cell 
lines of human and mouse fibroblasts (Radna, Caton et al. 1989; Ikram, Norton et al. 
1994). The growth of the stable cell lines was observed only at the permissive 
temperature. The temperature shift induced the cellular senescent state in 
concordance to the observations used MMTV-controlled T-antigen.  
Following the success in generating the conditionally immortalized cell lines 
using temperature-sensitive T-antigen, the attempt to establish the transgenic mouse 
carrying tsA58 was performed (Yanai, Suzuki et al. 1991). The transgenic mice 
consistently developed tumors at the age 5-6 weeks showing leakiness of the 
system. Nevertheless, the mouse was successfully used to establish several lines of 
immortalized primary cells (Okuyama, Yanai et al. 1995). 
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To perform the additional control on the Large T-antigen expression, tsA58 
was placed under control of H-2Kb promoter, and used to generate the transgenic 
mouse line (Jat, Noble et al. 1991). Histocompability complex H-2Kb is widely 
expressed and can be further upregulated by interferon treatment. The hybrid 
construct of tsA58 under control of H-2Kb promoter was injected into fertilized 
oocytes of the mice, and the transgenic mouse line was established 
(“immortomouse”). The conditionally immortalized fibroblasts were obtained from 
those mice. The growth of conditionally immortalized cells was temperature-
dependent, and colony-forming efficiency and T-antigen expression was enhanced 
upon interferon treatment. The transgenic mice were showing hyperplasia’s in 
thymus, but did not develop the tumors. Subsequently, different conditionally 
immortalized primary cell lines were successfully established from the 
“immortomouse” providing experimental systems to study cell functions (Whitehead, 
VanEeden et al. 1993; Okuyama, Yanai et al. 1995). 
 
1.2.5. Conditional immortalization of mouse cells using tetracycline-
regulated SV40 Large T-antigen 
 Recently our group has developed a system for the precise conditional 
immortalization of cells using SV40 Large T-antigen (Anastassiadis, Rostovskaya et 
al. 2010). We reasoned that the transcriptional control of the transgene expression is 
preferable for the tight and reversible regulation. The most commonly used system 
for the transcriptional regulation is a tetracycline-inducible system.  The system 
consists of two components – a tetracycline regulator and a regulatable transgene 
under control of tetracycline operator and minimal promoter. The tetracycline-
inducible system exists in two versions, TET-OFF and TET-ON. In case of TET-OFF 
system, the tetracycline transactivator (tTA) is constantly active, and adding of 
Doxycycline (Dox) removes tTA from the tet-operator and represses transgene 
expression. In case of TET-ON, reverse tetracycline transactivator (rtTA) is active 
only in the presence of a ligand, Dox, to induce the transcription of transgene. We 
used the TET-ON strategy to generate a system for tightly controlled transgene 
expression.  
 The idea to utilize tet-regulated system for Large T-antigen expression was 
already successfully applied by the others (May, Hauser et al. 2004). The tet-
regulated Large T (TET-ON) was established and used for the conditional 
immortalization of MEFs. However, the attempt to generate a tet-regulated T-Antigen 
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transgenic mouse using TET-OFF or TET-ON faced with the following difficulties 
(Bendiksen, Van Ghelue et al. 2004). The TET-OFF system tightly controlled the 
expression of T-antigen in the mice and the cells from those mice, but the mice 
needed constantly administration of Dox during the entire life to repress the T-
antigen expression. The TET-ON system was found to be not efficient and the Large 
T was not expressed in the mouse tissues and in the cells from those mice after the 
Dox treatment. 
Considering these problems, we aimed to improve the system for conditional 
expression of Large T-antigen and subsequently generate a transgenic mouse (Fig. 
10). Previously, the improved version of rtTA by codon optimizing was reported, irtTA 
(Anastassiadis, Kim et al. 2002). The irtTA was placed under control of constitutively 
expressed CAGGs promoter, and could be induced by the Dox treatment. The 
second level of control was added by the fusion of irtTA with a mutated 
Glucocorticoid Binding Domain (GBD*) capable for binding of Dexamethasone. In the 
uninduced state the fusion protein irtTA-GBD* is bound to heat-shock protein 
(Hsp90) in cytoplasm and the system stays inactive. The adding of Dexamethasone 
(Dex) releases the irtTA-GBD* and makes it available for the induction with Dox. In 
the presence of both ligands, the irtTA is active and stimulates the expression of the 
transgene under the tet-operator. For the experiments shown here we used both 
versions, the original irtTA (Dex-independent) and irtTA-GBD* (Dex-dependent). 
The Large T-antigen was placed under control of the tet-tk minimal promoter. 
The double stable colonies of mouse ES cells E14TG2a were established by the 
sequential electroporation of CAGGs-irtTA(-GBD*) and tet-tk-TAg, and antibiotic 
selection. The transgenic mice were generated either by pronucleus co-injection of 
DNA constructs or by injection of mES into the blastocysts. The mice had normal 
phenotype and did not show abnormalities or tumor formations. The expression of 
Large T in the mice was tested with Western blot before and after the intraperitoneal 
administration of ligands (Dox or Dex/Dox). In case of irtTA-GBD*-TAg mice the 
Large T was expressed only in the presence of both ligands in all the examined 
tissues. In case of irtTA-TAg mice, only 1 founder line out of 17 tested expressed the 
irtTA at very low level. Hence, we confirmed the advantage of the irtTA-GBD*-TAg 
system. We showed that the MEFs isolated from the transgenic irtTA(-GBD*)-TAg 
mice could be conditionally immortalized and expanded practically indefinitely. 
Finally, we isolated conditionally immortalized stromal lines from the bone marrow 
and confirmed their identity by the marker expression and differentiation potential. 
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Thus, we generated a system for the conditional immortalization of primary mouse 
cells with excellent properties for regulation. 
 
 
 
50 
1.2.6. Immortalization of bone marrow mesenchymal stromal cells 
 The cell culture model represents an important tool to study the biological 
properties of the cells. Bone marrow mesenchymal stromal cells have a limited 
proliferation potential, therefore immortalized cells are often used as a model to study 
bone marrow mesenchymal stromal cells and the processes of differentiation into 
mesodermal tissues. In this chapter we will describe some examples of the 
generation of immortalized cell lines with BM MSC properties. 
 
1.2.6.1. Spontaneously immortalized stromal lines. 
Several spontaneously immortalized stromal cell lines are known from the 
literature. C3H10T1/2 cells were established from the mouse embryos using the 
modified “3T3” protocol, seeding 0,5x105 cells into 60mm dishes every 10 days 
(Reznikoff, Brankow et al. 1973). Later it was found that the cells of this line can be 
induced into the bone, fat, cartilage and muscle cells by the 5-azacytidine treatment 
(Pinney and Emerson 1989). 
ST2 clonal stromal line was established from the bone marrow of adult mice 
by spontaneous immortalization (Ogawa, Nishikawa et al. 1988). The cells were 
supporting haematopoiesis and were used to study B-cell development. The cells 
were able to differentiate into osteo- and adipocytes, were applied as a model for 
multipotential mesenchymal stromal cells. 
The subclones of NIH 3T3 fibroblasts with adipogenic potential are widely 
used to study the regulation of adipogenic differentiation. 3T3-L1 and F442A clones 
were selected by the screening of clones for the adipogenic potential. The L1 and 
F442A cells might represent a faithful model of adipogenic induction, however, the 
clones need different stimulation to convert into adipocytes that questions the identity 
of those cells (Cornelius, MacDougald et al. 1994; Wu, Xie et al. 1995). 
 
1.2.6.2. Induced immortalization in stromal lines 
Despite the utility of the described above spontaneously immortalized cell 
lines, the undefined identity of those cells and the unknown genetic alterations might 
interfere with the interpretation of the results obtained using those cells. Therefore, 
the directly induced immortalization could be advantageous to establish stably 
proliferating stromal lines. 
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 Human BM MSCs were immortalized by the combination of hTERT, and 
papillomavirus proteins E6 and E7 (Okamoto, Aoyama et al. 2002). The clonally 
derived lines were examined for the differentiation potential into osteo-, adipo- and 
chondrocytes. The properties of the clones varied considerably, and the clones with 
potentials “OAC”, “AO”, “OC”, “O”, “A”, “C” were established (“O” – osteo, “A” – 
adipo, “C” - chondro). The authors suggested the heterogeneity of stromal cell 
populations. 
 
1.2.6.3. Conditionally immortalized stromal lines from transgenic mice. 
There are several known examples of the establishment of conditionally 
immortalized BM MSCs from the transgenic mice in the literature. 
Mesenchymal stromal cell lines were established from temperature-sensitive 
Large T-antigen transgenic mice (Okuyama, Yanai et al. 1995). The cells were grown 
at the permissive temperature 33°C. A variety of clonally derived lines were obtained 
and characterized. Amongst them different cell types were found, such as endothelial 
cells, fibroblasts, pre-adipocytes, osteoblasts. One of the clones from this study, 
TBR31-2, had a potential for multilineage differentiation (osteo-, adipo-, chondro- and 
myogenic) and was reported separately (Negishi, Kudo et al. 2000). 
Conditionally immortalized BM MSCs were isolated from the “immortomouse” 
harboring tsA58 T-antigen in the H-2Kb locus, described before (Jat, Noble et al. 
1991; Dennis, Merriam et al. 1999). The cells were growing at the permissive 
conditions (temperature 33°C and adding of interferon) upon the induction of Large 
T-antigen. One of the clonally derived lines was able for quadripotential 
differentiation into osteocytes, adipocytes and chondrocytes (clone BMC9). Thus, the 
authors reported the isolation of multipotential early mesodermal progenitor, and this 
was one of the first confirmations that multipotent BM MSC exist in the adult bone 
marrow, which appeared at the same time with (Pittenger, Mackay et al. 1999).  
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2. Materials and methods 
2.1. General materials 
2.1.1. Reagents 
2.1.1.1. Cell culture media and supplements 
Reagent  Company producer Cat. number 
    
DMEM - Low Glucose (1000mg/l) with GlutaMax  Gibco Invitrogen 21885-025 
DMEM-High Glucose (4500mg/l) with GlutaMax  Gibco Invitrogen 61965-026 
DMSO Hybri-Max  Sigma D2650 
Fetal Calf Serum  PAA A15-101 
L-Glutamine  Gibco Invitrogen 25030-024 
OPTI MEM with GlutaMax  Gibco Invitrogen 51985-026 
Penicillin/Streptomycin  Gibco Invitrogen 15140-122 
Trypsin/EDTA 1x  Gibco Invitrogen 25300-054 
TGFβ1  Peprotech 100-21 
 
2.1.1.2. Chemicals and dyes 
Reagent  Company producer Cat. number 
    
Acrylamide/bis-acrylamide 30%  Severn Biotech Ltd. 20-2100-10 
Alizarin Red  Sigma A5533 
Alcian blue  Sigma A3157 
Apo-transferrin  Sigma T1147 
Ascorbate-2-phosphate  Fluka 49752 
Ascorbic Acid  Sigma A4544 
BIO  Sigma B1686 
β-glycerophosphate  Sigma G9891 
BSA  Sigma A7906 
CT99021  ABCR AB253776 
DAB Substrate  Vector Lab. SK-4100 
Dexamethasone  Sigma D4902 
Doxycycline  Sigma D9891 
Formaldehyde 37%  Merck 1.040003.100 
Glycogen  Calbiochem 361507 
Guanidine Hydrochloride  Sigma G3272 
Indomethacin  Sigma I7378 
Insulin  Sigma I6634 
Isobutyl-methylxantine  Sigma I5879 
Lithium Chloride  Sigma L4408 
Nuclear Fast Red  Fluka 60700 
Oil Red  Sigma O0625 
TEMED  Sigma T9281 
TRI reagent  Invitrogen T9424 
Troglitazone  Sigma T2573 
TWEEN-20  Sigma P7949 
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2.1.1.3. Other reagents (markers, inhibitors etc) 
Reagent  Company producer Cat. number 
    
Eukitt Quick Hardening 
Mounting Medium 
 Fluka 03989 
NuPAGE 4x loading buffer  Invitrogen NP0007 
Prestained Protein Marker, 
broad range (7-175 kDa) 
 New England Biolabs P7708S 
Protease Inhibitors Cocktail  Sigma P8340 
TriDye 100bp DNA ladder  New England Biolabs N3271S 
 
2.1.1.4. Buffers and solutions 
 
1x PBS: 
NaCl 171 mM 
KCl 3.4 mM 
Na2HPO4 10 mM 
KH2PO4 1.9 mM 
 
1x TBE: 
Tris 0.9 M 
Boric Acid 0.9 M 
EDTA pH 8.0 1 mM 
 
10xSDS Running buffer for Western blot: 
Tris 0.25 M 30.2 g 
Glycin 2.5 M 188 g 
SDS (20% stock solution) 1% 50 ml 
H2O  up to 1L 
 
Transfer buffer for Western blot (pH 8.3): 
Tris 48 mM 5.8 g 
Glycin 39 mM 2.9 g 
SDS (20% stock solution) 0.037% 1.85 ml 
Methanol 20% 200 ml 
H2O  up to 1L 
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Running gel for Western blot: 
 Stock solution Final 
concentration 
Volume 
Acrylamide/bis-acrilamide  30% 10% 4 ml 
TRIS 1.5M pH 8.8 0.375 M 3 ml 
SDS 20% 0.1% 60 µl 
APS 10% 0.033% 40 µl 
TEMED  0.067% 8 µl 
H2O   5 ml 
 
Stack gel for Western blot: 
 Stock solution Final 
concentration 
Volume 
Acrylamide/bis-acrilamide  30% 4.5% 1.5 ml 
TRIS 1.0M pH 6.8 0.25 M 2.5 ml 
SDS 20% 0.1% 50 µl 
APS 10% 0.033% 30 µl 
TEMED  0.15% 15 µl 
H2O   6 ml 
 
2.1.1.5. Antibodies 
2.1.1.5.1. Primary antibodies 
Antibody  Company producer Cat. number 
anti-CD9  BD Pharmingen, USA Rat anti-mouse monoclonal IgG2a 
553758 
anti-CD34-PE  BD Pharmingen, USA Rat anti-mouse monoclonal IgG2a 
551387 
anti-CD44-PE  BD Pharmingen, USA Rat anti-mouse monoclonal IgG2b 
553134 
anti-CD45-PE  BD Pharmingen, USA Rat anti-mouse monoclonal IgG2b 
553081 
anti-CD49e-PE  BD Pharmingen, USA Rat anti-mouse monoclonal IgG2a 
557447 
anti-CD117-PE (c-Kit)  BD Pharmingen, USA Rat anti-mouse monoclonal IgG2b 
553355 
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Anti-CD146-FITC 
(MCAM) 
 GenTex Mouse monoclonal IgG1 
GTX18166 
anti-CD184-PE 
(CXCR4) 
 BD Pharmingen, USA Rat anti-mouse monoclonal IgG2b 
551966 
anti-Flk1-PE (VEGF-
R2) 
 BD Pharmingen, USA Rat anti-mouse monoclonal IgG2a 
555308 
anti-Sca1-FITC  BD Pharmingen, USA Rat anti-mouse monoclonal IgG2a 
557405 
Anti-CD271 (p75, 
NGFR) 
 Abcam Rat anti-mouse IgG2b monoclonal 
Ab27007 
IgG2a-FITC  BD Pharmingen, USA FITC-conjugated rat IgG2b 
monoclonal isotype control 
553929 
IgG2b-PE  BD Pharmingen, USA PE-conjugated rat IgG2b 
monoclonal isotype control 
553989 
anti-CD140b-PE 
(PDGFRb) 
 eBioscience Inc, USA  Rat anti-mouse monoclonal 
IgG2a, 12-1402 
anti-collagen II  Chemicon Mouse anti-chicken monoclonal 
IgG1, MAB8887 
anti-aggrecan  Chemicon Rabbit anti-mouse polyclonal 
antibody, AB1031 
anti-T-antigen  Santa Cruz Mouse monoclonal IgG2a, sc-148 
anti-p53  Santa Cruz Rabbit polyclonal IgG, sc-6243 
anti-cyclin D1  Cell Signaling Mouse monoclonal IgG, 2926 
anti-p27  Cell Signaling Rabbit polyclonal IgG, 2552 
anti-β-actin  Sigma Mouse monoclonal, ascites fluid, 
A5441 
anti-C/EBPα   Santa Cruz Rabbit polyclonal, 14AA, sc-61 
anti-C/EBPβ   Santa Cruz Rabbit polyclonal, C-19, sc-150 
anti-C/EBPδ   Santa Cruz Rabbit polyclonal, C-22, sc-151 
anti-PPARγ1,2  Santa Cruz Rabbit polyclonal, E-8, sc-7273 
anti-PPARγ1  Abcam Mouse monoclonal, ab41928 
 
2.1.1.5.2. Secondary antibodies 
Antibody  Company producer Cat. number 
FITC-conjugated goat 
anti-rat IgG 
 Jackson 
ImmunoResearch 
laboratories, USA 
112-045-107 
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TRITC-conjugated 
goat anti-mouse IgG, 
IgM 
 Jackson 
ImmunoResearch 
laboratories, USA 
115-025-068 
Horseradish 
peroxidase-
conjugated mouse 
anti-rabbit IgG 
 Pierce, Thermo 
Scientific 
31464 
Horseradish 
peroxidase-
conjugated goat anti-
mouse IgG 
 Pierce, Thermo 
Scientific 
31430 
 
2.1.1.6. Kits and enzymes 
Name  Company Producer Cat. number 
    
Chondroitinase ABC  Sigma C2905 
DNase I, Amplification Grade  Invitrogen 18068-015 
Dual-Luciferase Reporter Assay 
System 
 Promega E1910 
Lipofectamine LTX  Invitrogen 15338-100 
SuperScript III First-Strand 
Synthesis System 
 Invitrogen 18080-051 
SuperSignal West Femto 
Substrate kit  
 Thermo Scientific 34096 
Taq DNA polymerase  5PRIME 2200010 
Vectastain ABC RTU kit  Vector Laboratories PK-7200 
 
2.1.1.7. Primer sequences 
 
Product 
size 
(bp) 
Forward 
(5’ – 3’) 
Reverse 
(5’ – 3’) 
Msx2 107 AATTCCGAAGACGGAGCAC CGGTTGGTCTTGTGTTTCCT 
Osterix 191 TCTCCATCTGCCTGACTCCT AGCGTATGGCTTCTTTGTGC 
RUNX2 105 CCTCTGACTTCTGCCTCTGG ATGAAATGCTTGGGAACTGC 
Osteopontin 170 TGTGATGAGACCGTCACTGC AGGTCCTCATCTGTGGCATC 
Osteocalcin 175 TGACAAAGCCTTCATGTCCA TTTGTAGGCGGTCTTCAAGC 
PPARγ1 91 TGAAAGAAGCGGTGAACCACTG TGGCATCTCTGTGTCAACCATG 
PPARγ2 153 CTCCTGTTGACCCAGAGCAT AATGCGAGTGGTCTTCCATC 
C/EBPα 198 GCAGTGTGCACGTCTATGCT AGCCCACTTCATTTCATTGG 
C/EBPβ 156 CAAGCTGAGCGACGAGTACA AGCTGCTCCACCTTCTTCTG 
C/EBPδ  177 ATCGCTGCAGCTTCCTATGT AGTCATGCTTTCCCGTGTTC 
Klf-5 199 GCTCACCTGAGGACTCATACG AGTTCTGGTGGCGCTTCAT 
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Krox20 
(Egr2) 
148 CTCTACCCGGTGGAAGACCT GGAGATCCAGGGGTCTCTTC 
Adipsin 169 CGTACCATGACGGGGTAGTC GTATAGACGCCCGGCTTTTT 
Adiponectin 170 GGAACTTGTGCAGGTTGGAT CCTTCAGCTCCTGTCATTCC 
PEPCK 194 TTGTAGGAGCAGCCATGAGA CTTCCGGAACCAGTTGACAT 
UCP-1 182 TTCAAAGGGTTTGTGGCTTC ATTCGTGGTCTCCCAGCATA 
Aggrecan 150 GGTCACTGTTACCGCCACTT CCCCTTCGATAGTCCTGTCA 
Collagen II 200 AGAGACCTGAACTGGGCAGA GCACCATTGTGTAGGACACG 
β-actin 440 GGCCCAGAGCAAGAGAGGTATCC ACGCACGATTTCCCTCTCAGC 
 
 
2.1.2. Materials 
Tissue culture plastic  Falcon (BD Biosciences) or 
NUNC 
Nitrocellulose Membrane for 
protein transfer PROTRAN 
 Schleicher +Schuell 
(Whatman) 
 
2.1.3. Plasmids and constructs 
The luciferase reporter assay was done using pGL3 BAR containing Firefly 
Luciferase reporter gene under control of twelve TCF/LEF tandem elements, Promega 
(Biechele and Moon 2008). pGL4.73hRluc/SV40 containing constitutively expressed Renilla 
luciferase gene was used for the transfection efficiency control. The plasmids were kindly 
gifted by G. Weidinger (CRTD, Dresden). 
The following expression constructs were obtained from different sources as listed 
below: PPARγ1 and PPARγ2 from Addgene kindly provided by Bruce Spiegelman group, 
C/EBPβ, LIP and C/EBPδ from Addgene kindly provided by Peter Johnson group, and 
C/EBPα and Klf5 from the commercial source (Geneservice). C/EBPβ, LIP and C/EBPδ 
cDNAs were cloned in pcDNA3.1(-) plasmid backbone under CMV promoter and carried 
neomycin resistance gene. PPARγ1 and PPARγ2 were in pSV Sport plasmid backbone under 
control of SV40 promoter, and C/EBPα and Klf5 were in pCMV Sport6 under control of CMV 
promoter, all without eukaryotic resistance genes. Those plasmids were modified by 
exchange of the ampicillin resistance gene to the PGK-neo-pA or PGK-BSD-pA cassettes 
using recombineering (not shown in the details).  
The control plasimds in different experiments were CAGGs-GFP-IRES-puro/neo-pA, 
constitutively expressing GFP. 
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2.2. Transgenic mice 
Double-transgenic mice with tetracycline-regulated SV40 Large T-antigen (irtTA/T-Ag 
and irtTA-GBD*/T-Ag) were generated in our group as was described in details before 
(Anastassiadis, Rostovskaya et al. 2010). The tetracycline activator plasmids CAGGs-irtTA-
IRES-Puro and CAGGs-irtTA-GBD*-IRES-Puro were constructed by ligating the irtTA and 
irtTA-GBD* fusion as EcoRI fragments in the EcoRI site of the CAGGs-IRES-puro construct. 
The ins-Hyg-TAg construct was generated by first cloning the Large T between the tet-tk 
minimal promoter and SV40 polyA in the pKS-tet-tk (Anastassiadis, Kim et al. 2002) and then 
by inserting the tet-tk-Large-T-pA fragment between the pair of insulators in the pins-Hyg-
Ad2, a construct that contains a multi-cloning site between the insulator sequences. 
The obtained constructs were sequentially electroporated into mouse embryonic stem 
cells (mES), E14Tg2a, and the double-stable cells (CAGGs-irtTA-IRES-puro/ins-Hyg-TAg and 
CAGGs-irtTA-GBD*-IRES-puro/ins-Hyg-TAg) were selected using 200 µg/ml Hygromycin 
(Roche) and 1 µg/ml puromycin (Sigma). Transgenic mice were generated either by injection 
of those double-stable E14Tg2a mES cells (CAGGs-irtTA-IRES-puro/ins-Hyg-TAg and 
CAGGs-irtTA-GBD*-IRES-puro/ins-Hyg-TAg) into blastocysts or by pronucleus co-injection of 
the same combinations of constructs. All manipulations were done in the Transgenic Core 
Facility (TCF) of the MPI-CBG, Dresden. 
 
2.3. Cell culture methods 
2.3.1. Isolation of bone marrow mesenchymal stromal cells (BM MSCs) 
For the isolation of bone marrow mesenchymal stromal cells (BM MSCs) femurs and 
tibiae from mice were used. The bones were collected and cleaned carefully from the muscle 
fibers. The bone marrow was flashed out from the bones with 5 ml of DMEM-low glucose 
supplemented with 10% FCS (MSC growth medium) using 2 ml syringe with 24G needle. The 
suspension of bone marrow was centrifuged for 5 min at 200g. The pellet was resuspended in 
3 ml of the MSC growth medium and plated into a well of 6-well tissue culture plate. The 
medium was changed in 24 hours. Usually the cells reached the confluence after 10-14 days. 
 
2.3.2. Basic procedures with BM MSCs 
For the passaging the confluent monolayer of cells was washed with PBS, then 
treated with trypsin (0.5ml/well of 6-well plate) for 5 minutes at 37°C. The cells were pipetted 
up and down in the MSC growth medium and centrifuged for 5 minutes at 200g. The cell 
pellet was resuspended in the MSC growth medium and distributed to the dishes. 
For the cryopreservation of BM MSCs the cells were trypsinized and pelleted as 
described above, then resuspended in the MSC growth medium. Ice-cold freezing medium 
was added in the ratio 1:1 to the cells, and then the suspension was distributed to the 
cryovials (1ml/vial) and quickly transferred to -80°C. After 1-2 days the frozen cells were 
moved to the liquid nitrogen for the long-term storage.  
Freezing medium: 
  For 10 ml 
DMEM-low glucose (1g/L) 50% 5 ml 
FCS 30% 3 ml 
DMSO 20% 2 ml 
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2.3.3. Induction of immortalization of the bone marrow mesenchymal 
stem cells 
The immortalization of primary cells was induced by the conditional expression of 
Large T-Antigen of simian virus 40 (SV40). Primary BM MSCs were grown till confluence 
(passage 0, P0). During the first passage the cells were diluted in the ratio 1:2. One half of 
the cells was plated in the MSC growth medium, whereas another half was cultured in the 
MSC growth medium supplemented with inductors of large T-antigen. In case of the cells 
from irtTA-GBD*/TAg mice the combination of 10-7M Dexamethasone (Dex) and 1µg/ml 
Doxycycline (Dox) was used for the induction. In case of the cells from irtTA/TAg mice 1µg/ml 
of Dox alone was added. The growth of the immortalized cells was observed after 7-10 days. 
All the procedures with immortalized cells were held routinely as described above. The 
medium was changed every other day. The cells were passaged every 3-7 days in the 
dilution 1:5-1:20. 
 
2.3.4. Colony-forming units fibroblasts (CFU-F) assay 
For the colony-forming units fibroblasts (CFU-F) assay the bone marrow cells were 
isolated from femurs and tibiae of 5 mice as described above. The cells in the suspension 
were counted and plated in the concentration 5x105 and 5x106 cells per 10cm tissue culture 
dish in the MSC growth medium. The rest of the cells were plated in the well of 6-well plate to 
derive the stromal cell lines from the same mice. After 2 weeks the growing colonies were 
counted. At this time point the medium was supplemented with Dex and Dox to induce Large 
T-antigen expression. 2 weeks later the single colonies were picked using the cloning 
cylinders and then expanded. 
 
2.3.5. Cell proliferation assay 
Cell proliferation assay was performed with conditionally immortalized BM MSCs. The 
cells were plated into 6-well plates in the concentration 5x103 cells per well. After 48 hours the 
medium was exchanged to the MSC growth medium supplemented with either Dex (10-7M) 
and Dox (1µg/ml), or with Dex alone, or Dox alone, or without the drugs (day 0 of the 
experiment). The cells were counted in triplicates using heamatocytometer every day from the 
day 0 to the day 5 of the experiment in all the conditions described above. At the same time 
points the cell pellets were collected for protein extraction. On the day 5 Dex and Dox were 
added again to the cell culture medium to the deinduced cells in order to re-induce the 
expression of Large T-antigen again. The cells were counted 3 days later (day 8 of the 
experiment) and the cell pellets for the protein extraction were collected. 
 
2.3.6. In vitro differentiation assays 
Conditionally immortalized BM MSCs were assayed for the differentiation into osteo, 
adipo- and chondrogenic pathways. The expression of Large T-Antigen was deinduced prior 
differentiation by withdrawal of Dex and Dox for at least 3 days before starting differentiation.  
 
2.3.6.1. Osteogenic differentiation 
For the osteogenic differentiation the cells were plated at 2-5x104 cells/cm2 in 6-well 
plate in the osteogenic medium (DMEM-low glucose, 10% FCS, 10-8 M dexamethasone, 300 
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µM ascorbic acid, 10 mM β-glycerophosphate). The medium was replaced every 2-3 days 
during 28 days. Then the cells were washed with PBS and fixed with methanol for 10 minutes 
at –20°C. The staining for the calcification of extracellular matrix was done with 2% (w/v) 
Alizarin Red solution in PBS at pH 4.3 for 10 minutes, followed by washing with water and 
drying. 
For the quantification of the calcification of extracellular matrix Alizarin Red was 
extracted from the stained cells using 4M guanidine chloride solution at 37°C overnight 
(4ml/well of 6-well plate). The optical density of the extract was measured at 490 nm using 
spectrophotometer Ultrospec 2100pro (Amersham Biosciences). 
 
2.3.6.2. Adipogenic differentiation 
Adipogenic differentiation was induced with the cells at 50-70% of confluency in 6-
well plates with the adipogenic medium. The composition of adipogenic medium: (1) DMEM-
low glucose, 10% FCS, 10-7 M dexamethasone, 5µg/ml insulin, 0.2mM indomethacin, 0.5mM 
isobutyl-methylxantine; or (2) DMEM-low glucose, 10% FCS, 10-7M dexamethasone, 5µg/ml 
insulin, 5µg/ml Troglitazone. 
The medium was replaced every 2-3 days during 10 days. Then the cells were 
washed with PBS and fixed with formaldehyde for 1 hour at room temperature. 
Oil Red solution was prepared freshly (0.3% stock solution of Oil Red in isopropanol 
mixed 3:2 with water) and filtered through 0.22µm filter. Cells were quickly washed with 60% 
isopropanol and stained with Oil Red for 5 minutes followed by extensive wash with water. 
Oil accumulation in the differentiated cells was assessed by the extraction of Oil Red 
dye after the staining. The cells were air-dried and the dye was extracted with isopropanol 
(1ml/well of 6-well plate) by gentle pipetting up and down several times. Optical density of the 
extract was measured at 510 nm using spectrophotometer Ultrospec 2100pro (Amersham 
Biosciences). 
 
2.3.6.3. Chondrogenic differentiation 
2.3.6.3.1. Differentiation in vitro 
Chondrogenic differentiation was performed using the micromass culture technique 
or by aggregation in the pellet.  
Briefly, 10µl of concentrated BM MSCs suspension (106 cells) was plated in the well 
of 4-well plate and allowed to aggregate at 37°C in CO2 incubator. Chondrogenic medium 
(DMEM high glucose, 1% FSC, 10ng/ml TGF-β1, 10-7M dexamethasone, 6,25µg/ml apo-
transferrin, 6,25µg/ml insulin, 50µg/ml ascorbate-2-phosphate) was gently overlaid after 4 
hours. After less than 24 hours the cells formed dense nodules and detached from plastic.  
Alternatively, 106 cells were resuspended in 1ml of the chondrogenic medium 
described above and spun down in 15ml Falcon tubes. The lids were half-unscrewed. Then 
the tubes were carefully placed into CO2 incubator at 37°C without disturbing the pellet. After 
1-2 days the cells formed dense nodules on the bottom of the tube. 
The medium was carefully changed every 2-3 days. After 4 weeks of the differentiation 
the aggregates were fixed in 4% formaldehyde for 10 minutes at room temperature.  
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2.3.6.3.2. Paraffin sectioning 
Fixed nodules were washed with PBS 3 times, then once with physiological solution 
(0.08% NaCl and 0.002% KCl), each wash for 10 minutes. The dehydration was performed by 
sequential incubation in the solutions: 
1) 70% ethanol (2 times for 10 minutes),  
2) 80% ethanol (one time for 10 minutes),  
3) 95% ethanol (2 times for 10 minutes),  
4) 100% ethanol (3 times for 10 minutes), 
5) xylene (3 times for 10 minutes).  
Paraffinization of the samples was done by treatment with paraffin 3 times for 15 minutes 
using the Paraffin Embedding Center EG1160 Leica. 5µm sections were prepared using 
microtom (Microm).  
For deparaffinization and rehydration the sections were incubated for 15 minutes at 55°C and 
proceeded in the next solutions (5 minutes each step): 
1) xylene, 
2) 100% ethanol, 
3) 96% ethanol, 
4) 90% ethanol, 
5) 70% ethanol, 
6) water. 
For dehydration the sections were incubated in the same solutions in the opposite order, 
30 seconds each step. The slides were mounted using Eukitt Quick Hardening Mounting 
Medium. 
The differentiation was confirmed using the histological stain Alcian blue or with 
immunostaining for aggrecan. 
 
2.3.6.3.3. Alcian Blue staining 
Rehydrated sections were washed with 0.1 N HCl for 5 minutes, then stained with 1% 
solution of Alcian Blue in 0.1N HCl (pH 1.0) for 5 hours at room temperature. Excess of the 
staining was removed with 0.1 N HCl. Counter staining was done with Nuclear Fast Red (30 
seconds). 
 
2.3.6.3.4. Immunohistological staining 
Rehydrated sections were treated with 0.1 U/ml chondroitinase ABC for 1 hour at 
37°C to facilitate the antibodies access. Endogenous peroxidase activity was quenched by 
incubating in 0.3% solution H2O2 for 30 minutes at room temperature. Non-specific sites were 
blocked by incubation in 2.5% solution of horse serum for 20 minutes at room temperature. 
The sections were subsequently incubated with primary antibodies to aggrecan (1:100) for 1 
hour at 37°C, and following the washing, treated with a kit for detection of primary antibodies 
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according to manufacturer protocol (Vectastain ABC RTU kit, Vector Labs Inc.) 
Counterstaining was performed using hematoxylin. 
 
2.3.7. Cobblestone-area forming assay (CAFC) 
The cobblestone-area forming assay was performed in collaboration with Martin 
Bornhaeuser group (Uniklinikim, Dresden), Dr. Manja Wobus. 
 Conditionally immortalized BM MSCs were deinduced by Dex/Dox withdrawal for at 
least 3 days and plated to 24-well plates in the concentrations 104 and 5x104 cells/well. 
 Mobilized peripheral blood was collected from healthy donors after treatment with 
7.5µg/kg granulocyte colony-stimulating factor (G-CSF) for 5 days. Haematopoietic Stem 
Cells (HSC) were purified from leukapheresis samples using CD34 antibody conjugated 
magnetic beads according to manufacturer’s instruction (Myltenyi Biotec). CD34+ suspension 
was plated at a density of 104 cells/cm2 onto BM MSCs layer. The cobblestone formation was 
assessed visually after 8 days.  
 
2.3.8. Transfection of conditionally immortalized MSCs 
Conditionally immortalized BM MSCs were transfected either by electroporation or 
lipofection. 
 
2.3.8.1. Electroporation of conditionally immortalized BM MSCs 
Conditionally immortalized BM MSCs were trypsinized, resuspended in the growth 
medium and centrifuged at 200g for 5 minutes. 3x106 cells were resuspended in 900µl of cold 
PBS, mixed with appropriate amount of DNA and transferred into the cuvette with 4mm gap. 
Electroporation was done using Biorad Gene Pulser with parameters 250V and 500µF. The 
cuvette was placed on ice, and then the cells were plated to the 10cm tissue culture dish. 
 
2.3.8.2. Lipofection of conditionally immortalized BM MSCs 
The lipofection of conditionally immortalized BM MSCs was done using Lipofectamine 
LTX (Invitrogen) according to the manufacturer protocol. The cells were plated in the 
concentration 5x104/cm2 one day before transfection. The DNA for one well of 6-well plate 
was thoroughly mixed with 500µl of Opti-MEM medium and 2.5µl of PLUS reagent and 
incubated for 5 minutes at room temperature. 6.25µl of Lipofectamin 2000 was added to the 
mix for the further incubation for 30 minutes. The mix was distributed dropwise to the cells. 
After 24 hours the medium was changed. 
For the transfection of the cells in the other size of tissue culture plates all the 
volumes of the reagents could be scaled. 
 
2.3.9. Wnt-reporter assay 
Wnt/β-catenin pathway activation was measured using transient transfection of the 
cells with β-catenin-activated reporter (pBAR), which represents twelve tandem TCF/LEF 
DNA-binding sites controlling firefly luciferase reporter gene in the pGL3 plasmid backbone 
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(Promega). The plasmid was co-transfected with pGL4.73hRluc/SV40 containing 
constitutively expressed Renilla luciferase gene to control the transfection efficiency. 
Conditionally immortalized BM MSCs were plated in 96-well plates one day before 
transfection. 293 cells were used as a positive control of Wnt/β-catenin pathway induction. 
The cells were lipofected with 30ng of pBAR and 5ng of hRluc per one well. At the same time 
different activators of Wnt pathway were added to the half of the wells (LiCl, BIO or 
CT99021). After 24 hours the medium was changed. On the second day after transfection the 
cells were lysed in 25µl Passive Lysis Buffer (Promega) for 15 minutes at room temperature, 
and then an extra portion of 15µl of Passive Lysis Buffer was added and carefully mixed with 
multichannel pipette for the complete lysis. The activity of luciferase was measured using 
Dual-Luciferase Reporter Assay (Promega) with 96-well Microplate Luminometer GloMax 
(Promega). 12µl of lysate from each well was transferred to the reader plate. The activity of 
firefly luciferase was measured in the reaction with 50µl of LARII substrate (integration time 
6s, delay 2s), then renilla luciferase was measured with 50µl of Stop&Glo reagent (integration 
time 3s, delay 2s). 
The activity of Wnt/β-catenin pathway was calculated as firefly activity normalized to 
the transfection efficiency (evaluated as renilla luciferase activity) and expressed in Relative 
Luciferase Units (RLU). All the measurements were performed in triplicates. 
 
2.3.10. Establishment of the clonally derived conditionally 
immortalized BM MSCs 
2.3.10.1. Cellular cloning of conditionally immortalized BM MSCs 
Cellular cloning of conditionally immortalized BM MSCs was done (a) by limiting 
dilutions or (b) using FACS. 
(a) The cells were trypsinized, washed with the MSC growth medium and counted. The 
dilutions of 1, 5 and 10 cells/100µl were prepared, and each cell suspension was plated into 
96-well plate (100µl/well) using multi-channel pipette in the MSC growth medium 
supplemented with Dex and Dox. 
(b) Conditionally immortalized BM MSCs were grown till confluence. The medium from the 
cells was collected and filtered through 0.22µm filter (conditioned medium). The cells were 
trypsinized, washed with the MSC growth medium, counted and resuspended in DMEM-low 
glucose with 2% FCS in the concentration 106/ml. The cells were plated into 96-well plates 
with conditioned medium prepared before using FACS sorter (Becton Dickinson) in the 
concentration 1, 5 or 10 cells per well. The plates were centrifuged for 2 minutes at 700 rpm. 
After 2 days the medium was exchanged for the usual MSC growth medium supplemented 
with Dex and Dox. 
In both cases after 2 weeks the plates were assessed for the clone growth. The wells 
with only 1 single-cell derived clone were marked. Single-cell derived clones were collected 
into one 96-well plate. 
 
2.3.10.2. Manipulations with the clonally derived cells in the 96-well 
plates 
The clonally derived conditionally immortalized cells were grown in 96-well plates, 
passaged and frozen using multichannel pipette following standard protocols. Moreover, the 
cells could be deinduced, differentiated into osteocytes and adipocytes, and stained with 
appropriate protocols scaling down the volumes of the reagents. For the chondrogenic 
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differentiation the clones of interest were expanded till the needed number of cells and 
proceeded with the standard protocol described above.  
 
2.4. Flow cytometry analysis 
Conditionally immortalized and deinduced for 3 days BM MSCs were analyzed by 
flow cytometry analysis. The following antibodies were used for the staining: primary anti-
CD9, CD34-PE, CD44-PE, CD45-PE, CD49e-PE, CD117-PE, CD184-PE, Flk1-PE and Sca1-
FITC (all from BD Pharmingen, USA) and CD140b-PE (eBioscience Inc, USA), and 
secondary goat anti-rat FITC-coupled antibodies (Jackson ImmunoResearch laboratories, 
USA). Isotype controls were FITC-conjugated IgG2a or PE-conjugated IgG2b (both from BD 
Pharmingen, USA).  
Cells were trypsinized and washed with 1x PBS with 2% FCS, then incubated with 
primary antibodies (dilution 1:100 in PBS with 2% FCS) for 30 minutes at +4°C followed by 
washing. For indirect labeling the cells were then incubated with the secondary antibodies 
(dilution 1:200 in PBS with 2% FCS) for 30 minutes at +4°C and washed again. Cells were 
fixed with 4% formaldehyde in PBS. Measurement was performed with flow cytometer LSR II 
(Becton Dickinson) and the data was processed using FloJo software. 
 
2.5. Immunostaining 
 For the immunostaining the cells were plated into 24-well plates with gelatinized glass 
cover slips 12mm in diameter, in the concentration 105 cells/well. The cells were fixed with 4% 
formaldehyde solution in PBS for 10 minutes at room temperature and washed twice with 
PBS. The permeabilization was done with 0.5% Triton X-100 in PBS, for 15 minutes at room 
temperature. After the wash with PBS, the cells were blocked in 3% BSA solution in 
PBS+0.1% Tween-20, for 30 minutes at room temperature. The primary antibody (anti-T-
antigen) was diluted 1:100 in the blocking solution and the cells were incubated with the 
antibody for 1 hour at room temperature in a wet chamber. After the wash in PBS, the cells 
were incubated with the secondary antibody (TRITC-conjugated goat anti-mouse, 1:500 in 
blocking solution) for 1 hour at room temperature in a wet chamber. Then the cells were 
washed again and stained with DAPI (100ng/ml), for 3 minutes. After sequential wash in PBS 
and water, the slides were mounted using Mowiol. 
 
2.6. Molecular biological methods 
2.6.1. RNA isolation and RT PCR 
2.6.1.1. Total RNA isolation 
Total RNA isolation was done using TRI reagent (Sigma). Cells were lysed directly on 
the tissue culture dish (1 ml of TRI reagent per 10cm dish) and transferred to the Eppendorf 
tube. Alternatively, frozen or fresh cell pellets were resuspended in TRI reagent by pipetting 
several times. Samples were incubated for 5 minutes at room temperature. Then 1/5 volume 
of chloroform was added, samples were vortexed and allowed to stand additionally 10 
minutes at room temperature. The mixture was centrifuged at 16000g for 15 minutes at +4°C. 
The aqueous phase was transferred to the fresh tube. 0.7 volume of isopropanol was added 
(and 2 µl of glycogen as carrier in case of small amount of RNA). After incubation for 30 
minutes on ice, RNA was precipitated by centrifugation at 16000g for 15 minutes at +4°C. 
RNA pellet was washed twice with 75% ethanol, then air-dried and dissolved in DEPC-treated 
water. 
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2.6.1.2. DNase treatment of total RNA 
Elimination of genomic DNA from RNA samples was performed by DNaseI treatment 
(Invitrogen) according to the manufacturer protocol. Up to 1µg of total RNA was used in 10µl 
reaction mix containing 1U of DNase in the DNase buffer. The tubes were incubated for 15 
minutes at room temperature. Inactivation of DNase was achieved by addition of 1µl of 25mM 
EDTA to the reaction mix and heating up for 10 minutes at 65°C. 
 
2.6.1.3. Reverse transcription 
DNase I treated samples of RNA were used for the reaction of cDNA synthesis with 
SuperScript III First-Strand Synthesis System. Up to 1µg of total RNA were incubated in 
DEPC treated water with 5µM oligo(dT)20 primers and 1mM dNTP mix in a total volume of 
10µl at 65°C for 5 minutes to allow annealing and placed on ice. 10µl of cDNA synthesis mix 
were added to RNA to the final concentrations of 5mM MgCl2, 10mM DTT, 2U/µl RNase OUT, 
10U/µl SuperScript III RT in the buffer contained 20mM TRIS-HCl (pH 8.4) and 50mM KCl. 
The synthesis was performed at 50°C for 50 minutes, and then the reaction was terminated at 
85°C for 5 minutes. The samples were treated with 2U RNaseH to remove the RNA template 
from heteroduplexes at 37°C for 20 minutes. 
 
2.6.1.4. PCR analysis 
 For the PCR analysis 0.5µl of the reverse transcription reaction was used. The 50 µl 
of PCR mix contained 1x buffer including 1.5mM MgCl2 (5 Prime), 0.2 mM of each dNTP, 
0.4µM forward and reverse primers, DNA template and 1U Taq polymerase (5 Prime). The 
elongation step for 5 Prime Taq has to be performed at 68°C.  
The PCR programm was 94°C – 2min; 35 cycles x (94°C – 30sec, 60°C – 1min, 68°C 
– 1min); 72°C – 3min. 
 10µl of the mix were checked by electropheresis in 1% agarose gel, visualizing using 
the gel documentation system G:box (Syngene). 
 
2.6.2. Protein methods 
2.6.2.1. Protein extraction 
For protein extraction the cells from 10cm tissue culture dish were washed twice with 
cold PBS, scraped and spun down at 1500g for 4 minutes at +4°C. The cell pellets were 
resuspended in 50µl of the extraction buffer containing 20mM Hepes pH 8.0, 350mM NaCl, 
10% glycerol, 0.1% Tween-20, 2mM EDTA, 1mM DTT, 1mM PMSF, 1% Protease Inhibitors 
Cocktail (Sigma). Cell suspension was repeatedly frozen in the liquid nitrogen and thawed in 
hot water, 3 times. The cellular fragments were pelleted in mini-centrifuge at 13000 rpm for 15 
minutes at +4°C and discarded. The protein extracts was stored at -80°C. 
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2.6.2.2. Immunoprecipitation (IP) 
 For protein extraction for the IP the cells from 10cm tissue culture dish were washed 
twice with cold PBS, scraped and spun down at 1500g for 4 minutes at +4°C. The cell pellets 
were resuspended in 1ml of the homogenization buffer containing 20mM Hepes pH 8.0, 
150mM KCl, 1.5mM MgCl2 10% glycerol, 0.05% Tween-20, 2mM EDTA, 1mM DTT, 1% 
Protease Inhibitors Cocktail, PIC (Roche). The cells were spun down and washed again with 
1 ml of the homogenization buffer. The pellet was resuspended in 1ml of the homogenization 
buffer and sonicated 1 cycle, 30 sec for 10 min. The homogenate was centrifuged for 10 min 
at 12000g at +4°C to pellet the cellular fragments. The supernatant was stored at -80°C. An 
aliquote from the homogenate could be used as an “Input” for the Western blot.  
 The sepharose beads for IP were washed two times with PBS. 500µl of the protein 
extracts were incubated with 5µg of the antibody (anti-T-antigen or anti-p53) and 100µl of the 
beads, in a total volume of 1ml. The incubation was done for 4 hours, at +4°C rotating the 
tubes. After that the beads with bound antibody complexes were centrifuged at 6000rpm for 
10 min. The beads pellet was quickly washed with homogenization buffer 3 times. Then the 
beads were resuspended in 20µl of water and 20µl of protein loading buffer (NuPage). The 
samples were boiled for 10 min and cooled down to the room temperature. The samples were 
used for Western blot. 
 
2.6.2.3. Western blot 
Western blot analysis was done with 20µg of protein extracts, or 15µl of IP samples. 
Extracts were mixed with the 4x NuPage loading buffer containing 4% β-mercaptoethanol, 
denatured at 70°C for 10 minutes and cooled down. The samples were fractionated using 
PAGE-electrophoresis (4.5% stack gel and 10% running gel) at 70V. The proteins were 
transferred to the nitrocellulose membrane PROTRAN using semidry electroblotting at 15V 
for 60 minutes (TransBlot SD, BioRad). The membranes were blocked in 5% milk powder in 
0.1% Tween-20 in PBS overnight at +4°C.  The incubation with the primary antibodies was for 
1 hour at room temperature in the blocking solution (dilution 1:250-1:1000) followed by 3 
times washing in 0.1% Tween-20 in PBS. The membranes were incubated with 
correspondent secondary horseradish peroxidase-conjugated antibodies (1:2000 in blocking 
solution) for 1 hour at room temperature and washed again 3 times. The detection was 
performed with SuperSignal West Femto Substrate kit. Visualization has been done using 
FujiFilm LAS-3000 luminiscent imager and AIDA software 3.20 (Raytest). Alternatively, the 
signals were detected using autoradiographic Kodak films. 
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3. Results 
 
3.1. Establishment of conditionally immortalized bone marrow 
mesenchymal stromal cells (BM MSCs) 
3.1.1. Isolation of mouse BM MSCs 
Bone marrow mesenchymal stromal cells (BM MSCs) represent a plastic-
adherent fraction of the bone marrow cells (Friedenstein, Chailakhjan et al. 1970; 
Pittenger, Mackay et al. 1999). The bone marrow was flushed out from the long 
bones (tibia and femurs) using the growth medium, spun down to clear from the cell 
debris and matrix fibers, and plated in DMEM with low concentration of glucose 
(1000mg/L) supplemented with 10% FCS. The number of cells pooled from tibia and 
femurs of one mouse ranged from 4.4 to 6.7x107.  The cells from each animal were 
plated into one well of 6-well plate. After 8-12 days the cells reached confluency and 
were passaged in the dilution of 1:2 (Fig. 11A). Totally 44 lines were established from 
the bone marrow of the mice from the strains C57Bl/6, CD1 or mixed 129/C57Bl/6.  
The cells were examined for the expression of the surface markers by flow 
cytometry (Fig. 11E). Primary lines from bone marrow were positive for CD44, 
negative for the haematopoietic marker CD34, and heterogeneously expressed Sca-
1, resembling the known phenotype of BM MSCs. The primary lines from bone 
marrow could be differentiated into osteocytes (result not shown), supporting the 
evidence that the cells represented BM MSCs. Nevertheless, in all the cases after 2-
3 passages the cells stopped growing showing senescent phenotype (Fig. 11B). The 
low proliferation capacity of mouse BM MSCs is generally discussed in the literature 
and also concords to the experience of many others (Peister, Mellad et al. 2004; 
Morikawa, Mabuchi et al. 2009; Prockop 2009). According to our observations, the 
poor expansion ability of mouse BM MSCs was independent of the age, sex, or strain 
of the mice. 
 
3.1.2. Conditional immortalization of BM MSC 
3.1.2.1. Transgenic tetracycline-inducible Large T-antigen mice 
The tetracycline-inducible SV40 (simian virus 40) Large T-antigen transgenic 
mice were established before as described in the Introduction (Anastassiadis, 
Rostovskaya et al. 2010). The system used for the regulation of the transgene 
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expression was TET-ON, where the transgene placed under the control of 
tetracycline operator and minimal promoter is not transcribed unless the inductors 
are added.  
Two variations of the inducible system were used (Fig. 11D). In one case, the 
improved reverse tetracycline transactivator (irtTA) was regulating Large T 
expression in Doxycycline (Dox)-dependent fashion. Otherwise, a modified irtTA by 
fusion with a mutated version of glucocorticoid-binding domain (irtTA-GBD*) was 
introduced, and it required the presence of two inductors, Dexamethasone and 
Doxycycline (Dex/Dox) for the activation of the transgene expression. 
Large T-Antigen was expressed in the mouse tissues after intra-peritoneal 
administration of the inductors (Dox for irtTA-TAg mice or Dex/Dox for irtTA-GBD*-
TAg mice) and was very tightly controlled (Anastassiadis, Rostovskaya et al. 2010). 
Also the cells isolated from these mice could be induced for the expression of Large 
T-antigen when the appropriate ligands are added to the cell culture medium. Both 
transgenic mouse lines (irtTA-TAg and irtTA-GBD*-TAg) were used in this work. 
 
3.1.2.2. Large T-antigen can be induced in BM MSCs 
 BM MSCs were established from the transgenic tet-regulated T-antigen mice. 
During the first passage the cells were split 1:2, and half of the cells was plated in the 
usual MSC Growth Medium, whereas another half was induced by adding of the 
inductors of the tet-system (Dox or Dex/Dox). The cells without induction stopped 
growing and exhibited senescent phenotype during next 1-2 passages. At the same 
time the cells in the induction conditions showed increased proliferation and could be 
passaged indefinitely long, for at least 40-50 passages (Fig. 11B, 11C). SV40 Large 
T-antigen is known to stimulate cell proliferation and inhibit apoptosis. Western blot 
analysis confirmed that primary BM MSCs started expressing Large T-antigen after 
induction with Dox or Dex/Dox (Fig. 11F). After withdrawal of tet-inducers (Dox or 
Dex/Dox) the cells were not expressing Large T anymore and stopped proliferating, 
showing that the induction of large T-antigen in BM MSCs was reversible.  
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Since the cells were proliferating as stable lines in T-antigen-dependent 
manner without signs of senescence, and this effect was reversible, we termed this 
phenomenon as “conditional immortalization” and the cells as “conditionally 
immortalized BM MSCs. Interestingly, immortalization could be switched “on” and 
“off” many times for those cells. 
The time and the efficiency of induction of primary cells were significantly 
different for the two systems of irtTA activation. The proliferation of BM MSCs from 
irtTA-TAg mice was usually observed 12-35 days after the start of induction. Notably, 
only 8 lines out of 25 were established resulting from the uniform proliferation of the 
stromal cells within 12 days. In 4 isolates only few cells were proliferating, giving rise 
to the stromal line. Also, the cells from 13 irtTA-TAg mice could not be induced 
completely. These observations are in accordance to the known mosaicism in the 
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irtTA mice, reported before (Anastassiadis, Rostovskaya et al. 2010). The level of the 
induction in those mice is often poor because the system is probably getting silenced 
and can be activated only in some of the cells. 
  The BM MSCs from irtTA-GBD*-TAg mice showed rapid growth after 6-8 
days of Dex/Dox induction (11/11 lines, 100%).  In all cases the majority of the cells 
were uniformly proliferating suggesting the high efficiency of the induction. The fusion 
with GBD* domain gives an additional level of regulation for irtTA, making the 
expression more tightly controlled and efficient.  
  
3.1.2.3. Proliferation of conditionally immortalized BM MSCs 
 BM MSCs isolated from tet-regulated Large T-antigen mice were conditionally 
immortalized upon the induction of the Large T. In order to check whether 
proliferation of the immortalized cells is T-antigen-dependent, the following 
experiment was performed. The cells from irtTA-GBD*-TAg mice were seeded into 6-
well plates in a low density and different conditions were applied – (1) with inductors 
(Dex/Dox), (2) withdrawing one or the other ligand (Dex or Dox) or  (3) withdrawing 
both ligands (deinduction). The number of cells per well was counted for 13 
consecutive days (Fig. 12A). The cells induced with Dex/Dox were gradually 
increasing the number until they reached confluency at day 6. In the absence of one 
or both inductors the cells slowed down the proliferation and did not increase their 
numbers from day 3 after withdrawal. On day 6 of the experiment the deinduced cells 
were induced again by adding Dex/Dox into the medium. The cells started 
proliferating from day 9, onwards reaching similar growth speed as the original 
induced cells. 
These results strongly show that proliferation of the conditionally immortalized 
BM MSCs from irtTA-GBD*-TAg mice depends on the presence of both inductors of 
tet-system (Dex and Dox). Similarly, we observed in our experiments that 
proliferation of the cells from irtTA-TAg mice (Dox) is ligand-dependent and tightly 
regulated (results not shown).  
Additionally, the immortalization of BM MSCs can be reversibly induced and 
deinduced. We have never observed the proliferation of the cells after deinduction of 
conditionally immortalized BM MSCs, suggesting that the cells do not become 
spontaneously transformed after expansion in the immortalization conditions. 
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3.1.2.4. Expression of Large T is tightly regulated 
 The previous experiment demonstrated that conditionally immortalized BM 
MSCs from irtTA-GBD*-TAg mice stop proliferating in the absence of at least one of 
the ligands for the tet-system induction (Dex, Dox, Dex/Dox). The expression of 
SV40 Large T-antigen in different conditions was monitored by Western blot analysis. 
The Large T-antigen expression in the cells was gradually decreasing and could not 
be detected from 3-4 days after deinduction (Fig. 12B). The expression of Large T 
was fully reversed after adding of the inductors to the cells again. The level of T-
antigen expression was in a strong agreement with the proliferative activity of the 
cells.  
The similar dynamics of T-antigen deinduction was observed in the 
conditionally immortalized BM MSCs from irtTA-TAg mice upon Dox withdrawal. 
Here, the downregulation of T-antigen was also showed on the cellular level with 
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immunostaining for Large T-antigen (Fig. 12C). In the induction conditions all of the 
cells were expressing Large T-antigen, which localized in the nucleus. The cells were 
uniformly loosing T-antigen after Dox removal and were completely negative for the 
immunostaining after 3 days. 
Altogether, these results demonstrated that the expression of large T-antigen 
completely depends on the presence of the inductors and is fully reversible. The 
transgene expression and subsequently cell proliferation were tightly controlled and 
thus, the conditional immortalization system can be characterized as excellently 
regulated.  
 
3.1.2.5. The effects of Large T-antigen on the cells are reversible 
 The mechanism by which SV40 Large T-antigen contributes to the cellular 
transformation involves importantly the interaction with the main tumor suppressors, 
retinoblastoma protein (pRb) and p53, and their inactivation (Jiang, Srinivasan et al. 
1993; Ahuja, Saenz-Robles et al. 2005). These events cause large changes in the 
protein interaction networks regulating the cell cycle and apoptosis. The expression 
of some of the components playing role in the cell cycle regulation of the 
conditionally immortalized BM MCSs was examined by Western blot. 
 Conditionally immortalized BM MSCs from irtTA-TAg mice were expanded in 
the induction conditions (+Dox) and deinduced by Dox withdrawal for 5 days. Dox 
was added again to the cells for 3 days. Cell pellets were collected every day during 
the course of deinduction and after re-induction again. Western blot analysis showed 
gradual decrease of the Large T after deinduction and from the 3 day T-antigen was 
not detected in the cells. The expression of Large T was reversed after the re-
induction (Fig. 13A). 
p53, p27 and cyclin D1 were detected on the same membrane using the 
appropriate antibodies. The basal level of p53 is usually reported as low in the cells 
(Coutts and La Thangue 2005). According to our observations Large T-antigen binds 
p53 leading to the accumulation of p53 in the cells. High level of p53 expression was 
detected in the induced conditionally immortalized BM MSCs. p53 was 
downregulated after the deinduction of the cells and in an absolute agreement with 
Large T level. p53 expression was re-gained after the cells were re-induced with Dox 
again (Fig. 13A). To support those data, p53 and Large T-antigen were co-
immunoprecipitated from the induced conditionally immortalized BM MSCs and 
detected by Western blot (Fig. 13B). This result shows the direct interaction between 
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T-antigen and p53 proteins. Similar intensity of the signal for Large T in the input and 
anti-p53 IP suggests that a large proportion of T-antigen is in the unbound state. At 
the same time p53 was highly enriched in anti-Large T IP showing that the most of 
p53 is bound to the T-antigen. Upon deinduction both of the components of the 
complex were not detected in the cells. 
p27 is a negative regulator of the cell cycle and it forms a complex with 
cyclins D and E upholding the cells in G1 check-point. The p27 expression is usually 
elevated in the senescent cells (Kato, Matsuoka et al. 1994; Polyak, Lee et al. 1994). 
Western blot analysis showed the increase of p27 level in the deinduced BM MSCs 
and its downregulation after re-induction. At the same time cyclin D1 was 
accumulating in the non-proliferating deinduced cells, reflecting the formation of the 
inhibitory complex p27-cyclins. Nevertheless, after re-induction of the cells the 
expression of D1 returned to the same level as in the initial induced state (Fig. 13A). 
 Taken together, we have observed the main changes in the cell cycle 
regulators mediating Large T-antigen-induced immortalization (Ahuja, Saenz-Robles 
et al. 2005). Importantly, those changes were reversed after T-antigen deinduction in 
a strong concordance with the cell proliferation and the expression of T-antigen itself. 
Re-induction led to the “immortal” state of the cell cycle machinery again. All those 
data reveal that conditional immortalization of cells is functioning according to the 
well-described classical T-antigen mechanism. The advantage of the conditional 
system makes it possible to deinduce immortalization and revert the expanded cells 
to their initial state at least without obvious alterations associated with cell cycle 
progression. 
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3.2. Properties of conditionally immortalized BM MSCs 
 
Conditionally immortalized BM MSCs were established from transgenic irtTA-
GBD*-TAg mice by induction with Dex/Dox, or alternatively from irtTA-TAg mice by 
Dox induction. The cells were proliferating as stable lines maintaining the properties 
typical for BM MSCs. To verify the identity of the cell lines we analysed the 
expression of surface antigens by flow cytometry, their ability to support 
haematopoietic stem cells and their differentiation potential in vitro. 
 
3.2.1. Expression of surface antigens  
Conditionally immortalized BM MSCs were analyzed for the expression of 
surface markers by flow cytometry (Fig. 14A, B). Antigens with different cellular 
functions and with known pattern for the expression in human BM MCSs were 
chosen for the analysis. The cells were found to be homogeneously positive for the 
proteins involved in the adhesion of stromal cells CD9 (p24), CD44 (HCAM, 
hyaluronan receptor), CD49e (α5-integrin). Conditionally immortalized MSCs were 
negative for the markers responsible for adhesion and migration of haematopoietic 
and endothelial cells CD34 (sialomucin) and CD146 (MCAM). Conditionally 
immortalized MSCs expressed receptors for growth factors CD140b (PDGF receptor 
β) and Sca-1 (stem cell antigen). The cells were negative for the signal transduction 
molecules and chemokine receptors of haematopoietic cells CD45 (leukocyte 
common antigen, LCA), CD117 (c-kit, receptor for stem cell factor SCF), CD184 
(SDF1-receptor, CXCR4), CD271 (p75, NGFR), Flk-1 (VEGF-R2).  
Murine BM MSCs are generally poorly characterized for the marker 
expression. We found that the profile of the surface markers was similar to the known 
markers for human BM MSCs with some minor changes. For example, CD146 
(MCAM) is often used as a marker for multipotent human BM MSCs (Sacchetti, 
Funari et al. 2007), despite murine cells appeared to be negative. At the same time, it 
is often reported that similar stem cell types from different species are different in 
marker expression. For example, mouse embryonic stem cells are different in the 
expression of SSEA1 and SSEA4 from their human counterparts (Henderson, Draper 
et al. 2002). The commonly accepted markers for murine haematopoietic stem cells 
are CD34-/CD38+ whereas human HSCs have phenotype CD34+/CD38- (Spangrude, 
Heimfeld et al. 1988; Baum, Weissman et al. 1992).  
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The expression of markers was similar in the cells induced with Dex/Dox 
(n=7) and for the Dox-induced cells (n=6) indicating that dexamethasone did not 
have influence on the antigen expression (Fig. 14C). The markers were also not 
changed when the cells were deinduced for 3 days, showing that Dox and 
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combination of Dex/Dox, and the expression of Large T-antigen itself do not change 
this property of BM MSCs. Importantly, the expression of surface antigens was not 
altered during long-term passaging (passage 9 versus passage 21).  
Taken together, our data suggest that conditional immortalization does not 
influence the marker expression, and conditionally immortalized BM MSCs can be 
used as a relevant model for surface marker characterization of murine stromal cells. 
 
3.2.2. Support of haematopoietic stem cells in vitro 
 An important systemic function of bone marrow stroma is to support 
haematopoiesis in vivo (Dexter 1982; Friedenstein, Latzinik et al. 1982; Patt, 
Maloney et al. 1982; Bianco, Robey et al. 2008). As a reflection of this property BM 
MSCs can re-create the haematopoietic niches also in in vitro conditions, thus 
supporting haematopoietic stem cells (HSCs) and their repopulation potential, and 
expansion/differentiation of the committed progenitors in co-culture. 
One of the functional quantitative tests for the interaction of the BM MSCs 
with HSCs is Cobblestone-Area Forming Cells assay (CAFC). HSCs can settle 
between the layer of stromal cells and the tissue culture dish forming phase-dark 
clusters of cells that can be visualized under the microscope and counted (Olesen, 
Tonder et al. 2001; van Os, Dethmers-Ausema et al. 2008).  
Conditionally immortalized BM MSCs from two irtTA-GBD*-TAg mice 
(induction with Dex/Dox) were checked for their ability to support HSCs in CAFC 
assay (Fig. 15). The experiment was performed in collaboration with Manja Wobus, 
Prof. Bornhauser group, Uniklinikum, Dresden. BM MSCs were expanded upon 
induction of Large T-antigen and then deinduced for at least 3 days before the assay 
to stop proliferation. CD34+ HSCs were sorted form the human mobilized peripheral 
blood using CD34-conjugated magnetic beads and seeded onto the confluent layer 
of BM MSCs. The CAFC areas were counted after 8 days (endpoint of the 
experiment). 2-3 areas of CAFC per well of 24-well plate for both BM MSC lines were 
observed. Thus, conditionally immortalized BM MSCs can support HSCs in vitro and 
maintain this property after induction of Large T-antigen. 
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3.2.3. In vitro differentiation potential of conditionally immortalized BM 
MSCs 
One of the characteristic properties of BM MSCs in vitro is their ability to 
differentiate into the cells of mesenchymal lineages: osteocytes, adipocytes and 
chondrocytes (Prockop 1997; Pittenger, Mackay et al. 1999; Colter, Sekiya et al. 
2001). In vitro differentiation of BM MSCs is believed to reproduce closely those 
processes taking place in vivo and can be used as an appropriate model to study 
their mechanisms. Conditionally immortalized BM MSCs were tested for their 
differentiation potential. The cells were expanded upon induction of Large T-antigen, 
deinduced to stop the proliferation, and then differentiated using the known protocols 
for human BM MSCs. Conditionally immortalized BM MSCs from both transgenic 
mouse lines irtTA-GBD*-TAg (Dex/Dox induction) and irtTA-TAg (Dox induction) 
were used in the experiments to exclude the influence of Dex during the induction 
period. 
 
3.2.3.1. Osteogenic differentiation 
 Conditionally immortalized BM MSCs were differentiated to the osteogenic 
lineage using the medium containing Dex, β-glycerophosphate and ascorbic acid. 
The cells were proliferating during the first 5-7 days (the expansion of progenitors 
phase) and then stopped divisions (the differentiation phase). The cells secreted 
dense protein matrix and started mineralization after 7 days of differentiation. The 
accumulation of mineralization was monitored using Alizarin Red staining (Fig. 16A, 
B) and quantified by extraction of the dye with guanidine chloride solution and 
measurement of optical density at 490 nm. The maximum of mineralization was 
reached between 21-28 days of the differentiation (terminal stage). The expression of 
 
78 
osteocyte markers such as Msx2, osterix, RUNX2, osteopontin and osteocalcin was 
detected by RT-PCR from day 14 (Fig. 16C). 
 The osteogenic potential was compared for the cells of the same line on the 
earlier passage (p11) and after the long-term culturing (p23). The kinetics of 
mineralization and osteocyte marker expression was similar between the samples. 
Hence, the osteogenic potential was not changed after expansion of the cells in 
culture indicating that conditional immortalization does not influence the 
differentiation properties of those cells and the cells do not undergo spontaneous 
differentiation during passaging. 
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3.2.3.2. Adipogenic differentiation 
 Conditionally immortalized BM MSCs were differentiated to adipogenic 
lineage using the medium containing Dex, insulin, methyl-isobutyl-xanthine (MIX) and 
indomethacin. The cells changed the morphology to flat large polygonal shape and 
started accumulating the oil drops visible from day 3-4 (Fig. 17A). Adipocytes were 
visualized using Oil Red staining. The efficiency of adipogenic differentiation was 
expressed as a percent of mature adipocytes from the total cell number, or as an 
optical density of Oil Red extracted with isopropanol from the stained samples. The 
differentiation proceeded till day 10, when it reached its maximum (the result after 10 
days is not shown). The expression of adipocyte markers was monitored by RT-PCR 
before and after 4, 7 and 10 days of differentiation. The transcript level of important 
regulators of adipogenesis such as PPARγ2, C/EBPβ and C/EBPδ was increasing 
during the course of differentiation. C/EBPα was found already in undifferentiated 
cells and then during differentiation as well. The markers of mature adipocytes such 
as adiponectin and adipsin were expressed from day 4, PEPCK was detected later, 
from day 7. In vitro-derived adipocytes belonged to the white and not brown adipose 
tissue-type indicated by the absence of UCP-1 expression. 
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 Similarly to the osteogenic differentiation, adipogenic potential of BM MSCs 
was compared for the cells that have proceeded different number of passages (Fig. 
17A-C).  The efficiency and the kinetics of differentiation were very close between 
the cells on the passage 11 and passage 23. The expression of the markers between 
samples was also almost not different. This shows that conditional immortalization 
does not influence the differentiation capacity of those cells and the cells do not 
loose adipogenic potential spontaneously during passaging. 
 
3.2.3.3. Chondrogenic differentiation 
 Conditionally immortalized BM MSCs were differentiated to chondrocytes by 
forming aggregates in low serum conditions (1%) and in the presence of TGF-β1, 
Dex, ascorbic acid and insulin. The starting numbers of the cells were 5x104, 105, 
5x105 or 106. The aggregation of cells was achieved by micromass or cell pellet 
method (details explained in the Material and Methods section). The cells formed 
dense nodules, which were increasing in size only in the presence of TGF-β1. The 
differentiation was tested after 10 and 23 days for the expression of the cartilage 
matrix components aggrecan and collagen II by RT-PCR and immunostaining (Fig. 
18). The cells were positive for those markers from the day 10 of differentiation, 
increasing the level of transcript and the area and intensity of the antibody staining at 
the later stages. The aggregates showed lacunal structure typical for cartilage on the 
histological sections. The extracellular matrix contained proteoglycans characteristic 
for cartilage as shown by alcian blue staining. The efficiency of differentiation was 
dependent on the starting cell number according to the transcripts level and the 
intensity of the antibody staining. The chondrocyte formation was more efficient 
starting with 106 cells comparing to 5x104, 105 or 5x105 cells (Fig. 18B, RT-PCR). 
 
 Summarizing the results described above, conditionally immortalized stromal 
lines established from the bone marrow maintain the properties to differentiate in 
vitro into the cells of mesodermal origin providing the evidence for their identity of BM 
MSCs. 
 We could differentiate BM MSCs from both transgenic mouse lines irtTA-
GBD*-TAg and irtTA-TAg into osteo-, adipo- and chondrocytes indicating that the 
presence of Dex during induction of immortalization does not change differentiation 
capacity (result not shown). 
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Importantly, the differentiation capacity (at least toward osteocytes and 
adipocytes) was not changed during the long passaging in the cell culture conditions 
showing the stability of properties of the conditionally immortalized BM MSCs lines.  
Interestingly, we have observed variation between isolates from different mice 
in terms of the efficiency of differentiation. In many cases the cells from males were 
more efficient for osteogenesis and less efficient for adipogenesis in vitro than the 
cells from females (result not shown).  
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3.2.4. Genetic modifications of conditionally immortalized BM MSCs 
 Genetic manipulation of primary cells is often inefficient and represents an 
obstacle for generating reporter lines that can be used for gene function studies. Due 
to the low proliferative potential the establishment of stably transduced somatic cells 
is almost an impossible task. One of the advantages of conditional immortalization is 
an easy expansion of stably transfected clones after their establishment. Additionally, 
DNA integration is usually more efficient in proliferating cells. 
 Conditionally immortalized BM MSCs were checked for the transfection ability 
using lipofection and electroporation. Both induced (+Dex/Dox) and deinduced (-
Dex/Dox for 3 days) cells were tested in the experiment. The cells were transfected 
with different amount of CAGGs-GFP-IRES-puro-pA construct and checked for GFP 
expression by flow cytometry after 48 hours (Fig. 19A, B). BM MSCs under induction 
showed high transfection efficiency using both methods (up to 30-40% of GFP-
positive cells). At the same time deinduced non-proliferative cells showed maximum 
10% of transfected cells using lipofection. Deinduced BM MSCs had very low 
survival after electroporation and only few cells were found to be GFP-positive (up to 
3%). 
 We were able to select conditionally immortalized BM MSCs electroporated 
with CAGGs-GFP-IRES-neo construct and to expand stably transfected GFP-positive 
clones (Fig. 19C). The frequency of the transgene integration was estimated as 1 in 
5x103 – 5x104 electroporated cells. 
 Notably, we were able to transfect stably bacterial artificial chromosomes 
(BACs) in conditionally immortalized BM MSCs using lipofection (result not shown). 
Taken together, conditional immortalization provides a useful tool for genetic 
manipulation of the somatic cells. 
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3.3. Establishment of conditionally immortalized populations of CFU-
F’s from bone marrow 
The existence of clonogenic cells (colony forming unit-fibroblasts, CFU-F’s) in 
the bone marrow which can re-build bone and haematopoietic tissue after ectopical 
transplantation has been shown years ago (Friedenstein, Chailakhyan et al. 1974; 
Friedenstein, Gorskaja et al. 1976; Patt, Maloney et al. 1982; Owen and Friedenstein 
1988). The transplant could be passaged through the series of hosts, thus those cells 
possess self-renewal and differentiation properties. The size of new-forming marrow 
tissue correlated to the number of CFU-F’s. This brought up the idea that CFU-F’s 
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are bona fide self-renewing mesenchymal stem cells or at least the closest 
descendants of them. 
Most of the works on CFU-F’s were performed on the cells from human bone 
marrow; at the same time isolation of their mouse counterparts is problematic due to 
the low proliferation capacity (Sacchetti, Funari et al. 2007; Morikawa, Mabuchi et al. 
2009). The aim of this chapter was to obtain conditionally immortalized populations of 
murine CFU-F’s and explore their differentiation potential.  
 
3.3.1. Establishment of CFU-F’s 
Bone marrow was flushed out from femurs and tibia of 5 transgenic irtTA-
GBD*-TAg mice and plated to the tissue culture dishes at high density (~5x106/cm2) 
and at low density (104/cm2 and 105/cm2), separately for each mouse. The cells at the 
high density (bulk population) were induced with Dex/Dox for Large T-antigen 
expression and they proliferated as stable immortalized lines. 
Plating of the bone marrow at the low density resulted in appearance of the 
cell colonies; at least most of them were single-cell derived (colony-forming units-
fibroblasts, CFU-Fs). We counted from 78 to 360 CFU-F’s on the 10cm dish for bone 
marrow from different mice when plated at 105/cm2. At the lowest density (104/cm2) 
only 6-21 CFU-F’s per 10cm dish grew. The frequency of CFU-F’s in the bone 
marrow varied between mice and was not due to the sex or age, and was estimated 
as from 10-5 to 7x10-5 in the total bone marrow (Table 1). 
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Nevertheless, it was not possible to expand the CFU-F’s further since they 
showed senescent phenotype and stopped growing. Dex/Dox were added to the 
medium to induce Large T expression. The proliferation of the cells was observed, 
and after 14 days the CFU-F’s were picked to 96-well plates (from 5 to 8 CFU-F’s 
from each mouse). CFU-F’s were picked from the dishes with the lowest density, 
presuming that they were derived from single cells and represent clones. 
Immortalized cell lines were established from all picked CFU-F’s. 
 
3.3.2. Differentiation assay of CFU-F’s 
 Conditionally immortalized stromal lines of MCSs were derived from the bulk 
populations of bone marrow cells from 5 mice (further called as “stromal lines” or “BM 
MSCs”). Alternatively, populations from clonogenic cells (CFU-F’s) were established 
from the same mice. The single-cell derived clones were individually picked and 
expanded by induction of Large T-antigen in the presence of Dex/Dox (those CFU-
F’s descendants are mentioned further in the text as “immortalized CFU-F’s”). The 
stromal lines (n=5) and immortalized CFU-F’s (totally n=27 from 5 mice) were tested 
for their differentiation into osteogenic and adipogenic pathways (Fig. 20), 
chondrogenic differentiation was not analyzed. The differentiation was performed and 
evaluated as described in the previous section. 
The analysis of BM MSCs showed that 4 out of 5 lines exhibited both osteo- 
and adipogenic potentials (“OA”). One line was not efficient to differentiate to 
adipocytes and could be differentiated only to osteocytes (“O”). We found diversity in 
differentiation potential between the immortalized CFU-F’s. All possible combinations 
of two differentiation pathways were found: bipotential osteo-adipogenic populations 
(“OA”, 8/27 clones), and monopotential osteogenic (“O”, 17/27 clones) and 
adipogenic populations (“A”, 2/27 clones).  
We observed that the correlation between the properties of the stromal line 
and CFU-F’s derived from one mouse was not always strong. “OA” lines were 
correspondent to “OA”, “O” and “A” CFU-F’s.  
At the same time, although the stromal line derived from mouse 6423 was 
osteogenic (“O”), we identified one adipogenic CFU-F (“A”). This might reflect the 
diversity of the cells within the bone marrow, and even in case of the dominating of 
osteogenic progenitors in the stromal bulk population, adipogenic cells are still 
present. 
Our results revealed heterogeneity within CFU-F’s compartment in terms of 
multipotentiality. These data suggests possible hierarchy in CFU-F’s organization, as 
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only a fraction of CFU-F’s is multipotent. Still, growth in density-insensitive mode can 
be an attribute for the stem cells, but not sufficient ground of stemness. Our in vitro 
observations are confirmed by some recent literature data showing that not all CFU-
F’s are multipotent in transplantation assays (Kuznetsov, Krebsbach et al. 1997; 
Sacchetti, Funari et al. 2007; Nifontova, Svinareva et al. 2008). 
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3.4. Heterogeneity of bone marrow stromal cells 
 
Conditionally immortalized BM MSCs were established from transgenic irtTA-
GBD*-TAg or irtTA-TAg by induction of SV40 Large T-antigen, and subsequently 
characterized. We showed that conditionally immortalized BM MSCs maintain the 
properties of primary stromal lines. Even though the culture conditions are not 
identical to the “niche” environment, the cultured cells represent the most available 
model to study their biological properties. We applied conditionally immortalized lines 
as a system to study the bone marrow stroma. 
We also obtained and immortalized CFU-F’s (Colony Forming Units-
Fibroblasts) from mouse bone marrow, and found heterogeneity within CFU-F’s 
population. This showed the existence of different types of mesenchymal progenitors 
in the bone marrow. At the same time, bone marrow stromal lines varied in 
differentiation potential indirectly showing that they might represent a mixture of 
progenitors with different ratio between different types. 
For comprehensive analysis of bone marrow stromal cells we tried to dissect 
the population of BM MSCs at the single-cell level, to establish single-cell derived 
clones from immortalized lines and to compare their properties. 
 
3.4.1. Establishment of the single-cell derived clones of BM MSCs 
Conditionally immortalized BM MSCs were cloned by manual dilutions (line 
1556, irtTA-GBD*-TAg, Dex/Dox induction). The cells were seeded to 96-well plates 
in the dilutions 1, 5 and 10 cells/well. The growth of clones was observed from the 
4th day after plating. The single-cell origin of the clone was considered visually as a 
single colony of the regular round shape in the well. Totally, 66 out of 288 seeded 
wells contained clones after plating 1 cell/well (22.9% efficiency), most of them raised 
from single cells. The plating of 5 and 10 cells per well resulted in higher efficiency 
(61.4% and 82.3% respectively), at the same time the majority of the wells contained 
more than one clone. Only the clones derived from single cells were picked and 
expanded. 
Alternatively, we performed cellular cloning using FACS with the line 4190 
(irtTA-TAg, Dox induction). 1 cell was introduced to each well of 96-well plate. To 
improve cell survival after the procedure, the medium used for cell sorting had been 
conditioned by the same cells and the plates after the sorting were gently centrifuged 
to let the cells to settle down. In parallel we performed cellular cloning by manual 
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dilutions. The number of clones was analyzed after 12 days. 34,8% of the wells 
seeded by FACS contained clones, visually raised from single-cells. The manual 
dilutions resulted in 39,8% of wells with the clones, and a small proportion of them 
contained more than one clone (around 1/10). The clones from FACS sorting were 
picked and expanded. 
Hence, single-cell derived clones of stromal cells can be established from 
conditionally immortalized BM MSCs. 
 
3.4.2. Differentiation assay of the single-cell derived clones of BM MSCs 
 Single-cell derived clones obtained from the line 1556 (irtTA-GBD*-TAg, 
Dex/Dox induction) were expanded and assayed for the differentiation potential to 
osteogenic, adipogenic and chondrogenic lineages (Fig. 21). The cells were cultured 
in 96-well plates, split using multi-channel pipette, and the replicates were frozen 
directly in 96-well plates. The osteogenic and adipogenic differentiation were 
performed in 96-well format. For chondrogenic differentiation the cells were 
expanded till the required number. The differentiation was carried out using the 
protocols for the stromal lines described in the previous section. Totally 30 clones 
were tested.  
Osteogenic differentiation was done at least in triplicates. The cells were 
stained with Alizarin Red (Fig. 21B), and the efficiency of differentiation was 
evaluated visually (positive/negative staining). The final potency of the clone 
(efficient/non-efficient for the given pathway) was considered only if the differentiation 
was reproducible in all the attempts, without variation. We found 18 out of 30 clones 
to have osteogenic potential. 6 clones were non-osteogenic, and 6 clones gave non-
reproducible results. 
Adipogenic differentiation was performed in tri- or quadruplicates as well. 
Adipocytes were stained with Oil Red and assessed visually. 11 clones out of 30 
were found to be adipogenic and 15 – non-adipogenic. For 4 clones the result was 
poorly reproducible. To confirm the result, total RNA was extracted from the 
differentiated cells and checked by PCR with primers for markers of adipocytes, 
adiponectin and adipsin, after reverse transcription reaction (Fig. 21C). 
Chondrogenic differentiation was performed once, and those 18 clones that 
had defined osteo-adipogenic potential were taken into analysis. The aggregates 
after differentiation were sectioned and stained with antibodies for aggrecan and 
collagen II, and with Alcian Blue dye. The efficiency was estimated by observing the 
area of positive staining. All samples with positive staining acquired cartilage-specific 
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lacunal structure. Additionally, RNA was extracted from differentiated cells and RT-
PCR was performed for aggrecan expression (Fig. 21D). The results were consistent 
between the section staining and PCR. Totally, 12 clones were found to be efficient 
for chondrocyte differentiation and 6 clones were negative. 
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Taken together the results of differentiation into 3 lineages, we have identified 
the single-cell derived clones of BM MSCs with different properties (Fig. 21E): tri-
potential (“OAC”, 8 clones), bipotential osteo-chondrogenic (“OC”, 2 clones) and 
adipo-chondrogenic (“AC”, 2 clones), monopotential osteogenic (“O”, 3 clones) and 
adipogenic (“A”, 1 clone), and clones that did not exhibit differentiation capacity (2 
clones). 
Thus, single-cell derived clones of stromal cells vary in differentiation 
potential and might represent distinct populations of progenitor/stem cells. These 
results confirm heterogeneity of the bone marrow stromal cells. 
 
3.4.3. Subcloning of single-cell derived populations of BM MSCs and 
differentiation assay 
 Conditionally immortalized subpopulations of BM MSCs were obtained by 
manual dilutions and expansion of the clones. These subpopulations showed distinct 
differentiation potential suggesting that they represent different types of progenitors 
or intermediates from bone marrow stroma. Single-cell origin implies homogeneity of 
the subpopulations, which is required for the analysis of those cells. On the other 
hand, expansion of the cells in vitro might cause spontaneous differentiation and 
variation in characteristics. In order to check the homogeneity of the cells 
populations, the clones of conditionally immortalized BM MSCs were subjected to the 
second round of cloning and analyzed for the differentiation potential (Fig. 22). 
Six clones of BM MSCs with defined differentiation potential were used for the 
second round of cellular cloning by manual dilutions. At first we concentrated on the 
analysis of osteogenic and adipogenic pathways, which are easier to perform in the 
large scale. In terms of osteogenic (“O”) and adipogenic (“A”) properties, the clones 
were: “OA” (2 clones), “O” (2 clones) and “A” (2 clones). The resulted cell populations 
will be referred as “subclones” further in the text. Up to 24 subclones of each clone 
were picked into the 96-well plate, expanded and analyzed for osteogenic and 
adipogenic differentiation (Fig. 22B, C). The differentiation was analyzed visually 
using color staining with Alizarin Red and Oil Red, respectively. A large proportion of 
the subclones reproduced the differentiation properties of the parental clone (up to 
96%, clone 1C, 23/24 subclones). Hence, the clones of BM MSCs subjected for the 
subcloning represented homogeneous populations with stable differentiation 
potential. 
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 To make the analysis of differentiation more comprehensive we tested 
chondrogenic potential (“C”) for the limited number of the subclones (in total n=51). In 
terms of differentiation into three lineages, the initial clones were “OAC” (22 
subclones tested), “OC” (12 subclones), “AC” (8 subclones) and “O” (9 subclones). 
The cells were expanded till the required amount and differentiated using the pellet 
culture (more detailed in Materials and Methods). The resulted three-dimensional 
structures were sectioned, stained with Alcian Blue, and the analysis was done 
visually by the intensity of staining. We found that many of the subclones had the 
same potential as the parental clone. The summary of differentiation of the subclones 
into three lineages is presented on Fig. 23A. The results for “O”, “A” and “C” lineages 
were calculated separately. We counted the number of the subclones, which had the 
given potential (“+”) and which are not efficient for it (“-“). We calculated the rate of 
the subclones reproducing the property of parental clone, which means the percent 
of the efficient subclones (“+”) if the initial clone was capable for this pathway, or 
alternatively the percent of inefficient subclones (“-“) if the initial clone was not 
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capable for this pathway. This percent reflects how stable this property is in culture 
and how homogeneous the clone is. We found osteogenic and adipogenic 
differentiation to be highly reproducible (90.2% and 92.2%, respectively). The 
chondrogenic differentiation was less reproducible; from the total number of 
subclones 74.5% had the property of the parental clone. As a result, we identified the 
subclone with new bipotential “OA” property, which were not presented within the 
initial clones. 
Taken together, the second round of cloning showed that the clonal lines of 
BM MSCs represent homogeneous populations of cells with inherited stable 
differentiation potential. We observe some variability between the subclones, mostly 
in chondrogenic capacity. There could be different explanations for the reduced 
stability of this property. First of all, chondrogenic differentiation is difficult to perform 
and the efficiency can vary between the experiments. Moreover, there is lack of 
efficient protocols for the mouse BM MSCs and those ones for human might not give 
the reliable result. Second, the chondrogenic differentiation occurs at the low level of 
serum and is more efficient in hypoxic conditions, whereas the normal culturing 
environment (10% FCS, 21% oxygen) might influence the chondrogenic properties of 
the cells.  
Nevertheless, the high level of reproducibility of osteogenic and adipogenic 
potentials indicates homogeneity of the clones and proves their single-cell origin. We 
conclude that the isolated populations represent conditionally immortalized 
progenitors/stem cells with defined potential. Since the subclones often showed high 
efficiency of differentiation (when it is positive) and might be considered as more 
“pure” populations with higher confidence of differentiation properties, we decided to 
use populations of the subclones for the further experiments. The final panel of the 
subclones with defined properties is represented on Fig. 23B.  
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3.4.4. Expression of the surface markers in different subpopulations of 
BM MSCs progenitors 
 We established conditionally immortalized single-cell derived subpopulations 
of BM MSCs representing different types of progenitors/stem cells. These 
subpopulations were identified by the screening of differentiation potential of the 
large number of clones. Direct isolation or sorting of particular progenitor types 
cannot be achieved because the specific markers for BM MSCs and/or their 
subgroups are not known. The subclones of conditionally immortalized BM MSCs 
were tested for the expression of the surface markers for characterization and 
comparison. 
 Flow cytometry analysis for 12 markers was performed with 6 different 
subclones of conditionally immortalized BM MSCs. The differentiation properties of 
the subclones were: “OAC” (clone 8C-12A), “OA” (clone 8C-2B), “AC” (clone 1C-1A), 
“OC” (clone 5A-12A), “O” (2B-3A) and “A” (clone 1C-3A). The subclones showed 
similar pattern of the surface markers expression between each other, and not 
different from the initial stromal line of BM MSCs from which they were derived 
(Table 2). This result confirms that most of the known markers are homogeneously 
expressed in BM MSCs despite the presence of different subsets of the cells and 
cannot be used to enrich the population for individual cell types. The specific markers 
of bone marrow progenitors need to be further investigated. 
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3.4.5. Different subpopulations of BM MSC progenitors support HSCs in 
vitro 
Bone marrow represents a complex system consisting of closely interacting 
haematopoietic cells and supportive stroma (Dexter 1982; Krebsbach, Kuznetsov et 
al. 1999; Gregory, Prockop et al. 2005). One of the main functions of bone marrow is 
haematopoiesis whereby HSCs provide the source for all blood cell lineages and 
MSCs supply the signals for regulation and maintenance of haematopoiesis. 
Currently it is not exactly known which components of stroma support 
haematopoiesis. Different models of the niche of HSCs have been proposed, 
consisting of vascular cells or osteoblasts (Calvi, Adams et al. 2003; Zhang, Niu et al. 
2003; Arai, Hirao et al. 2004; Avecilla, Hattori et al. 2004; Kiel, Yilmaz et al. 2005). 
Also the role of bone marrow adipocytes in the regulation of haematopoietic 
differentiation was discussed in the literature (Naveiras, Nardi et al. 2009). Hense, it 
is not excluded that different cell types within bone marrow stroma regulate different 
processes of haematopoiesis providing homeostasis of the blood system. 
CAFC assay (described in the section 2.2) was done with the clonally 
established lines of different progenitors from the bone marrow (Fig. 24). The 
experiment was performed in collaboration with Manja Wobus, Prof. Bornhauser 
group, Uniklinikum, Dresden. The differentiation properties of the progenitors were 
“OAC”, “OA”, “OC”, “AC”, “O”, “A” (“O” - osteogenic, “A” - adipogenic, “C” - 
chondrogenic). The initial stromal line was also included in the experiment. Human 
CD34-positive HSCs isolated from mobilized peripheral blood were seeded onto the 
confluent layer of BM MSCs and cobblestone areas were counted after 8 days, as 
summarized in the table. The number of CAFC’s was relatively low in all the cases, 
which might be explained by the differences in the inter-species interactions of 
mouse stromal cells and human HSCs. Nevertheless, many clones supported HSCs 
in vitro (“OAC”, “OA”, “AC”, “A”), with slightly higher number for multipotent clones. 
Surprisingly, only the clones retaining the adipogenic potential supported CAFC 
formation, and clones “OC” and “O” did not show any cobblestone formation, 
although their ability to support CAFC might not be completely excluded because of 
the relatively low statistics in this experiment. Another possibility might be that 
osteoblastic components have different function in haematopoiesis regulation, and 
promote quiescent state of HSCs rather than proliferation, or lineage differentiation 
rather than maintenance. 
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Taken together, different components of bone marrow stroma can support 
HSCs in vitro and their proliferation. The differences in the progenitor functions can 
be further investigated. 
 
 
 
3.5. Regulation of differentiation of mesenchymal stem/progenitor 
cells by GSK3 and Wnt/β-catenin pathway 
 
Our studies confirmed the heterogeneity of progenitors in the bone marrow. 
The regulatory pathways of differentiation of stromal cells have been extensively 
studied, however little is known about the mechanisms of lineage priming or cell fate 
choice. Essentially canonical Wnt signaling is involved in the development of skeletal 
tissues and possibly has a role in the molecular switch between osteo/adipogenesis 
(Davis and Zur Nieden 2008; Ling, Nurcombe et al. 2009; Muruganandan, Roman et 
al. 2009). Therefore it was particularly interesting to explore and compare the 
function of Wnt/β-catenin pathway and its central regulator GSK3 in the progenitors 
with distinct differentiation potential. 
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3.5.1. Functional inhibition of GSK3 in BM MSCs 
 GSK3 is the central regulator of canonical Wnt signaling and at the same time 
it is involved in the number of different cellular regulation pathways (Nelson and 
Nusse 2004). The studies of GSK3 function often include the application of inhibitors, 
which might exhibit different activity, specificity and toxicity for the cells (Wagman, 
Johnson et al. 2004). One of the most often applied GSK3 inhibitors is lithium 
chloride (LiCl). However lithium is not highly potent or selective since it might inhibit 
other kinases such as casein kinase 2 (CK2) and MAPK-activated protein kinase 2. 
Pharmacological agent BIO ((2'Z,3'E)-6-Bromoindirubin-3'-oxime) is another 
synthetic GSK3 inhibitor, but might be toxic for the cells from certain concentrations. 
Relatively recently another small molecule, Chiron inhibitor (CT99021), started being 
widely used because of its high selectivity to GSK3. We applied these 3 inhibitors to 
the cells in the further experiments in order to specify the effect to GSK3 function.  
To determine the optimal conditions for GSK3 inhibition and activation of Wnt 
downstream genes we performed luciferase reporter assay using pGL3 BAR 
construct containing Firefly Luciferase reporter gene under control of twelve 
TCF/LEF tandem elements (Biechele and Moon 2008), Fig. 25A. Conditionally 
immortalized BM MSCs and 293 control cells were seeded in 96-well plates and co-
lipofected with pGL3 BAR (30ng/well) and Renilla luciferase expression construct as 
a control of transfection efficiency (5ng/well). The visualized control of transfection 
was CAGGs-GFP expression plasmid lipofected in the separate well. At the moment 
of transfection different conditions were applied to the cells to inhibit GSK3: LiCl (0, 
1, 5, 10, 20, 30mM), BIO (0, 1, 3, 5, 7, 10µM) and Chiron inhibitor, CT99021 (0, 0.5, 
1, 3, 5, 10µM).  Firefly and Renilla luciferase activity were measured in the cell 
lysates prepared after 48 hours of transfection and GSK3 inhibition. The activity of 
TCF/LEF elements was calculated as Firefly activity normalized to transfection 
efficiency represented by activity of Renilla (Fig. 25C).  
 All tested GSK3 inhibitors activated TCF/LEF elements in 293 and BM MSCs 
in concentration-dependent manner. The maximum response of BM MSCs to LiCl 
was detected at the concentration of 10mM, further increase of the concentration 
caused the drop of the activity correspondent to the observed toxicity to the cells. 
BIO showed maximum of activation at 5µM, higher concentrations were found to be 
very toxic for the cells. Chiron inhibitor was the less toxic for the cells and caused the 
highest response compared to the other GSK3 inhibitors in the tested range of 
concentrations. 
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 Hence, downstream Wnt/β-catenin targets can be induced by application of 
GSK3 inhibitors in BM MSCs, and the optimal concentrations were determined as 
10mM for LiCl, 5µM for BIO and 10µM for Chiron inhibitor. 
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3.5.2. Activation of Wnt/β-catenin target promoters by inhibition of GSK-
3 in conditionally immortalized BM MSCs 
Different lines of conditionally immortalized BM MSCs were tested for the 
ability to activate Wnt downstream targets. BM MSCs used for the experiment were: 
line 4190 irtTA-TAg (Dox induction), 6472 line irtTA-GBD*-TAg (Dex/Dox induction), 
and 1556 line irtTA-GBD*-TAg (Dex/Dox induction) on the earlier passage (p11) and 
on the later passage (p23). The assay was performed as described before, using the 
concentrations of inhibitors determined in the previous section. 
All of the checked BM MSC lines were able to activate Wnt/β-catenin 
downstream targets upon inhibition of GSK3 (Fig. 26A). The cells on the different 
passages did not exhibit significant difference in the response to inhibitors. Notably, 
the basal activity of TCF/LEF binding sites in the cells was virtually absent. 
 
3.5.3. Activation of Wnt/β-catenin target promoters by inhibition of GSK-
3 in conditionally immortalized clonal progenitors/stem cells from 
BM MSCs 
 The subpopulations of progenitors/stem cells from BM MSCs were 
established from single cells and purified by two rounds of cellular cloning. As was 
described before, by screening of differentiation in vitro into osteo-, adipo-, 
chondrocytes we identified populations capable for “OAC”, “OA”, “AC”, “OC”, “O” and 
“A” lineages. Since Wnt/β-catenin pathway is involved in the regulation of 
differentiation of BM MSCs and often suggested as the mechanism for the lineage 
switches, it was particularly interesting to compare the clones for the ability to 
activate TCF/LEF promoter elements. 
 The experiment was performed with one clone of each differentiation property 
and the initial stromal line of BM MSCs (1556, irtTA-GBD*-TAg). The reporter assay 
was performed as described before, and GSK3 was inhibited by LiCl. The activity of 
TCF/LEF binding sites was represented as the reporter activity (Firefly luciferase) 
normalized to the transfection efficiency (Renilla luciferase), Fig. 26B. All the 
populations of progenitors/stem cells showed ability to activate Wnt targets, with 
slight variation in the efficiency. Nevertheless, there was no significant difference in 
the rate of response to LiCl, neither correlation with the differentiation properties of 
the cells. Similar result was obtained in the independent experiment using CT99021 
(result not shown). Also all the clones did not exhibit the basal activity of Wnt/β-
catenin pathway.  
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3.5.4. Role of GSK3 during adipogenic differentiation of BM MSCs 
The negative regulation of adipogenesis by Wnt/β-catenin signaling is 
extensively explored using different models, such as 3T3-L1 adipogenic fibroblasts or 
mice (Ross, Hemati et al. 2000; Bennett, Ross et al. 2002). We tried to investigate 
the role of canonical Wnt and GSK3 in BM MSCs and different types of progenitors 
from bone marrow during adipogenic differentiation using GSK3 inhibitors. We 
considered BM MSCs as more biological relevant model than fibroblasts to study 
adipogenesis. Furthermore, cultured cells allow attributing the effects to the particular 
cellular processes and states, which is more difficult to conclude using mice. 
An important note is that it is not possible to distinguish different functions of 
GSK3 by application of the inhibitors, and we cannot assign the observations solely 
to the activation of Wnt/β-catenin pathway. We could not apply Wnt3a conditioned 
medium in our experiments because it caused significant cell death. The role of 
GSK3 in the other pathways during adipogenesis has to be considered. 
 
3.5.4.1. Block of adipogenesis by GSK3 inhibitors 
Adipogenic differentiation was performed in conditionally immortalized 
stromal line from irtTA-GBD*-TAg mouse (Dex/Dox induction). Inhibitor of GSK3 LiCl 
was applied during differentiation (Fig. 27A). The cells without GSK3 inhibition 
formed efficiently adipocytes, in contrast LiCl blocked completely differentiation even 
during prolonged adipogenic stimulation (up to 21 days). However, adipocytes 
appeared in the differentiated culture after withdrawal of LiCl showing that the block 
of differentiation was reversible. 
To determine the role of GSK3 in different types of progenitors the inhibitors 
LiCl, BIO and CT99021 were applied during adipogenic differentiation. The clonal 
lines capable to adipogenesis were used in the experiment (“OAC”, “OA”, “AC” and 
“A”). After 10 days adipocytes were readily formed in the differentiation conditions. 
Presence of any of GSK3 inhibitors completely blocked the differentiation (Fig. 27B). 
This shows that the effect was attributed to GSK3 function. Hence, active GSK3 is 
needed for the adipogenic induction in the progenitors with different potential. 
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3.5.4.2. Requirement of GSK3 activity during adipogenic differentiation 
The differentiation in vitro proceeds through the steps of the lineage 
commitment of the cells and terminal differentiation, when the cells irreversibly 
acquire the specialized phenotype. To determine the stage of adipogenic 
differentiation when GSK3 is essential, the time course experiment was performed 
(Fig. 28). The single-cell derived lines of progenitors with potential for adipogenesis 
were used and the properties of the cells were “OAC”, “OA”, “AC” and “A”. 
Adipogenic differentiation was induced for 10 days. The cells were fixed and stained 
with Oil Red on the days 0, 3, 5, 7 and 10 to observe the dynamics of differentiation. 
The efficiency of differentiation was estimated by the optical density of the dye 
extracted from the stained samples. The inhibitors of GSK3 LiCl, BIO and CT99021 
were applied on the different days of stimulation: day 0, 3, 5 or 7. On the day 10 of 
the experiment the cells were fixed and stained with Oil Red (Fig. 28A). 
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The cells in the adipogenic conditions were gradually proceeding 
differentiation, increasing both the number of adipocytes and the size of oil drops till 
they reached terminal phenotype, as monitored by fat accumulation. In the presence 
of inhibitors differentiation was completely blocked. Inhibition of GSK3 at the 
intermediate stages caused stop of differentiation at the state when inhibitors were 
applied, and the results were reproducible for three reagents (LiCl, BIO, CT99021), 
Fig. 28B. Measurement of accumulated oil confirmed, that differentiation did not 
progress anymore as soon as the inhibitor is added (Fig. 28C). Some variations in 
quantification of the efficiency can be explained by toxicity of the chemicals to the 
cells because the cell death was detected, but it did not change the main 
conclusions. Similar results were observed for all the clones included in the 
experiment. 
These results show that active GSK3 is needed for adipogenesis on every 
stage. The inhibition of GSK3 does not cause the adipocyte death, but prevents 
further progression in the differentiation.  
Another conclusion can be drawn that Wnt/β-catenin pathway and/or GSK3 
are rather implicated in negative regulation of adipogenic differentiation than 
maintaining of pre-adipocytes in the undifferentiated state, otherwise differentiation 
would proceed in the presence of GSK3 inhibitors once induced. This is in 
concordance with the previous results that TCF/LEF target sites are inactive in BM 
MSCs without exogenous stimulation.  
 
3.5.5. Role of GSK3 during osteogenic differentiation of BM MSCs 
Studies of mutant mice and phenotypes of human patients indicate that 
Wnt/β-catenin signaling is critically involved in bone homeostasis, possibly through 
the regulation of BM MSC differentiation (Krishnan, Bryant et al. 2006; Baksh, Boland 
et al. 2007; Liu, Vijayakumar et al. 2009). The implication of canonical and non-
canonical Wnt’s in binary switch between osteo/adipogenic pathways is often 
discussed. However, the data from mice and in vitro cultured cells from different 
sources are not always in concordance. We addressed a question about the role of 
GSK3 and Wnt/β-catenin signaling in osteogenic differentiation of bone marrow 
progenitors/stem cells using conditionally immortalized single-cell derived lines. 
Osteogenic differentiation was performed in clonally established BM MSCs 
progenitors with or without GSK3 inhibitors. We observed large proliferation defect in 
the cells critically influencing the efficiency of osteogenic differentiation. The effect 
was especially prominent during the first days of differentiation correspondent to the 
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stage of progenitor expansion. To avoid this problem we applied inhibitors at the later 
stages of differentiation. Nevertheless, it was not always possible to achieve similar 
cell concentration for all of the lines included in the experiment and the conclusions 
were not always drawn from the whole panel of the cell lines.  
The osteogenic differentiation was induced in the clones with osteogenic 
properties (“OAC” and “OC”). GSK3 inhibitor LiCl was added after 5 and 10 days of 
differentiation. After 28 days of differentiation the cells were fixed and stained with 
Alizarin Red, and the efficiency was quantified by measurement of optical density of 
the extracted dye. We observed that inhibition of GSK3 with LiCl during 
differentiation of osteogenic clones resulted in the increase of mineralization, 3.4-fold 
when added on day 10 and 9.3-fold when added on day 5 (Fig. 29A).  
To confirm that the effect was due to GSK3 function, different inhibitors (LiCl, 
BIO, CT99021) were applied to the clone “OAC” after 22 days of osteogenic 
differentiation. On the day 27 the cells were checked for the efficiency of 
differentiation. All three reagents, LiCl, BIO and CT99021 resulted in the increase of 
mineralization 2.2 - 3.7 fold, indicating that indeed inhibition of GSK3 caused 
enhancement of osteogenic differentiation (Fig. 29B). 
Following those results we checked the potential for osteogenesis of “AC” 
and “A” clones (non-osteogenic in the regular conditions) upon GSK3 inhibition. We 
applied GSK3 inhibitors (LiCl, BIO or CT99021) from the day of induction of 
osteogenic differentiation, and observed that inhibition of GSK3 did not change the 
lineage commitment (Fig. 29C). 
Taken together, our results indicate that active GSK3 is not required for 
osteogenic differentiation of bone marrow progenitors, at least in vitro. Activation of 
canonical Wnt resulted in the enhancement of osteogenic differentiation. At the same 
time, the role of canonical Wnt might be stage-specific, since we noticed different 
effects when GSK3 inhibitors were applied from the start or during the course of 
differentiation. Finally, we haven’t observed that Wnt/β-catenin signaling can cause 
the switch of the lineage fate of non-osteogenic cells. 
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3.5.6. Activity of Wnt/β-catenin target genes during the early induction 
of differentiation 
In the previously described experiments we observed the effect of GSK3 
inhibitors added exogenously during BM MSC differentiation in vitro. Inhibition of 
GSK3 stimulated osteogenesis and blocked adipogenesis. To determine whether this 
regulation pathway is utilized endogenously in the cell during differentiation and 
whether it is mediated by Wnt pathway, we monitored TCF/LEF activity in the cells 
during the differentiation. 
The experiment was performed with the single-cell derived clones of 
progenitors (“OAC”, “OA”, “OC”, “AC”, “O”, “A”), the initial stromal line 1556 (Dex/Dox 
induction), and 293 cells were included as a control. The cells were seeded in 96-
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well plates, osteogenic and adipogenic differentiations were induced. After 2 days the 
cells were transfected with reporter construct for TCF/LEF promoter activity, as 
described before. Differentiation conditions were maintained. For positive control the 
cells were treated with CT99021. 2 days later the cells were lysed and luciferase 
activity was measured. In all of the cells under differentiation conditions there was no 
significant increase of the reporter over basal activity (numbers are not shown). 
During this experiment the differentiation was induced for 4 days. At this 
stage we observe the appearance of adipocytes in the adipogenic cultures, and in 
the osteogenic conditions the cells might be already committed to the osteogenic 
lineage. The absence of Wnt activity during the first stage of differentiation leads to 
several conclusions. First of all, non-adipogenic clones (“OC” and “O”) are prevented 
from adipocyte differentiation not through the activity of Wnt, despite Wnt was shown 
to be negative regulator of adipogenesis. The block happens through another 
mechanism. Second, at least on the early stage of osteogenic differentiation the cells 
(“OAC”, “OA”, “OC”, “O”) do not activate Wnt signals. Moreover, as was discussed 
before, adipogenic progenitors do not activate Wnt to keep undifferentiated. One 
possible explanation might be that GSK3 is indeed involved in those processes but 
through different signaling pathways. On the other hand, Wnt pathway might be 
responsive in those cells and utilized during development of the tissues in response 
to extracellular signals, but BM MSCs do not utilize Wnt signaling for regulation of 
differentiation by themselves. 
 
3.6. Regulation of adipogenic commitment in BM MSC progenitors 
  
The adipogenic differentiation is regulated by at least two families of 
transcription factors, C/EBP (CCAAT/enhancer-binding proteins) and PPAR 
(peroxisome proliferator-activated receptors). The important knowledge about the 
mechanism of adipogenic induction is rising from the studies of clones of NIH 3T3 
fibroblasts (L1 and F422A) specifically selected by the ability to form adipocytes in 
vitro (Green and Meuth 1974). According to the currently accepted model C/EBPβ 
and C/EBPδ cooperate together to induce C/EBPα and PPARγ expression. In turn, 
C/EBPα and PPARγ sustain the expression of each other and control the entire 
terminal differentiation process, Fig. 2, reviewed by (Rosen, Walkey et al. 2000; 
Farmer 2006). Additionally, it was shown that Krox20 (Egr2, early growth response 2) 
 
108 
might be upstream of C/EBPβ and could be one of the earliest regulators of 
adipogenic commitment. Klf5 (Krueppel-like factor 5) was identified as a factor, which 
is induced by C/EBPβ, and then participates in PPARγ initiation in association with 
C/EBPβ;C/EBPδ (Chen, Torrens et al. 2005; Oishi, Manabe et al. 2005).  
  The aim of this chapter was to dissect the process of adipogenic commitment 
and differentiation of BM MSCs. First, we analysed the factors, which control 
adipogenic potential of the undifferentiated stromal cells by comparing their 
expression in non-adipogenic versus adipogenic progenitors. Second, we tried to 
identify the mechanism of adipogenic commitment of BM MSCs in vitro. Third, we 
attempted to find the factors, which are able to convert non-adipogenic progenitors to 
adipogenic lineage. The use of BM MSCs to study mechanisms of differentiation and 
lineage commitment can give a new insight to this field of knowledge. 
 
3.6.1. Expression of adipogenic regulators during differentiation of BM 
MSCs into adipocytes 
Conditionally immortalized BM MSCs were differentiated into adipocytes for 
10 days. Expression of adipocyte markers and transcription factors involved in 
adipogenesis was analysed in undifferentiated cells and after 4, 7 and 10 days of 
induction by RT-PCR (Fig. 30A). Adipocyte differentiation was confirmed by the 
expression of adiponectin and adipsin from day 4 of induction. PPARγ1 was present 
at mRNA level from undifferentiated cells through the whole course of differentiation. 
Adipose tissue-specific PPARγ2 appeared at detectable level after 7-10 days of 
differentiation. C/EBPα mRNA was expressed at high level in all the samples. 
C/EBPβ, C/EBPδ and Klf5 were present as transcripts in undifferentiated cells, 
increasing their expression during differentiation. Krox20 was shown in 
undifferentiated cells and terminally differentiated adipocytes as well. 
 Expression of PPARγ, C/EBPα, C/EBPβ and C/EBPδ at the protein level was 
analysed by Western blot in undifferentiated cells and after 3 and 10 days of 
differentiation (Fig. 30B). PPARγ1 was detected at low level in the undifferentiated 
cells, and it was upregulated during the differentiation. We detected only PPARγ1 
isoform, but not PPARγ2 due to the specificity of the antibody (Abcam, ab41928). 
C/EBPα was found at low level in BM MSCs and the expression highly increased 
during differentiation. Both isoforms, 42kDa and 30kDa, were detected. C/EBPβ 
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expression was shown in all the samples at similar level. We could detect the three 
known isoforms for C/EBPβ - 38kDa, 32kDa (liver-activatory protein, LAP) and 
21kDa (liver-inhibitory protein, LIP), (Ramji and Foka 2002). Interestingly, 
undifferentiated cells expressed mostly the large isoform 38kDa, and during 
differentiation two other isoforms were detected. C/EBPδ was not expressed at a 
detectable level in undifferentiated cells (in some independent experiments we could 
detect a weak band), but its expression was highly increasing during the 
differentiation. 
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 We observed some discrepancy in PPARγ1 and C/EBPα expression at the 
transcript and at the protein levels. mRNAs were present at similar levels in 
undifferentiated and differentiated cells, whereas the proteins increased many fold 
during differentiation. This might be an indication of post-transcriptional regulation of 
PPARγ1 and C/EBPα expression. 
 
3.6.2. Expression of adipogenic regulators in the single-cell derived 
progenitors from BM MSCs 
 Single-cell derived clones of BM MSC progenitors were obtained by two 
rounds of cellular cloning of stromal line from transgenic irtTA-GBD*-TAg mouse 
(Dex/Dox induction). The clones were tested for differentiation, as described before, 
and the populations with different potential were found. 
 In order to identify the factors important for adipogenic commitment of the 
cells, the clones were tested for the expression of the main adipogenic regulators 
(Fig. 31). Undifferentiated cells from the initial stromal line 1556 and progenitors with 
adipogenic potential (“OAC”, “OA, “AC” and “A”) and without adipogenic potential 
(“OC” and “O”) were deinduced for 3 days by Dex and Dox withdrawal to eliminate 
the influence of Dex and T-antigen to the cells. Total RNA and proteins were isolated 
from the cells for the expression test. RT-PCR revealed the presence of transcripts of 
PPARγ1, C/EBPα, C/EBPβ, C/EBPδ, Klf5 and Krox 20 (Egr2) in all of the cells. 
PPARγ2 was absent in those conditions.  
 We performed Western blot to confirm the expression of the factors at the 
protein level (Fig. 31B). We observed differences from the result of RT-PCR analysis, 
and between the clones. PPARγ1 was found at the higher level in “AC” and “A” 
clones and at the lower level in “OAC”, “OA” and the stromal line. At the same time 
we could not detect PPARγ1 in non-adipogenic clones (“OC” and “O”) by Western 
with any of the two antibodies (anti-PPARγ1, γ2, E-8, Santa Cruz, and anti-PPARγ1, 
ab41928, Abcam). PPARγ2 was absent in all the clones. C/EBPα was expressed in 
“OAC”, “OA”, “AC” and “A” clones, and weaker in the stromal line. In non-adipogenic 
clones (“OC” and “O”) C/EBPα was not detectable. We found the expression of 
C/EBPβ in all the clones at the comparable level. C/EBPδ was not detected by 
Western blot in this test, although we observed a weak expression in the 
undifferentiated cells in the independent experiments. In any case we haven’t 
observed the difference in C/EBPδ level between the clones with different potential. 
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 Our results revealed the differential expression of PPARγ1 and C/EBPα in 
undifferentiated BM MSC progenitors with adipogenic potential compared to non-
adipogenic clones. The important role of those factors in the adipogenesis was 
known before (Tontonoz, Hu et al. 1994; Rosen, Sarraf et al. 1999; Wu, Rosen et al. 
1999; Rosen, Hsu et al. 2002). Our observations might be an indication that those 
transcription factors are involved in the commitment of the cells towards the 
adipogenic lineage. Taken into account that “OAC” and “OA” clones expressed both 
factors, it is very possible that PPARγ1 and C/EBPα “direct” the cells into adipogenic 
fate and not “restrict” from the osteogenic. It is unlikely that C/EBPβ and C/EBPδ play 
a role in the adipogenic commitment of the cells, because they were expressed 
similarly in the cells with different properties. 
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3.6.3. Commitment to adipogenic differentiation in the clonally derived 
BM MSC Progenitors 
In order to find the factors critical for adipogenic commitment in BM MSCs we 
tried to dissect the mechanism of adipogenic stimulation in vitro. The known 
conditions for adipogenic differentiation of BM MSCs, 3T3-L1 fibroblasts and mES 
cells include (1) glucocorticoids, which have at least two known functions, to induce 
the expression of C/EBPδ and to activate the heterodimer complex C/EBPβ;C/EBPδ 
that stimulates PPARγ and C/EBPα expression; (2) PPARγ agonist troglitazone for its 
activation and (3) insulin to support the expression of adipogenesis-related genes, 
Fig. 2 (Tontonoz, Hu et al. 1994). We applied different combinations of 
dexamethasone (Dex), insulin (Ins) and troglitazone (Tro) to BM MSCs to find 
minimal conditions capable to induce adipogenic differentiation in the cells. 
We used the cells of adipogenic clone (“AC” properties) and non-adipogenic 
clone (“OC” properties) for the experiment (Fig. 32). The medium containing the 
single effector (Dex, Ins, Tro), combination of two (Dex/Ins, Ins/Tro, Dex/Tro) or all 
three compounds (Dex/Ins/Tro) was applied for 10 days to the cells. Adipocyte 
formation was shown by Oil Red staining and amount of bound Oil Red was 
quantified spectrophotometrically at OD510. Adipocyte differentiation was observed 
only in the cells of adipogenic clone. None of the inductors could stimulate 
adipogenesis in the clone, which was identified as non-adipogenic before. 
We found that Tro is necessary for the adipocyte formation in adipogenic 
clone. We observed very low number of adipocytes in the cells treated with Tro alone 
or in combination Ins/Tro, and much enchanced in Dex/Tro conditions. Complete 
adipogenic conditions (Dex/Ins/Tro) led to the most efficient differentiation. Taking 
into account that non-osteogenic clone did not express PPARγ, we assume that 
activation of PPARγ is necessary and sufficient to stimulate adipogenesis in BM 
MSCs. 
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To determine the specific changes induced by Dex, Ins or Tro, we checked 
the expression of the main adipogenic markers and regulators by RT-PCR and 
Western blot in the cells cultured in different combinations of those compounds (Fig. 
33A). In order to specify, which of the regulators could be triggering for the 
adipogenic programm, we compared the effects of different conditions on the cells 
between the clone capable for adipogenesis and non-adipogenic clone.  
The expression of adiponectin and adipose-specific PPARγ2 mRNA was 
found consistently in the conditions where we observed adipocyte formation (“AC” 
clone - Tro, Ins/Tro, Dex/Tro and Dex/Ins/Tro). At the same time the expression of 
PPARγ1, C/EBPα and Krox20 was similar in the adipo- and non-adipogenic clones in 
all conditions, according to RT-PCR. RT-PCR analysis revealed the mRNA 
expression of C/EBPβ, C/EBPδ and Klf5 in all of the analysed cells, which increased 
in the conditions including Dex, especially pronounced for C/EBPβ and C/EBPδ.  
To verify the protein content, we analysed the expression of PPARγ1 
C/EBPα, C/EBPβ and C/EBPδ by Western blot (Fig. 33B). PPARγ1 was present at 
low level in the adipogenic clone, and increased upon adipocyte formation (slightly in 
Ins/Tro, and highly in Dex/Tro and Dex/Ins/Tro). Notably, the expression of PPARγ1 
was markedly increased during the Dex/Ins treatment, despite no adipocyte 
formation was observed. At the same time PPARγ1 could not be induced in the non-
adipogenic clone after any treatment. 
C/EBPα was expressed in the undifferentiated adipogenic cells. The level of 
expression was increasing, if Tro is present in the medium, and hence PPARγ1 is 
active (conditions Tro, Ins/Tro, Dex/Tro, Dex/Ins/Tro). The highest content was 
observed, when adipocytes were efficiently formed (Dex/Tro, Dex/Ins/Tro). 
Therefore, in the adipogenic cells PPARγ1 upregulation by itself was not sufficient to 
enhance C/EBPα (conditions Dex/Ins), but the activation of PPARγ1 with Tro 
stimulated C/EBPα. The osteogenic clone did not express C/EBPα in the 
undifferentiated state. However, in the presence of Dex C/EBPα was detected at the 
low level (Dex, Dex/Tro, Dex/Ins/Tro, and very weakly Dex/Ins). 
C/EBPβ was expressed in the adipogenic and non-adipogenic clones 
exposed to different conditions, although at lower level in the non-adipogenic cells. 
We detected an increase in C/EBPβ level after the Dex treatment. 
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C/EBPδ was weakly expressed in the untreated adipogenic and non-
adipogenic clones. As expected, the content was highly increased after the Dex-
containing conditions were applied in both types of progenitors consistent with the 
increase of the transcript (conditions Dex, Dex/Ins, Dex/Tro, Dex/Ins/Tro). Especially 
significant was the increase in the efficiently differentiated cells. 
Notably, the level of C/EBPβ and C/EBPδ in the adipogenic clone was 
comparable after the treatment with single Dex (no adipocyte formation) and with 
Dex/Tro or Dex/Ins/Tro (efficient adipogenesis) indicating that C/EBPβ;C/EBPδ 
complex cannot trigger the cells into adipocyte conversion. The fact that the cells of 
non-adipogenic clone were able to upregulate C/EBPβ;C/EBPδ in response to Dex 
supports our conclusion that C/EBPβ;C/EBPδ does not commit the cells to become 
adipocytes. 
Taken together, we observed that Dexamethasone upregulates C/EBPβ and 
C/EBPδ, and the complex C/EBPβ;C/EBPδ in the presence of Dex stimulates the 
expression of C/EBPα. These events can occur in both, adipogenic and non-
adipogenic clones, although at lower level. Insulin alone does not influence the levels 
of expression of the main adipogenic regulators. But in the presence of Dex 
activating the C/EBPβ;C/EBPδ complex, insulin results in upregulation of PPARγ1 in 
the adipogenic cells. However, only further activation of PPARγ1 with Troglitazone 
can promote adipogenesis. Importantly, non-adipogenic clone failed to express 
PPARγ1 at the protein level in any conditions. 
Summarizing our observations with the result of the previous experiment (6.2, 
Fig. 31), we don’t see the evidence that C/EBPβ and C/EBPδ determine the 
adipogenic commitment of BM MSC progenitors. C/EBPα was expressed only in the 
undifferentiated adipogenic cells, and not in the non-adipogenic, but it was inducible 
in both types of progenitors, although at lower level in non-adipogenic clone. PPARγ1 
expression was distinctive for the adipogenic clone, which explains the 
responsiveness of this clone to Troglitazone. We attribute the role of the main 
adipogenic determinant in BM MSCs to PPARγ, despite the level of C/EBPα might 
also have an influence.  
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3.6.4. Converting of osteogenic BM MSC progenitors into adipogenic 
lineage 
 The experiments on activation of adipogenesis in non-adipogenic cells by 
ectopical expression of transcription factors were performed by different groups 
before (Tontonoz, Hu et al. 1994; Wu, Xie et al. 1995). These studies had a large 
impact on elucidating the transcriptional network controlling adipogenesis. 
Nevertheless, the mechanism of the lineage commitment of BM MSC progenitors still 
has to be unraveled. We tried to overexpress the main factors regulating 
adipogenesis in the osteogenic cells and checked their ability to differentiate into 
adipocytes. 
 
3.6.4.1. Validation of the expression constructs 
 The expression constructs were obtained from different sources as listed 
below: PPARγ1 and PPARγ2 from Addgene kindly provided by Bruce Spiegelman 
group, C/EBPβ, LIP and C/EBPδ from Addgene kindly provided by Peter Johnson 
group, and C/EBPα and Klf5 from the commercial source (Geneservice). C/EBPβ, 
LIP and C/EBPδ cDNAs were cloned in pcDNA3.1(-) plasmid backbone under CMV 
promoter and carried neomycin resistance gene. PPARγ1 and PPARγ2 were in pSV 
Sport plasmid backbone under control of the SV40 promoter, and C/EBPα and Klf5 
were in pCMV Sport6 under control of the CMV promoter, all without eukaryotic 
resistance genes. In order to include a eukaryotic selection marker, the plasmids 
were modified by exchange of the ampicillin resistance gene to the PGK-neo-pA or 
PGK-BSD-pA cassettes using recombineering (not shown in details). Finally, we 
obtained two expression constructs for each of PPARγ1, PPARγ2, C/EBPα, Klf5 
cDNAs, carrying neo or BSD resistance. With these modifications the constructs can 
be used for generating stable lines. 
 The constructs were tested in 293 cells for the protein expression (Fig. 34). 
The cells were lipofected with circular plasmids (3µg/9.5cm2 well), CAGGs-GFP-
IRES-puro-pA was used as a control for transfection. Whole cell extracts were 
prepared from the cells 48 hours after transfection. Western blot confirmed the 
expression of given proteins and functionality of the constructs. 
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3.6.4.2. Transient overexpression of transcription factors during 
adipogenic differentiation 
We have analysed the expression of transcription factors important for 
adipogenesis in undifferentiated cells and during differentiation in the previous 
experiments. In order to identify the factors capable of trigerring adipogenesis, we 
performed transient overexpression of the factors in the cells and induction of 
adipogenic differentiation. The adipogenic differentiation is visible in the cell culture 
conditions after 3-4 days, which made it possible to perform the experiment using 
transient transfection without selection of stable transfectants. We used single factors 
(PPARγ1, PPARγ2, C/EBPα, C/EBPβ, C/EBPδ and Klf5) and in combinations, which 
might have cooperative effect: PPARγ2 + C/EBPα; C/EBPα + C/EBPβ; C/EBPβ + 
C/EBPδ; C/EBPα + Klf5; PPARγ2 + C/EBPα + C/EBPβ + C/EBPδ. 
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The cells of osteogenic (“OC” properties) and adipogenic clones (“AC”) were 
seeded into 6-well plates and lipofected with 5 µg of circular plasmids (Fig. 35). 
CAGGs-GFP-IRES-puro-pA was used as a control for the transfection and further for 
the differentiation. Next day adipogenic conditions were applied. The cells were 
examined visually for adipocyte appearance 4 days later. At this time point RNA was 
isolated and checked for the marker expression by RT-PCR. 
At the day of analysis, differentiation of the cells in the positive control 
(adipogenic clone) was clearly recognized. In osteogenic cells transfected with GFP 
(negative control) adipocytes were not detected. We have observed adipocyte 
formation in the non-adipogenic cells transfected with C/EBPα, C/EBPβ, C/EBPδ, 
and consequently in all the combinations that included those factors (Fig. 35C). The 
efficiency was lower than in the positive control, nevertheless this can be explained 
that not every cell was transfected and that the levels of overexpressed proteins 
might vary. We also observed that adipogenic clone was differentiated with similar 
efficiency in all the transfections, indicating that the increase of those factors did not 
affect differentiation properties of the cells, neither stimulating nor inhibiting, and also 
was not toxic (results not shown). 
We performed RT-PCR to check the expression of markers at mRNA level 
(Fig. 35D). We showed the expression of adipocyte markers, such as adiponectin, 
adipsin and PPARγ2 in the cells overexpressing C/EBPα, C/EBPβ and C/EBPδ, in 
which we observed morphological adipocytes. This confirms their differentiated 
status and identity of adipocytes. We detected weak upregulation of adiponectin (but 
not adipsin) in PPARγ1- and to a less extent in PPARγ2-transfected cells, suggesting 
that those factors indeed might lead to adipogenic differentiation but less efficiently in 
our experimental conditions. The transcripts for PPARγ1, C/EBPα, C/EBPβ, C/EBPδ 
and Klf5 were found in all the samples. In some cases (PPARγ2 and C/EBPβ) we 
have seen an increase of the transcript in the cells, which were transfected with 
these constructs, indicating that at this time point the cells are still overexpressing the 
factors. This was not observed for all of the factors that might reflect different 
efficiency of transfection, overexpression, or stability of the construct in the cells 5 
days after transfection. 
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We conclude that factors of C/EBP family C/EBPα, C/EBPβ, C/EBPδ can 
start adipogenic programm in non-adipogenic bone marrow stromal progenitors. 
Certainly, C/EBPα, C/EBPβ and C/EBPδ play an important role during differentiation 
(Wu, Xie et al. 1995; Wu, Bucher et al. 1996). Previously (sections 6.2 and 6.3), we 
observed that non-adipogenic cells can express C/EBPα, C/EBPβ and C/EBPδ, and 
concluded that those factors are unlikely determinants of adipogenic commitment. 
Here we showed, that the overexpression of those factors could shift the cells to the 
adipogenic commitment. We can speculate that the high dose of C/EBP’s causes the 
differentiation of the cells. We also noticed that the C/EBPβ construct we used for the 
experiment led to the expression of LAP isoform (32kDa), whereas BM MSCs 
express full-length 38kDa protein and LAP increased only during adipogenic 
differentiation of BM MSCs. The role of C/EBPβ isoforms in adipogenic commitment 
should be further investigated. 
Unexpectedly, PPARγ1 and PPARγ2 alone did not support adipocyte 
differentiation of the cells. We have observed quite weak expression of the protein 
during the test of the constructs, and hence the dosage of overexpressed factor 
might not be enough for differentiation. Additionally, PPARγ1 and PPARγ2 were 
controlled by SV40 promoter, whereas all the others by CMV promoter, and the 
efficiency of the expression in the cells might be different, although we don’t have 
information about this.  
Additional experiments have to be done to elucidate the mechanism of the 
ectopical adipogenic induction, however we present the evidence that non-
adipogenic BM MSC progenitors can be converted to the adipogenic cell fate. This 
shows that non-adipogenic cells are blocked from the adipogenic differentiation not 
due to the mutations or chromosomal abberations, but via cellular regulatory 
mechanisms. 
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4. Discussion 
 
 Although bone marrow mesenchymal stem cells were discovered years ago 
(Friedenstein, Petrakova et al. 1968; Friedenstein, Chailakhyan et al. 1974; Owen 
and Friedenstein 1988), the identity of those cells is still far from understood. The 
bone marrow mesenchymal stromal cells, BM MSCs, represent a complex of 
progeny of mesenchymal stem cells functioning to support haematopoiesis and 
differentiate into skeletal tissues (Bianco, Robey et al. 2008). In the present study we 
isolated pure cell populations from the spectrum of BM MSC cell types, and 
subsequently characterized them. We aimed at elucidating the mechanisms of the 
lineage commitment and differentiation of BM MSCs and understanding the hierarchy 
of BM MSCs progeny. 
 
4.1. Generation of transgenic mice for conditional immortalization of 
primary cells 
Amongst more than 200 cell types in the organism only a limited number is 
characterized due to the rareness, lack of markers or limited ability to expand ex 
vivo. Cellular immortalization provides an important tool for expansion and 
subsequent characterization of cells. We generated a transgenic mouse for the 
conditional immortalization of primary cells described detailed in (Anastassiadis, 
Rostovskaya et al. 2010). The idea of making immortalization inducible was not new. 
The immortalization of cells is accompanied with the large changes in cell 
metabolism, which can make it difficult to interpret the results from spontaneously 
immortalized cells carrying mutations, genetically manipulated cells, or cells boosted 
with the viral oncoproteins. For those reasons, the advantage of conditionally 
immortalizing cells and going back to the initial state was taken into consideration in 
the studies using temperature-sensitive T-antigen, or transcriptionally regulated 
Large T (Radna, Caton et al. 1989; May, Hauser et al. 2004). The success of the 
reversible immortalization systems in cells made it possible to go further and produce 
transgenic mice carrying temperature-sensitive or tetracycline-controlled Large T-
antigen. A wide spectrum of conditionally immortalized primary cell lines were 
isolated from these mice (Jat, Noble et al. 1991; Yanai, Suzuki et al. 1991; 
Bendiksen, Van Ghelue et al. 2004). However, the leakiness of the system, weak 
expression of T-antigen and tumorigenicity still represented a problem for using 
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those models. We aimed to improve the performance of the system in order to make 
it tightly regulated and reliable (Anastassiadis, Kim et al. 2002). The transcriptional 
regulation using TET-ON system fulfilled these requirements. The codon optimization 
improved the expression of the rtTA (irtTA, improved rtTA) and the fusion with GBD* 
gave an additional level to control the irtTA. We were able to generate transgenic 
mice in two variations, irtTA-TAg and irtTA-GBD*-TAg. However, Large T expression 
was weakly induced in the irtTA-TAg mice. The irtTA-GBD*-TAg mice showed 
excellent properties in the T-antigen regulation and expression proving the 
advantage of the system (Anastassiadis, Rostovskaya et al. 2010). 
 
4.2. Conditional immortalization of primary bone marrow 
mesenchymal stromal cells 
 We have isolated conditionally immortalized bone marrow mesenchymal 
stromal cells (BM MSCs) from the transgenic mice. Mouse BM MSCs are known to 
have very limited proliferation potential, which is probably not associated with 
replicative senescence, but rather with the requirement of the specific extracellular 
mitogen signals (Peister, Mellad et al. 2004; Prockop 2009). The stromal cells from 
mouse bone marrow underwent 1-2 cell divisions and then stayed in the arrested 
state. The induction of Large T-antigen resulted in the extensive cell proliferation, 
which was practically indefinite (Fig. 11). We could passage the cells for at least 40-
50 passages and established large populations from single cells, meaning that the 
cells were indeed immortalized. We observed the changes in the cell cycle regulators 
in the immortalized cells (Fig. 13). SV40 T-antigen is unique in its properties to 
combine all functions required to induce cell proliferation. We have shown the 
stabilization of p53 and its direct interaction with Large T in the conditionally 
immortalized cells. We observed the downregulation of negative regulators of the cell 
cycle, such as p27, after induction of the T-antigen. But the most important fact was 
that all of the effects of T-antigen on the cell cycle were reversible upon 
induction/deinduction (Fig. 12). The proliferation of the cells was tightly dependent on 
the T-antigen expression, and could be switched on and off many times. We have 
never observed spontaneous transformation of the conditionally immortalized cells. 
Application of the tet-regulated T-antigen transgenic mice allowed us to establish a 
large number of the conditionally immortalized lines of BM MSCs, from irtTA-TAg 
(induction with Dox) and irtTA-GBD*-TAg (induction with Dex/Dox) mice. 
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4.3. Conditionally immortalized bone marrow mesenchymal stromal 
cells maintain the identity 
 The conditionally immortalized bone marrow stromal lines were characterized 
to confirm their identity. We examined the expression of surface markers and found it 
similar to the known for human BM MSCs (Fig. 14). We noticed a difference in the 
expression of CD146, MCAM, a presumable marker for self-renewing stem cells in 
human bone marrow (Sacchetti, Funari et al. 2007), which was negative in the 
conditionally immortalized mouse BM MSCs. However, to our knowledge there were 
no reports about the expression of CD146 in mouse BM MSCs, and we can attribute 
this fact to the difference between the species. Notably, the expression of markers 
was not different in the induced and non-induced state, indicating that T-antigen 
expression did not influence those characteristics of the cells. We did not observe 
significant differences between the cells from irtTA-TAg (Dox) and irtTA-GBD*-TAg 
(Dex/Dox) mice, hence, the presence of Dex in the medium did not change the 
surface marker expression. Another important observation was that markers were 
not altered after the long-term passaging.  
 The essential function of BM MSCs in vivo is to support haematopoiesis. This 
can be assessed in the in vitro co-culturing assays and after ectopic transplantation 
(Friedenstein, Chailakhyan et al. 1974; Dexter 1982). Using the cobblestone assay 
we confirmed the ability of conditionally immortalized BM MSCs to support 
haematopoietic stem cells in vitro (Fig. 15). 
The reversibility of immortalization makes it possible to perform differentiation 
assays with conditionally immortalized BM MSCs, because the differentiation is 
usually accompanied by the stop of proliferation. We tested differentiation potential of 
the conditionally immortalized BM MSCs after deinduction of the T-antigen. The 
stromal lines differentiated into osteocytes, adipocytes and chondrocytes, indicating 
that the differentiated properties were not affected by the expansion using T-antigen 
(Fig. 16-18). We didn’t observe differences in the differentiation properties between 
the BM MSC lines from irtTA-TAg (Dox) and irtTA-GBD*-TAg (Dex/Dox) mice. This is 
an important observation, because Dex is one of inducers of BM MSC differentiation, 
and Dex is constantly required to induce Large T expression in irtTA-GBD*-TAg cells. 
However, despite this disadvantage of the system we suggest that the presence of 
Dex does not change the differentiation state of the conditionally immortalized BM 
MSCs and the effect of Dex might be reversible after its withdrawal.  
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 It was often discussed in the literature, that the expression of Large T-antigen 
blocks the adipogenic differentiation of 3T3-L1 and F442A fibroblasts through the 
inactivation of CBP/p300 that is required for adipogenesis (Cherington, Morgan et al. 
1986; Cherington, Brown et al. 1988). According to other data, MEF’s expressing T-
antigen are able to generate adipocytes, but with the properties of brown adipocytes 
(Hansen, Jorgensen et al. 2004). In this study, it was suggested that Retinoblastoma 
protein acts as a regulator of the white type adipocyte development and the 
inactivation of pRb switches the fate from the white to brown types. The results of 
(Estervig, Minoo et al. 1990) demonstrate that SV40 T-antigen does not block 
adipogenesis per se, but makes it more difficult by altering of the cell cycle. In our 
study we haven’t observed the block of adipogenic differentiation of the conditionally 
immortalized BM MSCs when T-antigen is deinduced. Moreover, we could obtain 
efficient adipogenic differentiation of the cells induced for T-antigen expression 
(results are not shown). We conclude that the Large T does not perturb the 
adipogenic potential of the conditionally immortalized BM MSCs. The discrepancy 
with the data from 3T3-L1 fibroblasts can be attributed to the differences between the 
adipogenic induction in those cells and MSCs, considering the undefined identity of 
the 3T3-L1 cells.  
Importantly, the cells maintained differentiation potential after the long-term 
passaging. It was often noted that human BM MSCs change the differentiation 
properties spontaneously during the passaging, resulting in the enhancement of 
alkaline phosphatase expression and osteogenic potential (Bruder, Jaiswal et al. 
1997). In concordance to this, the clonally derived lines of human BM MSCs were 
able for osteo- and adipogenic differentiation on passage 2, but completely lost 
adipogenic properties at passage 12 and remained osteogenic (Digirolamo, Stokes 
et al. 1999). Similar observations were done by the group of R. Quarto (Banfi, 
Muraglia et al. 2000; Muraglia, Cancedda et al. 2000). The clonally derived BM 
MSCs were tested for the differentiation potential into osteo-, adipo-, chondrocytes 
on different passages. The majority of the clones had the potential for all three 
lineages, but lost the ability to differentiate into adipocytes after 22 population 
doubling (PD) times, and subsequently into chondrocytes after 24 PDs, resulting in 
the cell population with only osteogenic properties. The authors suggested that the 
observed phenomenon reflected the differentiation pathway of BM MSCs that the 
cells underwent during the culturing, and the osteogenesis might be the “default” 
lineage in BM MSC development (Fig. 35A). Therefore, the population of human BM 
MSCs is always predisposed toward osteogenic lineage during culturing in vitro. 
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Another explanation to this fact can be viewed from the observation that during 
osteogenesis BM MSCs undergo the stage of progenitor expansion and extensively 
proliferate. It was shown that the overexpression of osterix in BM MSCs resulted in 
the increased cell proliferation (Satija, Gurudutta et al. 2007). On the contrary, 
adipogenesis is accompanied with the growth cease and one of the major positive 
regulators of adipogenesis, C/EBPα, possesses an anti-mitogenic activity (Umek, 
Friedman et al. 1991). As a result, the fibroblasts overexpressing C/EBPα were 
growth arrested (Umek, Friedman et al. 1991). Hence, the cells with higher 
osteogenic potential can take an advantage over adipogenic cells during the 
passaging due to the higher proliferative potential. However, we didn’t observe any 
changes in the efficiency of differentiation after the long-term passaging, at least in 
adipo- and osteogenic properties. This might imply that (1) conditionally immortalized 
BM MSCs do not change the differentiation state spontaneously during the culturing, 
(2) the immortalized progenitors of different types proliferate with comparable rate. 
Notably, (Okamoto, Aoyama et al. 2002) made similar observations using human BM 
MSCs immortalized with hTERT and E6/E7 proteins of HPV. These cells proliferated 
without the loss of differentiation potential, and then non-osteogenic cell 
subpopulations with single adipogenic or chondrogenic potential were identified. 
Hence, immortalization might provide a tool to obtain the rare or low-proliferative cell 
types, and conditionally immortalized cells are likely not biased toward one or 
another differentiation lineage. 
In summary, we confirmed the identity of the conditionally immortalized BM 
MSCs by the expression of the markers, the ability to support HSCs and the potential 
for multilineage differentiation. We speculate that the conditional immortalization 
offers an advantage not only in the expansion of BM MSCs, but also in the 
prevention of spontaneous differentiation in the cell culture conditions.  
 
4.4. The population of mouse CFU-F’s (colony forming units-
fibroblasts) is heterogeneous 
 The main criteria for stemness imply (1) the potential for the differentiation at 
the single-cell level and (2) the ability for self-renewal. The differentiation of stem 
cells is commonly assessed in the in vitro tests confirmed further by the marker 
expression. However, the cell culture conditions may generally alter the state of the 
cells, and the cells become “adapted” to the non-physiological conditions. The most 
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rigorous examination for the differentiation of stem cells should include not only in 
vitro test, but also the differentiation in the in vivo situation, that means the 
transplantation assay. 
The self-renewal characteristic of stem cells means the ability to re-establish 
the population of identical stem cells. And of course, this is not equal to the 
proliferation in the cell culture conditions resulting in the population of the same type 
of cells. Also, an indefinite expansion of the cells in vitro cannot prove the stemness. 
Hence, the self-renewal ability can be tested in the in vivo assay (Bianco, Robey et 
al. 2008; Prockop 2009). 
The most firmly ascertained system of stem cells is undoubtedly embryonic 
stem cells. The contribution to chimeras and germline transmission provide a definite 
proof of stemness. However, it is more difficult to confirm those principles for the 
adult stem cells. The “golden standard” for stemness in the adults is a 
haematopoietic stem cell, which can reconstitute the whole haematopoietic system 
from a single cell, and be re-transplanted. One of the reasons of this “success” is a 
high turnover of the haematopoietic system that allowed the establishment of the 
reconstitution assays. 
Originally, BM MSCs were discovered by following those principles (Ashton, 
Allen et al. 1980; Friedenstein, Latzinik et al. 1982; Patt, Maloney et al. 1982). The 
plastic adherent fraction of human bone marrow plated with a low density resulted in 
single-cell derived colonies of fibroblastic cells, which could grow in a cell density-
independent manner (colony forming units-fibroblasts, CFU-F’s). The expanded 
pooled CFU-F’s could be ectopically transplanted under the renal capsule or 
subcutaneously, and in these conditions they differentiated into skeletal tissues and 
generated a niche for haematopoiesis, and could be re-established and re-
transplanted to the secondary recipients, implying self-renewal capacity. Thus, the 
population of human CFU-F’s contains “stromal stem cells” with the proven property 
of stemness. Nevertheless, the progeny of a single human CFU-F had limited 
potential to transfer the haematopoietic environment, indicating heterogeneity within 
this population (Friedenstein, Chailakhyan et al. 1987; Kuznetsov, Krebsbach et al. 
1997). Thus, CFU-F’s are considered as closest descendants of bona fide 
mesenchymal stem cells but not equal. 
Little is known about mouse CFU-F’s. To our knowledge, there is very limited 
information in the literature about the expanded mouse CFU-F’s obtained without 
pre-sorting for specific markers. From personal communications, the attempts to 
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show the self-renewal of mouse CFU-F’s so far failed and that is why only seldom 
discussed (Nifontova, Svinareva et al. 2008). That reasoned the particular relevance 
to establish expandable populations of CFU-F’s from the mice. 
Bone marrow from the transgenic irtTA-GBD*-TAg mice was plated with a low 
density and the appearance of single-cell derived CFU-F’s was observed. The 
immortalization was induced by adding of Dex/Dox to the cell culture medium. The 
individual CFU-F’s were expanded and tested for the differentiation capacity into 
osteo- and adipogenic pathways (Fig. 20). We found variability in the differentiation 
properties amongst CFU-F’s. The expanded cell populations exhibited bi-potential 
(“OA”) or monopotential (“O” or “A”) differentiation. Our observations confirm the 
heterogeneity of mouse CFU-F’s. The presence of CFU-F’s with restricted 
differentiation capacity (at least 70% from the analysis of the two pathways were 
single “O” or “A”) shows that the population of murine CFU-F’s contains committed 
progenitors, which are descendants of mesenchymal stem cells. Unlikely in the other 
studies using primary bone marrow cells, we presume that the conditional 
immortalization allows expansion of the cells without the loss of differentiation 
potential, and our results is probably not a consequence of an in vitro artifact. Thus, 
our observations likely reflect the characteristics of CFU-F’s existing within the bone 
marrow. Mouse bone marrow undoubtedly contains mesenchymal stem cells, which 
was demonstrated in the transplantation assays of bone marrow plug (Chertkov and 
Gurevitch 1980). But our data suggest that CFU-F’s represent a population of cells 
with various differentiation potential and only a subset of CFU-F’s can possess the 
properties of stemness. To our knowledge, this is a first report about the large 
screening of differentiation properties of the expanded mouse CFU-F’s. However, 
additional experiments are required for the more solid conclusion about the mouse 
CFU-F’s identity. 
 
4.5. Hierarchy of progenitors within bone marrow mesenchymal 
stromal cells 
Bone marrow stroma is a complex structure consisting of different cell types 
functionally united into one tissue. The integrity of the system is provided, firstly, by 
the functional interactions between the cells and, secondly, the common 
developmental origin. Mesenchymal stem cells are capable to generate the complete 
functioning stroma, thus, the stromal cells have a common ancestor. Therefore, the 
isolated stromal lines represent the whole spectrum of mesenchymal stem cells 
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descendants, on the different stages of differentiation and from different lineages. 
The heterogeneity of BM MSCs was reported before, and the progenitors of different 
types were found within the isolated BM MSCs (Pittenger, Mackay et al. 1999; Banfi, 
Muraglia et al. 2000; Muraglia, Cancedda et al. 2000; Okamoto, Aoyama et al. 2002). 
However, the molecular characterization of those cell types is far from 
comprehensive, and the main obstacle is in the inability to obtain reasonable 
amounts of pure cell populations for biochemical analysis. 
We isolated conditionally immortalized BM MSCs from irtTA-GBD*-TAg mice 
and expanded upon the induction of Large T-antigen. We performed cellular cloning 
and established the single-cell derived populations. The screening of differentiation 
into osteocytes (“O”), adipocytes (“A”) and chondrocytes (“C”) revealed that the 
clones had different properties for differentiation. We identified six types of clones 
that were “OAC”, “OA”, “OC”, “AC”, “O” and “A”. Hence, we confirmed the 
heterogeneity of the BM MSCs (Fig. 21). 
The heterogeneity of human BM MSCs was shown by many others 
(Pittenger, Mackay et al. 1999; Banfi, Muraglia et al. 2000; Muraglia, Cancedda et al. 
2000; Okamoto, Aoyama et al. 2002). The differentiation assays of clonally derived 
populations showed the presence of different types of progenitors. However, different 
sets of the progenitors were obtained in the studies of different groups. For example, 
the group of R. Quarto identified the clones with types “OAC”, “OC” and “O” (Banfi, 
Muraglia et al. 2000; Muraglia, Cancedda et al. 2000). The authors suggested the 
“linear” model of hierarchy in BM MSCs, in which the osteogenic pathway is the 
“default”, and adipogenic lineage segregates firstly, and the chondrogenic lineage 
separates downstream (Fig. 36A). In support to this model, it was observed that the 
cells are loosing the multipotentiality during the passaging, at first, adipogenic 
capacity, and secondly, chondrogenic (as we already discussed in the previous 
section). Similar loss of multipotentiality of BM MSCs in vitro during the passaging 
was shown by (Digirolamo, Stokes et al. 1999). However, the instability of 
differentiation properties of primary BM MSCs during the passaging questions the 
relevance of the differentiation assays of the clones. Indeed, even if the initial 
population was homogeneous, but stochastically some cells were loosing the 
differentiation capacity faster than the others, then the diverse clones would be 
isolated. The heterogeneity of the clones might reflect the in vitro artifact of 
spontaneous differentiation. To exclude this problem, the second round of cellular 
cloning should have been done, but the proliferation limitation did not allow 
performing of this experiment.  
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The conditional immortalization made it possible to expand the cells 
practically indefinitely. In order to check the homogeneity and the stability of the 
differentiation properties of the single-cell derived clones we performed the second 
round of cellular cloning and analysed the differentiation of the resulted “subclones” 
(Fig. 22 and 23). We tested more than 50 subclones for osteo-, adipo- and 
chondrogenic differentiation. The comparison of the properties of subclones with the 
parental clones showed a high rate of the maintainance of the differentiation 
potential, meaning that a large proportion of the subclones had the same potential as 
the initial clone. These results indicate that (1) the single-cell derived clones of 
conditionally immortalized BM MSCs represent homogeneous populations of cells, 
and (2) the differentiation potential of the single-cell derived clones of conditionally 
immortalized BM MSCs is stable after expansion in vitro. We assume that the 
populations identified in our study indeed reflect heterogeneity of BM MSCs in the 
bone marrow in vivo. The variation in the differentiation properties of CFU-F’s 
discussed above supports our conclusion. 
Those facts made it possible to apply the clonally derived populations of BM 
MSCs to study lineage commitment and differentiation pathways. We used the 
populations derived from the second round of cellular cloning for the next 
experiments. The multilineage potential for the differentiation allows us to name 
those cells as “progenitors” or “progenitors/stem cells”, however, considering that 
stemness of those cells is not proven in fact. 
Remarkably, similar results to ours were obtained using immortalized human 
BM MSCs (Okamoto, Aoyama et al. 2002). Human BM MSCs were immortalized by 
expression of hTERT, E6 and E7 HPV proteins and subsequently clonal populations 
were obtained. The differentiation capacities of the clones were “OAC”, “OA”, “OC”, 
“A”, “O” and “C”. “AC” clone was not identified in this study, presumably, by statistical 
reasons. These data support our observations since similar combinations of 
properties were found. 
During the preparation of this thesis, a similar approach to that we used was 
published (Russell, Phinney et al. 2010). In this study clonally derived cell 
populations were obtained from primary human BM MSCs. The authors found all 
possible combinations of differentiation properties: “OAC”, “OA”, “AC”, “OC”, “O”, “A” 
and “C”. These data perfectly agree with our results. Unfortunately, the characteristic 
of the clones did not go further and the study was presented as a developing of the 
differentiation assay and cryopreservation of the clones in 96-well plate format as a 
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success-providing unique technique, which was discovered in our group 
independently. 
It should be noted that we did not identify all the possible combinations of 
differentiation properties amongst the clones and subclones. We never observed “C” 
type of cells, but we explain it by the statistical reasons. However, the existence of all 
combinations of bi-potential progenitors (“OA”, “AC”, “OC”) shows that the hierarchy 
of BM MSC lineages can be more complicated than simple linear deterministic or 
divergence diagram (Fig. 36B). The data from immortalized and non-immortalized 
human BM MSCs support our suggestion (Okamoto, Aoyama et al. 2002; Russell, 
Phinney et al. 2010). For instance, the classical scheme of haematopoiesis implies 
that the HSCs proceed the differentiation step by step, segregating the lineages, and 
there is no way back or across the lineages. But this logic of commitment has never 
been shown for BM MSCs. The presence of “OAC”, “OA”, “OC”, “AC” clones 
suggests that osteo-, adipo- and chondrocyte lineages might exist independently in 
the cells. It is possible that during the maturation the undifferentiated progenitors 
eliminate the other possible pathways, leaving the only one possibility at the end, and 
then proceed the differentiation. In this case the way from “OAC” to “A” can happen 
through “OA” and “AC”, and the way from “OAC” to “O” can happen through “OA” 
and “OC”. Thus, the molecular signature for the osteogenic commitment in the 
“OAC”, “OA”, “OC” and “O” clones might be similar. However, this model of 
commitment is empirical and hypothetical and needs to be further proven. 
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4.6. The role of GSK3 and Wnt/β-catenin canonical pathway in BM 
MSC differentiation and lineage commitment 
 Although the data on the mechanisms of BM MSC differentiation in vitro and 
in vivo is rapidly accumulating, there is no commonly accepted model about the 
regulation of those processes. Multiple signaling pathways are considered to have an 
influence to the differentiation, amongst them canonical and non-canonical Wnt, 
BMP, MAPK, TGFβ. It is very likely that these pathways are interacting and working 
in concert. Wnt/β-catenin pathway plays an important role in the regulation of 
adipogenic and osteogenic differentiation and might be involved in the lineage choice 
in multipotential progenitors. We attempted to elucidate a role of Wnt and its central 
player GSK3 during the differentiation of BM MSC progenitors. The comparison of 
the different types of progenitors might provide information about the function of Wnt 
and GSK3 in lineage commitment. 
  The main approach we used was the inhibition of GSK3 and monitoring of 
Wnt activity using the Luciferase reporter pBAR. The application of different GSK3 
inhibitors, such as LiCl, BIO, CT99021, in parallel allowed to exclude the side effects 
on the other signaling pathways. We showed that BM MSC lines had minimal basal 
activity of the canonical Wnt, but inhibition of GSK3 activated the Wnt downstream 
target promoters many fold in a concentration-dependent manner (Fig. 25, 26). 
Similarly, the progenitors of different types did not exhibit Wnt activity, but could 
activate Wnt independently of the differentiation properties of the cells.  
Next we tested the influence of GSK3 inhibition on the differentiation into 
adipocytes and osteocytes. The application of GSK3 inhibitors during adipogenesis 
blocked the proceeding of the differentiation at any stage when the inhibitor was 
added (Fig. 27, 28). These results strongly show that active GSK3 and/or inactive 
Wnt are required to proceed the adipogenic differentiation. This is in discordance 
with the data from adipogenic fibroblasts 3T3-L1 and F442A (Ross, Hemati et al. 
2000; Bennett, Ross et al. 2002). Adipogenic fibroblasts show high Wnt basal activity 
without exogenous stimulation. It is assumed that Wnt/β-catenin pathway inhibits the 
initiation of PPARγ and C/EBPα expression and therefore maintains 3T3 fibroblasts 
in the undifferentiated state. Repression of Wnt activity promotes PPARγ and 
C/EBPα expression and the adipogenic differentiation in fibroblasts, and once 
PPARγ and C/EBPα are established, the differentiation cannot be blocked anymore. 
However, according to our data this is not the case in the BM MSCs. The 
undifferentiated state of BM MSCs is not maintained by Wnt/β-catenin and the 
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differentiation is sensitive to GSK3 inhibition at any stage. Interestingly, all types of 
the adipogenic progenitors (“OAC”, “OA”, “AC”, “A”) showed the same result. We 
assume that 3T3 adipogenic fibroblasts represent arrested preadipocytes on the late 
stage of commitment, or utilize different mechanism of adipogenic induction from BM 
MSCs due to the uncertain identity. Our model provides new information on the 
mechanism of adipogenesis in BM MSCs. 
We checked the influence of GSK3 inhibitors during the osteogenic 
differentiation of BM MSC progenitors. The inhibitors had stage-specific effects on 
the differentiation. The proliferation of progenitors during the first days of osteogenic 
induction was impaired by GSK3 inhibitors that reduced markedly the efficiency 
during the whole course of the differentiation. When applied on the later stages, 
GSK3 inhibitors increased the intensity of mineralization 3-9 fold (Fig. 29). Hence, 
GSK3 has a negative effect on the osteogenesis and/or Wnt/β-catenin might have a 
positive effect.  
We have already discussed the controversy in the literature on the role of the 
canonical Wnt in BM MSC differentiation. Whereas it is commonly accepted that 
canonical Wnt negatively regulates the adipogenesis, the effect to the osteogenesis 
was considered as positive (Kang, Bennett et al. 2007), negative (Baksh, Boland et 
al. 2007), or neutral (Takada, Mihara et al. 2007). It is difficult to compile the results 
from studies that used different models and approaches. Nevertheless, we can 
presume the reasons, which might explain the discrepancies in those data. (1) The 
effect of the canonical Wnt on the osteogenesis might be stage-specific, therefore 
the observations might be opposing. Our data indirectly support this suggestion. (2) 
The effect of the canonical Wnt on the osteogenesis might be concentration-
dependent, which is possible considering the gradients of signaling factors existing in 
the organism. Hence, the application of exogenous Wnt3a or Wnt10b might not 
reflect the physiological concentration of those factors. (3) The application of GSK3 
inhibitors does not allow separating the effect of activation of Wnt/β-catenin pathway 
from the other functions of GSK3. (4) The cells in vitro do not receive the signals 
from the normal tissue context. In summary, the precise role of the canonical Wnt/β-
catenin signaling in the osteogenesis is not known. 
However, inhibition of GSK3 did not promote osteogenesis in non-osteogenic 
clones (“AC”, “A”) revealing that it is unlikely that canonical Wnt or GSK3 participate 
in the lineage commitment of BM MSC progenitors (Fig. 29). Additionally, Wnt/β-
catenin activity was not detected in the osteogenic clones (“OC”, “O”) during the 
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attempt to induce adipogenesis. Hence, the Wnt/β-catenin pathway does not restrict 
non-adipogenic clones from adipogenic commitment. Finally, we didn’t observe an 
increase in Wnt/β-catenin signaling in the cells during osteogenesis, at least the first 
days, indicating that the cells do not stimulate themselves by Wnt. 
Taken together, we indeed observe the dual influence of GSK3/Wnt in terms 
of the inhibition of adipogenesis and the stimulation of osteogenesis. BM MSCs are 
responsive to the GSK3 inhibition during the differentiation in vitro, but we could not 
detect that they activate this pathway to control the differentiation endogenously. 
However, this is not a controversy. The progenitor cells are the parts of the complex 
tissues where they have to respond to the signals and maintain the integrity of the 
system. That is why those signals might be supplied from the other elements within 
the tissue in order to regulate or attenuate the differentiation, but not by themselves.  
It should be noted that Wnt/β-catenin signaling is often considered as a 
candidate for the determinant of the lineage choice in BM MSCs, committing the 
multipotential cells into osteogenesis in expense of adipogenic potential (Kang, 
Bennett et al. 2007; Ling, Nurcombe et al. 2009). The models used in those studies 
represent multipotential cells capable for osteogenesis and adipogenesis, and Wnt 
favored to one differentiation lineage versus another. However, the opposite 
influence of Wnt to the two alternative pathways does not imply that it’s a mechanism 
for the lineage choice. We apply different types of progenitors isolated from the same 
stromal population, which underwent the commitment step into osteo- or adipocyte 
direction. From our results, we don’t observe the evidence that Wnt participates in 
the cell fate choice in BM MSCs. 
 
4.7. The mechanism of adipogenic commitment in BM MSCs 
 The mechanism of adipogenic induction in vitro is well-described using the 
adipogenic fibroblasts 3T3-L1 and F442A, Fig. 2 (Tontonoz, Hu et al. 1994; Wu, 
Bucher et al. 1996). Nevertheless, it is often noted that L1 and F442 represent the 
cells arrested on the late stages of differentiation, pre-adipocytes. F442A are 
possibly more differentiated than L1, because Dex and insulin treatment is sufficient 
to induce adipogenesis in F442A, whereas additional stimulation of PPARγ or cAMP 
pathway is required for L1 (Wu, Bucher et al. 1996). Although these models provided 
important knowledge, they do not give information about the differentiation state of 
adipogenic progenitors from BM MSCs. 
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 Differentiation of BM MSCs into adipocytes was accompanied by the increase 
in expression levels of regulators of adipogenesis, such as PPARγ, C/EBPα and 
C/EBPδ, whereas C/EBPβ stayed at the similar level (Fig. 30). We checked which of 
those factors were expressed in the undifferentiated progenitors of different types 
(Fig. 31). We found differential expression of PPARγ1 and C/EBPα between 
adipogenic and non-adipogenic clones, and the basal level of C/EBPβ and C/EBPδ 
was similar in the cells with different properties. We assumed that PPARγ1 and 
C/EBPα might determine the adipogenic potential in BM MSCs.  
PPARγ2 isoform is specific for adipose tissue, whereas PPARγ1 is more 
abundant and widely expressed, that is why PPARγ2 is often considered as a 
regulator of adipocyte development. We haven’t detected the PPARγ2 isoform in the 
undifferentiated cells and on the early stages of differentiation, since the transcript 
was found only on the late days (day 7-10). So, presumably PPARγ1 might act as a 
regulator of adipogenesis and PPARγ2 can serve as a marker for adipocytes. This 
conclusion is in agreement with data showing that both isoforms can fulfill adipogenic 
function, but PPARγ2 has higher activity (Mueller, Drori et al. 2002). 
 We found that activation of PPARγ with its agonist Troglitazone is a minimal 
sufficient condition for the differentiation of adipogenic cells (Fig. 32). 
Dexamethasone treatment led to the induction and activation of C/EBPβ;C/EBPδ 
complex resulting in the expression of C/EBPα at the low level (all conditions 
included Dex, “OC” clone, Fig. 33B). However, those conditions were not enough for 
the adipogenic differentiation in the cells. Insulin was rather acting through a different 
pathway in parallel with C/EBP’s, because it did not influence the expression of the 
C/EBP’s and PPARγ when it was applied alone. Indeed, the role of insulin in 
adipogenic differentiation in vitro is not exactly known, possibly, it acts through the 
IGFR1 (insulin-like growth factor receptor 1) pathway (MacDougald and Lane 1995). 
But the combination of Dexamethasone and insulin resulted in an increase of 
PPARγ1 without promoting adipocyte formation. The additional activation of PPARγ1 
with Troglitazone to those conditions stimulated efficient adipogenesis. Activated 
PPARγ enhanced the expression of C/EBPα (all conditions included Tro, “AC” clone), 
but C/EBPα could not increase the PPARγ expression (all conditions included Dex, 
“OC” clone, Fig. 33B). Taken together, these data suggest that PPARγ is the main 
regulator of adipogenesis in BM MSCs. 
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 We should note that we observed the effect of Dex on the expression of 
important regulators of differentiation in the cells, and at the same time Dex had to be 
applied constantly to the cells to induce conditional immortalization of BM MSCs from 
irtTA-GBD*-TAg mice. This is a disadvantage of the irtTA-GBD* system, and we 
have to confirm our data using irtTA-TAg cells (induction with Dox). However, we 
never observed the differences between the differentiation properties of BM MSCs 
induced with Dex/Dox and Dox only. We also noted that the expression level of 
C/EBPα, C/EBPβ, C/EBPδ is changing in the presence or absence of Dex, therefore 
we assume that the Dex influence is reversible. Additional evidence for that was 
obtained using mouse ES cells carrying irtTA-GBD*-TAg system. Comparison of the 
transcription profiles of the cells before induction, during induction and after 
deinduction of the T-antigen showed that the effects of Dex/Dox on the cells were 
reversible (Anastassiadis, Rostovskaya et al. 2010). The reason to use irtTA-GBD*-
TAg cells in our study is connected to the excellent performance of this system in 
mice.  
 The role of PPARγ and C/EBPα as major regulators of adipogenesis was 
known before. Adipogenesis was stimulated in fibroblasts by the retroviral expression 
of PPARγ or C/EBPα, but it was much enhanced when PPARγ and C/EBPα were co-
expressed (Freytag, Paielli et al. 1994; Tontonoz, Hu et al. 1994). It was also shown 
that PPARγ and C/EBPα cross-regulate each other, and both of the factors are 
critical for adipogenesis (Wu, Rosen et al. 1999). The knockout cells for PPARγ or 
C/EBPα failed to undergo adipogenesis. However, it was demonstrated that 
constitutive expression of PPARγ can rescue the adipogenic properties of C/EBPα-/- 
fibroblasts, but not the other way around (Rosen, Hsu et al. 2002). Hence, PPARγ is 
a primary and essential regulator of adipogenesis. The sequence of events upstream 
of PPARγ was also explored. Conditional ectopic expression of C/EBPβ induced 
PPARγ expression and stimulated adipogenesis in non-adipogenic cells, fibroblasts 
and myoblasts, suggesting a critical role in the induction of adipogenesis (Wu, 
Bucher et al. 1996). From all those data it is difficult to conclude, which factor is the 
primary determinant of adipogenic commitment in BM MSCs.  
We assumed the role of C/EBPα and PPARγ in the adipogenic cell fate 
determination in BM MSCs due to the differential expression in adipogenic versus 
non-adipogenic BM MSCs progenitors. From the experiment above, non-adipogenic 
cells could express C/EBPα upon Dex stimulation, but they failed to express PPARγ 
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in all the conditions. Hence, we grant a primary role in the adipogenic commitment of 
BM MSCs to PPARγ. 
  
4.8. Conversion of non-adipogenic BM MSCs progenitors to the 
adipogenic lineage 
 We overexpressed transiently the main transcription factors regulating 
adipogenesis in the non-adipogenic cells (“OC” clone) and treated with adipogenic 
inducers Dexamethasone, insulin and Troglitazone (Fig. 35). We observed adipocyte 
formation in the cells overexpressing one of C/EBPα, C/EBPβ or C/EBPδ factors. 
Unexpectedly, PPARγ1 and PPARγ2 overexpression did not result in adipogenesis. 
 We conclude that factors of C/EBP family C/EBPα, C/EBPβ, C/EBPδ can 
start adipogenic programm in non-adipogenic bone marrow stromal progenitors in 
the overexpression conditions. The inability of PPARγ1 and PPARγ2 to induce 
adipogenesis can be explained by the insufficient level of the expression (as it was 
observed in the validation of the expression constructs in 293 cells, Fig. 34). 
However, these results do not oppose our previous conclusion that PPARγ is a major 
determinant of adipogenesis in the cells, and C/EBP’s are unlikely. The 
overexpression often leads to very high, non-physiological levels of the proteins, and 
this can be seen from the validation of C/EBP expression constructs. In this situation, 
the factors might cause the effects, which do not happen in the usual conditions.  
Our experiment confirms the adipogenic potential of C/EBPα, C/EBPβ, 
C/EBPδ and their role in the adipogenesis in BM MSCs. In the past, the role of 
PPARγ and C/EBP’s in adipogenesis was elucidated in the experiments using 
ectopic expression of those factors (Freytag, Paielli et al. 1994; Tontonoz, Hu et al. 
1994; Wu, Xie et al. 1995). However, there were some discrepancies in the results of 
different groups in the overexpression tests. For example, it was considered as 
difficult to obtain cells overexpressing C/EBPα due to its anti-mitogenic activity. All 
the stable clones obtained from the retroviral transfections of C/EBPα expression 
constructs into 3T3-L1 cells were negative for C/EBPα (Umek, Friedman et al. 1991). 
However, the other groups of authors reported the generation of clones from different 
lines of fibroblasts (i.e. 3T3-L1, BALB/C, NIH-3T3, Swiss 3T3, totally 10 lines) by 
retroviral expression of C/EBPα, which proliferated and could be induced for 
adipogenesis (Freytag, Paielli et al. 1994; Tontonoz, Hu et al. 1994). In the same 
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report, C/EBPβ was also transduced into the fibroblasts lines, but the cells 
expressing C/EBPβ failed in the adipogenic differentiation. It was concluded that 
C/EBPβ is not able to promote adipogenesis. However, the other studies 
demonstrated that the conditional ectopic expression of C/EBPβ in NIH-3T3 
fibroblasts converted them to preadipocytes revealing the role of C/EBPβ in the 
adipogenesis (Wu, Xie et al. 1995). In the study above only one half of the stably 
transfected clones was efficient for C/EBPβ expression and adipogenesis (4 out of 8 
shown clones), whereas the other half failed. 
In fact, overexpression of factors can provide important information about the 
mechanisms and even cause some interesting unnatural processes (for example, 
cell reprogramming, (Takahashi and Yamanaka 2006)). The chain of the reactions 
leading to the adipogenesis stimulated by C/EBPα, C/EBPβ and C/EBPδ seems to 
be important to investigate further. But overall, the conclusion about the precise role 
of the transcription factors in the cellular processes should be made avoiding the 
overexpression tests. 
Taken together, non-adipogenic BM MSC progenitors can be converted to the 
adipogenic lineage, and non-adipogenic clones are not blocked from the 
adipogenesis by mutations, loss of the chromosomes and other stochastic reasons, 
because the differentiation can be stimulated potentially. The factors of C/EBP family 
C/EBPα, C/EBPβ, C/EBPδ are powerful regulators of adipogenesis. 
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5. Summary 
 
Although the existence of mesenchymal stem cells in the bone marrow was 
confirmed years ago (Friedenstein, Petrakova et al. 1968), the identity of those cells 
still remains elusive, and the complex population of their descendants is the only 
available system to study the principles of differentiation and commitment into 
mesodermal lineages. At present, the conditions for the reliable expansion and 
maintenance of bone marrow mesenchymal stromal cells (BM MSCs) are not known, 
hence, the conditional immortalization provides an invaluable tool to study these 
cells. The transgenic mouse with improved tetracycline-regulated system of 
conditional immortalization using SV40 Large T-antigen was generated in our group 
previously (Anastassiadis, Rostovskaya et al. 2010). We confirmed the excellent 
properties of the Large T-antigen induction of those mice, and suggested as a tool for 
isolation of rare and low-proliferative cell types. We isolated BM MSCs from the 
transgenic mice and proved the maintenance of their identity. We showed the 
advantages of the system of conditional immortalization in (1) indefinite expansion of 
cell populations, (2) possibility to perform cellular cloning and (3) prevention from 
spontaneous differentiation in vitro.  
We focused our attention on the heterogeneity of the BM MSCs population. 
We demonstrated that colony forming units-fibroblasts (CFU-F’s) considered as close 
descendants of mesenchymal stem cells represent a heterogeneous population of 
progenitors with various differentiation potential. To our knowledge, this is a first 
report about the differentiation potential of the expanded mouse CFU-F’s. 
We identified 6 types of progenitors within BM MSCs population based on 
their differentiation potential (“OAC”, “OA”, “OC”, “AC”, “O”, “A”). The diversity of the 
differentiation properties within a progenitor pool suggested a complex model of BM 
MSC hierarchy. We hypothesized that the imprint for each of the three mesenchymal 
lineages (osteogenic, adipogenic, chondrogenic) might exist in the progenitors 
independently. 
The differentiation efficiency can be attenuated by the Wnt/β-catenin signaling 
pathway and GSK3 activity. We observed positive regulation of the osteogenesis and 
negative regulation of the adipogenesis in BM MSCs by the canonical Wnt. However, 
it is unlikely that Wnt is utilized endogenously by BM MSCs to trigger the cells to the 
differentiation. 
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We dissected the mechanism of adipogenic stimulation of BM MSCs in vitro 
and identified PPARγ1 as a key regulator of the adipogenesis in BM MSCs. By 
comparison of the adipogenic and non-adipogenic progenitors, we revealed that 
PPARγ1 expression determines the adipogenic potential of BM MSCs progenitors in 
the undifferentiated state. The demonstration of PPARγ1 role in the BM MSC cell fate 
determination adds more insight to the known functions of PPARγ1 in adipogenesis. 
Finally, we could convert the non-adipogenic BM MSCs progenitors to the 
adipogenic lineage using ectopical expression of the transcription factors C/EBPα, 
C/EBPβ and C/EBPδ. The mechanisms of the adipogenic induction by C/EBP’s have 
to be investigated further. 
Taken together, we enclose two major values in our study. First, we validated 
conditionally immortalized progenitor cells from the transgenic mice as a model to 
study differentiation and lineage commitment. Second, we applied an approach to 
characterize a large spectrum of mesenchymal stem cell descendants in order to 
elucidate the mechanism of differentiation and determination. Our findings provide a 
novel insight into the molecular mechanisms of BM MSC lineage commitment. 
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6. Abbreviations 
 
BM MSCs – bone marrow mesenchymal stromal cells 
CFU-F – colony forming unit-fibroblasts 
SV40 – simian virus 40  
TAg – Large T-antigen 
tet - tetracycline 
(i)rtTA – (improved) reverse tetracycline transactivator 
GBD* - mutated glucocorticoid bunding domain 
Dex - Dexamethasone 
Dox – Doxycycline 
Tro - Troglitazone 
Ins - Insulin 
O – osteogenic potential or lineage 
A – adipogenic potential or lineage 
C – chondrogenic potential or lineage 
CAFC – cobblestone area-forming cells 
Wnt – wingless-type MMTV integration site 
GSK3 – glycogen synthase kinase 3 
TCF/LEF – T-cell factor/lymphocyte enhancer factor 
PPAR – peroxisome proliferator-activated receptor 
C/EBP – CCAAT/enhancer-binding proteins 
LAP – liver activated protein 
LIP – liver inhibitory protein 
Klf5 – krueppel-like factor 5 
Egr2 – early growth response 2 
RUNX2 (Cbfa) – runt-related transcription factor 2 (core-binding factor a) 
Osx - osterix 
pRb – retinoblastoma protein 
tsA58 – temperature-sensitive Large T-antigen 
CD – cluster of differentiation 
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